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Summary
1. The aim of this study was to investigate the actions of nitric oxide (NO) 
donors i.e. nitrovasodilators, on the extracellular electrical and mechanical 
activity recorded from spontaneously active smooth muscle, in particular the 
rabbit distal colon (RDC), rabbit portal vein (RPV) and rat portal vein (rat PV), 
in vitro, using the Golenhofen apparatus. First, circular strips of RDC were 
examined for evidence of a "nitrergic" innervation.
2. Addition of carbachol (3 x 10'5M) to circular str ips of RDC mounted in a 
conventional (25ml) organ bath raised the tone to 7.73 ± 0.67g (n = 44). 
Electrical stimulation (16 pulses, l-16Hz, 0.1-0.5ms, supramaximal voltage), in 
the presence of phentolamine and propranolol (each 3 x 10_6M), produced 
frequency-dependent, non-adrenergic, non-cholinergic (NANC) neive-mediated 
relaxations and rebound contr actions.
3. NANC relaxations induced by nerve stimulation were mimicked by 
authentic NO (> 10'5M), and partially inhibited by the avid NO binding 
molecule, haemoglobin (Hb ; 3 x 10_5M), or by the inhibitor of endogenous NO 
synthesis, NG-nitro-L-arginine methyl ester (L-NAME ; 5 x 10'4M). On some 
occasions, L-NAME-induced inhibition was reversed by the precursor to NO 
synthesis, L-arginine. The response to authentic NO (2 x 10_5M) was abolished 
by Hb (3 x 10-5M).
4. Rebound contractions in response to inhibitoiy NANC nerve stimulation 
were mimicked by authentic NO (> 10_5M) and partially inhibited by L-NAME 
(5 x 1(HM) or the cyclooxygenase inhibitor, indomethacin (10"5M).
5. Unstretched, longitudinal strips of RDC mounted in the Golenhofen 
apparatus exhibited spontaneous, calcium-dependent spike bursts that were 
always accompanied by contraction. The frequency and duration of these
electrical events was 3.77 ± 0.18 bursts m itr1 (n = 80) and 7.91 ± 0.77s 
(n = 57) respectively, and each contained 7.84 ± 0.62 spikes (n = 61). The 
amplitude of the largest spike in each was 248.46 ± 28.37 pV (n = 63) while 
the amplitude of corresponding contraction was 2.21 ± 0 .13g (n = 79). 
Contractile bursts lasted for 12.23 ± 1.42s (n = 79) and each contained 
2.78 ± 0.33 mechanical peaks (n = 79).
6. Under an applied tension of lg, intact sections of RPV mounted in the
Golenhofen apparatus exhibited spontaneous spike bursts that were always
accompanied by contraction. The frequency and duration of electrical events
was 2.95 ± 0.41 bursts m iir1 (n = 5) and 7.40 ± 1.94s (n = 4) respectively, and
each contained 16.76 ±3.14 spikes (n = 4). The amplitude of the largest spike 
wqS
in each^24.67 ± 2.60 pV (n = 3) while the amplitude of corresponding 
contraction, including the lg applied, was 1.59 ± 0.2g (n = 5). Contractile 
bursts lasted for 12.17 ± 1.57s (n = 5) and each contained 1.50 ± 0.2 
mechanical peaks (n = 5).
7. Under an applied tension of lg, intact sections of rat PV mounted in the 
Golenhofen apparatus exhibited spontaneous, calcium-dependent spike bursts, 
that were always accompanied by contraction. The frequency and duration of 
electrical events was 2.61 ± 0.14 bursts m h r1 (n = 49) and 6.81 ± 0.56s 
(n = 24) respectively, and each contained 15.08 ±1.11 spikes (n = 20). The 
amplitude of the largest spike in each was 39.04 ± 3.69 pV (n = 24) while the 
amplitude of corresponding contraction, including the lg applied, was
1.48 ± 0.39g (n = 49). Contractile bursts lasted for 8.31 ± 0.36s (n = 49) and 
each contained 1.63 ± 0.08 mechanical peaks (n = 49).
8. Nitrovasodilators in the form of sodium nitroprusside (SNP), glyceryl 
trinitrate (GTN) or isosorbide dinitrate (IDN), each possessed both inhibitory
and excitatory properties in the RDC. SNP was the most effective and, 
consequently, was used as a model for this group of drugs. Each 
nitrovasodilator (> 10-5M) induced a short-lived period of quiescence in 
unstretched, longitudinal strips of RDC. Following this, an altered pattern of 
spontaneous electrical and mechanical activity returned abruptly. In tissues 
with a low initial frequency (< 6 bursts min-1), SNP or IDN (each > 10-5M) 
significantly enhanced the frequency of activity. In tissues with a high initial 
frequency (> 6 bursts m u r1), SNP (10_5M) significantly reduced the frequency 
of activity- Spike amplitude was increased significantly by GTN (10_6M) and, 
on occasion, by SNP (> 10"5M), while the number of spikes per burst and the 
duration of each burst were reduced significantly by SNP (> 10_5M) or IDN 
(> 10_5M and 10_4M respectively). Only SNP (> 10’5M) significntly reduced 
the number of mechanical peaks per burst but both SNP (> 10_6M) and IDN 
(> 10-5M) significantly decreased the duration of mechanical events. Each of 
the nitrovasodilators (each > 10_5M) significantly lowered the amplitude of 
spontaneous contraction.
9. In the intact RPV, SNP possessed only inhibitory properties and (10_5M) 
abolished both electrical and mechanical activity. In the intact rat PV, 
nitrovasodilators exhibited both excitatory and inhibitory properties. The 
pattern of spontaneous activity was altered without the prior induction of 
quiescence. As in the RDC, SNP was most effective. The frequency of 
activity was increased significantly by SNP (> 10_7M). Spike amplitude was 
reduced significantly by SNP (10_5M) but increased by IDN (10_5M), while the 
number of spikes per burst and the duration of each electrical burst were 
inhibited by SNP (> 10'6M) or GTN G0-7M). Only SNP (> 10"7M) significantly 
reduced the number of mechanical peaks per burst, but both SNP (> 10_6M) and 
GTN (10_7M) significantly decreased the duration of mechanical events. The 
amplitude of spontaneous contraction was lowered significantly by SNP
xi
(> 10-7M) and by GTN (10-6M).
10. In both RDC and rat PV, the actions of SNP on spontaneous electrical and 
mechanical activity were mimicked by the analogue of cyclic guanosine 
monophosphate (cGMP), 8-bromo cGMP, and inhibited by Hb, indicating that 
these effects were mediated by nitric oxide. Potassium ferrocyanide 
(K4Fe(CN)6) which structurally resembles SNP, but which does not release 
NO, had no effect on the spontaneous electrical or mechanical activity of either 
tissue.
11. The addition of a subthreshold dose of SNP (10_6M) to the RDC, together 
with a subthreshold dose of the potassium channel opener, BRL 38227 
(10~7M), abolished activity i.e. synergism occurred.
12. The means adopted to test directly for the ability of vasodilators to 
stimulate an efflux of potassium from gastrointestinal smooth muscle, was to 
load the RDC with radiolabelled rubidium (a marker for potassium) before 
mounting it in the Golenhofen apparatus. The muscarinic agonist, carbachol 
(10_5M), then enhanced the efflux rate constant for rubidium. Neither SNP, 
BRL 38227 nor isoprenaline (each 10_7-10_4M) had any effect on the basal 
efflux rate constant.
13. Similarly, the ability of vasodilators to stimulate the efflux of potassium 
from vascular smooth muscle was examined by loading the rat PV with 
radiolabelled rubidium, before mounting it in the Golenhofen apparatus. The 
contractile agonist, noradrenaline, or BRL 38227 (each 10_5M) then enhanced 
the efflux rate constant of rubidium. Neither SNP nor isoprenaline (each 
10_7-10-4M) affected the basal efflux rate constant.
14. In RDC, the SNP (10-5M)-induced reduction in contractile amplitude was 
reversed by the calcium-channel agonist, BAY K 8644 (10_7M) indicating that 
this effect of SNP was probably mediated by a fall in the cytosolic free calcium 
level. When added in reverse order, SNP (> 10_5M) reversed the 
desynchronization of activity produced by BAY K 8644 (10_7M).
15. The ability of SNP to alter the cytosolic free calcium concentration was 
examined on rat aortic vascular smooth muscle cells grown on glass cover slips. 
Angiotensin II (10_7M)elevated this parameter ; SNP (10_5M) did not.
16. The SNP (10_5M)-induced increase in the frequency of contraction of rat 
PV was antagonized by the prior addition of phentolamine and propranolol 
(each 3 x 10_6M) together, suggesting that SNP may have stimulated the release 
of noradrenaline. The means adopted to test for this in rat PV, was to 
radiolabel the stores of transmitter in the nerves and examine the effects of SNP 
on the overflow of noradrenaline from the tissue mounted in the Golenhofen 
apparatus. The indirect sympathomimetic, tyramine (10*5M), enhanced the 
overflow of noradrenaline ; SNP (10_7-10_5M) did not increase the overflow of 
noradrenaline from the rat PV.
17. In conclusion, in spontaneously active smooth muscle, nitrovasodilators 
possessed both excitatoiy (i.e. increased frequency of activity, increased 
electrical spike amplitude) and inhibitory properties (i.e. period of quiescence, 
reduced amplitude of contraction, reduced number of electrical 
spikes/mechanical peaks per burst and shorter duration of electrical/mechanical 
bursts). Each of these actions was mediated through the release of NO and 
probable stimulation of cGMP. Experiments in the presence of SNP and BAY 
K 8644 suggested that, at least in RDC, the nitrovasodilator-induced fall in 
contractile amplitude was mediated through a reduction in cytosolic calcium
levels. Beyond this, the mechanisms are less clear. However, the enhanced 
frequency of spontaneous activity, the decrease in spikes/peaks per burst and 
the reduction in the duration of each spontaneous event were possibly a 
consequence of a direct effect of NO on the smooth muscle pacemaker. 
Further, in RDC, the nitrovasodilator-induced period of quiescence may have 
been mediated via a mechanism that was similar to that of BRL 38227 but 
which did not involve a significant transmembrane efflux of potassium from the 
smooth muscle as a whole.
The finding that SNP had significantly greater effects than organic nitrates 
such as GTN and IDN, supported the proposal that this drug was activated 
differently. The significant excitation observed with SNP suggested that, in 
some cases, the relaxant properties of this compound could be compromised 
due to concomitant excitation.
The effects of SNP on the extracellular electrical and mechanical activity 
recorded from the RDC and the rat PV (+ = increase, o = no change, 
- = decrease).
Electrical
Frequency Spike Amplitude No. of spikes/burst Duration
RDC + 0
(sometimes +)
- -
Rat PV +
(sometimes +)
- -
Mechanical
Frequency Peak Amplitude No. of peaks/burst Duration
RDC +
(sometimes +)
- -
Rat PV + - - -
1Chapter 1: Introduction
21.1. The Nitrovasodilators
The term 'nitrovasodilator' describes any member of a chemically 
heterogeneous group of compounds that release nitric oxide (NO) i.e. they are 
prodrugs of NO. For this reason, they are frequently used, in biological 
systems, to mimic the effects of the highly unstable, authentic, NO. 
Nitrovasodilators include organic nitrates, organic and inorganic nitrites, 
sodium nitroprusside , S-nitrosothiols, sydnonimins and furoxans (Fig. 1). Of 
particular interest in this study, were the actions of sodium nitroprusside (SNP), 
glyceryl trinitrate (GTN) and isosorbide dinitrate (IDN).
More than one hundred years have elapsed since amyl nitrite (Brunton, 
1867) and GTN (Murrell, 1879) were first advocated for the relief of angina 
pectoris. Prior to this, therapy for this condition had been largely ineffective ; 
it included brandy, ether, chloroform or ammonia. The use of nitrovasodilators 
was a major advance in the therapy of anginal pain. Following his trial of amyl 
nitrite, Brunton recorded, "On pouring from five to ten drops of the nitrite on a 
cloth and giving it to the patient to inhale, the physiological action took place in 
from thirty to sixty seconds ; and simultaneously with the flushing of the face 
the pain completely disappeared, and generally did not return till its wonted 
time next night." However, although nitrovasodilators are potent coronary 
vasodilators their principal benefit arises, not from an action on the heart, but 
from an action on the systemic circulation where they act to reduce venous 
return and consequently left ventricular work. Amyl nitrite is no longer in 
common use, but GTN, IDN and SNP are still used, routinely, to treat angina 
pectoris, congestive heart failure, percutaneous coronary angioplasty, 
pulmonary hypertension and hypertensive emergencies (Abrams, 1987 ; see 
Moncada et al, 1991b).
GTN and IDN are organic nitrates, a group of drugs each of which contains 
one or more functional nitrate groups (N 03 ; Fig. 1). Amyl nitrite, though an
Fig. 1
The different chemical classes (with examples) of nitrovasodilator 
compounds.
Organic nitrates R—O— N+ 
\
O
O'
Glyceryl trinitrate
Isosorbide dinitrate
Organic nitrites R - O - N = O e.g. H3C. -O—N=0
Inorganic nitrite N 02
C
H3
Amyl nitrite
Sodium Nitroprusside Na2[Fe (CN)5(NO)]
S-nitrosothiols R - S - N = O
sJ+0
C N .V
Fe
\
CN CN
CN
Nitroprusside anion
Sydnonimins
Rn M
Nr©
Furoxans wN N+^ \
O O'
3organic nitrite, since it contains the nitrite functional group (N 02 ; Fig. 1), is 
often also referred to as an organic nitrate due to the similarities in 
pharmacologic effects to the other nitrates (Fung, 1992). Although SNP causes 
vasodilatation via the same biochemical pathway as the organic nitrates or 
nitrites, it is neither, since the nitroprusside anion lacks the requisite functional 
groups (Fig. 1). Despite the widespread clinical use of the nitrovasodilators, 
their mechanism of action has become clear only relatively recently (see 
Ignarro & Kadowitz, 1985 ; Waldman & Murad, 1987).
1.1.1. Mechanism of Action of Nitrovasodilators
The action of GTN was once attributed to its conversion, in the circulation, 
to N 0 2" which, unlike N 0 3", had weak vasodilator actions (Hay, 1883). 
However, an effective vasodilator dose of GTN could not provide sufficient 
N 0 2" to account for the relaxation observed (Krantz et al, 1940).
Other nitrovasodilators (e.g. sodium azide, hydroxylamine and N aN 02), 
activated soluble guanylate cyclase and raised cyclic guanosine monophosphate 
(cGMP) levels (Kimura el al, 1975 a,b ; Mittal et al, 1975), a property now 
known to be common to all nitrovasodilators, in certain vascular and non- 
vascular smooth muscles (Schultz el al, 1977 ; Katsuki et al, 1977 ; Kukovetz 
et al, 1979). Guanylate cyclase activation by nitrovasodilators was augmented 
by thiols such as cysteine or glutathione (Ignarro et al, 1980a ; Ignarro et al, 
1980b). These compounds reduced nitrovasodilator stability by promoting NO 
formation. The NO so released, was unstable and reacted with oxygen to form 
N 0 2. In solution, N 0 2 formed N 0 2’ and N 0 3”, each of which was relatively 
inactive. Alternatively, NO could react with thiols to form S-nitrosothiols 
which, although unstable, had half-lives greater than NO and were potent 
activators of guanylate cyclase (Ignarro & Gruetter, 1980 ; Ignarro et al, 
1980a,b ; see Ignarro, 1989). Indeed, SNP, GTN and isoamyl nitrite reacted
4with certain thiols to form the corresponding S-nitrosothiols (Ignarro et al, 
1981). Moreover, the haemodynamic profile of action of a series of S- 
nitrosothiols was almost identical to that of SNP or GTN (Ignarro et al, 1981). 
The relaxant action of the nitrovasodilators was thus attributed, at least in part, 
to the formation of S-nitrosothiols (Ignarro et al, 1981). This, however, is 
unlikely to be the case. Under physiological conditions, nitrosothiol formation 
from nitrite and cysteine was negligible (Yeates et al, 1985), although this did 
not discount the possibility that reaction of the organic nitrate with cysteine 
resulted in the transient formation of a nitrosothiol intermediate that 
disintegrated rapidly to release NO and the disulphide, cystine. In addition, the 
most effective nitrosothiols as activators of soluble guanylate cyclase were the 
least stable (Feelisch, 1991), suggesting that it was not the intact nitrosothiol, 
but rather a decomposition product (i.e. NO), that was reponsible for enzyme 
activation. In fact, soluble guanylate cyclase stimulation by the organic nitrates 
was dependent on the release of NO (Feelisch & Noack, 1987). This was in 
keeping with earlier findings that NO, itself, raised soluble guanylate cyclase 
activity (Katsuki et al, 1977 ; Arnold et al, 1977 ; Craven & DeRubertis, 1978). 
Together, this evidence indicates that NO per se rather than a nitrosothiol is the 
effector molecule of the nitrovasodilators, though the mechanisms for this 
release may not always be the same. For example, SNP, once believed to 
generate NO spontaneously, is now thought to spontaneously liberate NO only 
in the presence of light (Bates et al, 1991). When kept in the dark, SNP 
released NO only after the nitroprusside anion had been reduced and cyanide 
lost (Bates et al, 1991). Reduction was achieved by the addition of either 
vascular tissue or agents such as cysteine, sodium dithionite, haemoglobin (Hb) 
or partially purified cytochrome P450 with a reduced nicotinamide adenine 
dinucleotide phosphate (NADPH)-regenerating system. A schematic 
representation of the release of NO from the nitroprusside anion is 
shown in Fig 2. The release of NO from SNP differed from the release
SR
N+0
CN- .CN
Fe
CN CN 
CN
2-
RS-
O- t
N'O
CN- .CN
Fe
CN CN 
CN
NO
CN- .CN
Fe
CN ^ C N
2 -
CN' ^ w  HCN
►  NO
(iv)
NO
CN- .CN
Fe
CN CN 
CN
3-
(i)
3
(ii)
RSSR
Fig. 2
T he re lease  of NO from nitroprusside (adapted from B ates etal, 1991). The 
nitroprusside anion (i) m ay be reduced directly to (iii) by ag en ts  such  a s  
haem opro teins or indirectly via (ii) by thiols (R is any organic group). NO is 
re leased  from product (iv).
of NO from the organic nitrates. In rabbit aorta for instance, inhibitors of NO, 
such as methylene blue (MeB) and pyocyanin, not only failed to attenuate, but 
potentiated, SNP-induced relaxations (Gryglewski et al, 1992). Relaxations 
induced by GTN, on the other hand, were attenuated by both MeB and 
pyocyanin. To explain this, an intracellular site for the biotransformation of 
SNP was proposed (Gryglewski et al, 1992), where MeB and pyocyanin could 
each activate the transfer of NO from SNP to the active haem centre of the 
soluble guanylate cyclase. Thus, although SNP is a potent stimulator of soluble 
guanylate cyclase, it should not be thought of as a donor of NO in the same 
way as the organic nitrates (Gryglewski et al, 1992). Additionally, SNP has 
properties not mediated via soluble guanylate cyclase ; for example, SNP 
protected primary cultures of cerebellar granule cells from glutamate- or N- 
methyl-D-aspartate (NMDA)-induced death (Kiedrowski et al, 1991), a 
property not due to the release of NO, but determined by the ferrocyanide 
portion of the SNP molecule (Kiedrowski et al, 1991).
Organic nitrates, such as GTN or IDN, required bioactivation and failed to 
stimulate soluble guanylate cyclase in cell-free vascular smooth muscle 
preparations (Ignarro & Gmetter, 1980 ; Ignarro et al, 1981). In broken-cell 
preparations, organic nitrates reacted with thiols to induce NO formation 
(Ignarro & Gruetter, 1980 ; Feelisch & Noack, 1987a). All thiols generated 
N 0 2" from organic nitrates, but only a few (e.g. cysteine, N-acetylcysteine) 
also liberated NO (Feelisch, 1991). Those thiols that induced the release of 
NO, acted as coactivators of soluble guanylate cyclase. A schematic 
representation of the thiol-induced release of NO from the organic nitrates is 
shown in Fig 3. In intact blood vessels, biotransformation of the organic 
nitrates was believed to be catalyzed by glutathione S-transferase (Keen et al, 
1976 ; Brien et al, 1988) or by the cytochrome P450 enzyme system 
(McDonald & Bennett, 1990 ; Schroder, 1992), but this has recently been 
disputed (Salvemini et al, 1993).
i) RON02 + R'SH -------- ►  ROH + R'SNCfe
ii) R'SN02 + R'S" -------- ►  R'SSR' + N 0 2"
O
II
iii) R'SN02  ►  R ' S - O - N O  ►  R'S - NO
O  O
I I
iv) R'S - N O ----►  R'S • + NO •
Fig. 3
T he thiol-dependent re lease  of NO from organic nitrates (R, R' a re  any 
organic groups). T he reaction of any thiol with an  organic nitrate (i) results
the  re lease  of N 0 2" (ii). Only certain thiols e.g. cysteine, N-acetylcysteine, 
additionally g en era te  NO (iii and  iv).
6Unlike organic nitrates, organic nitrites did not require specific thiols as 
coactivators. The reaction of organic nitrites with thiols caused the formation 
of S-nitrosothiols, from which NO was liberated. The reactions leading to the 
release of NO from the organic nitrites is shown in Fig 4.
The receptor for NO was the active haem centre of soluble guanylate 
cyclase (Gerzer et al, 1988). The resultant increase in cGMP, following NO 
activation of this enzyme, produced relaxation presumably by reducing 
cytosolic calcium (Ca++) levels (Collins et al, 1986 ; Schini et al, 1987 ; 
Bukoski et al, 1989). One, or several, of the following mechanisms could 
explain this cGMP-evoked relaxation : intracellular Ca++ sequestration or 
binding (Lincoln, 1983) ; enhanced dephosphorylation of myosin light chain 
(Rapoport et al, 1983) ; activation of an ATPase involved in the extrusion of 
Ca++ (Popescu el al, 1985) ; inhibition of receptor-operated Ca++ channels 
(Godfraind, 1986) ; membrane hyperpolarization and closure of voltage- 
dependent Ca++ channels (Tare et al, 1990).
Following prolonged pretreatment, tolerance developed to the 
cardiovascular effects of nitrovasodilators (Crandall et al, 1931 ; Schelling & 
Lasagna, 1967 ; Needleman, 1970). In aortae from GTN-pretreated rats, both 
the relaxant response and the increase in cGMP declined markedly in response 
to a challenging dose of GTN (Axelsson & Anderson, 1983 ; Waldman et al, 
1986). Tolerance was attributed to a reduction in the metabolism of GTN 
(Brien et al, 1986). Similar effects occurred in human coronary artery 
(Waldman et al, 1986) possibly due to desensitization of soluble guanylate 
cyclase to the action of NO. Cardiovascular tolerance to the actions of these 
drugs could limit their efficacy in the long-term control of conditions such as 
angina pectoris or congestive heart failure (Abrams, 1986 ; Horowitz & Henry, 
1987 ; Packer et al, 1987). Interestingly, clinical investigations revealed that in 
the presence of the sulphydryl donors N-acetylcysteine and methionine, the 
short-term efficacy of GTN was increased and the GTN-induced tolerance
i) RONO + R'SH -► R'SNO + ROH
ii) 2R'SNO  ► R'SSR' + 2NO
Fig. 4
The thiol-dependent re lease  of NO from organic nitrites (R, R' a re  any organic 
groups). All thiols can g en era te  NO (ii) from a  reaction with an organic nitrite 
(i). The d eg ree  of NO liberation is depen d en t on the  rate of formation and  
decom position of the  nitrosothiol interm ediate.
7reversed (Horowitz et a!, 1983 ; Packer el al, 1987 ; Levy et al, 1988), 
probably through the formation of S-nitroso-N-acetylcysteine (SNAC ; 
Loscalzo, 1985 ; Fung et al, 1988). S-nitrosothiols may, therefore, prove to 
have a therapeutic use in attenuating organic nitrate-induced tolerance. 
Experiments using SNAC in bovine coronary artery supported this idea (Henry 
et al, 1989), but prolonged exposure to this compound led to a decrease in 
vascular responsiveness. Thus, there was likely to be a further site of tolerance 
in the bioconversion of organic nitrates to NO (Henry et al, 1989).
During the last decade, it was shown that, in addition to having an 
exogenous source, NO was synthesized endogenously in the vascular 
endothelium, the peripheral nervous system, the central nervous system (CNS) 
and the immune system (see Moncada et al, 1991b). This NO helped mediate a 
number of biological processes, including relaxation of vascular (see Ignarro,
1989 ; Marin & Sanchez-Ferrer, 1990 ; Feng & Hedner, 1990 ; Moncada,
1990 ; Moncada et al, 1991b) and non-vascular smooth muscle (see Gillespie, 
1990 ; Rand, 1992 ; Sanders & Ward, 1992 ; Stark & Szurszewski, 1992), 
inhibition of platelet aggregation (see Ignarro, 1989 ; Moncada et al, 1991b), 
intercellular communication in the central nervous system (see Garthwaite, 
1990 ; Moncada el al, 1991b), and macrophage cytotoxicity (see Hibbs et al, 
1990 ; Moncada et al, 1991b). To discuss the role of NO in each of these 
processes would be beyond the scope of this thesis. The role of endogenous 
NO in the vasculature - where it was first discovered - and as a non-adrenergic, 
non-cholinergic (NANC) neurotransmitter in the gastrointestinal tract, each of 
which is relevant to the aims of this thesis, will be discussed in detail.
1.2. Endothelium-derived Relaxing Factor (EDRF)
The well-documented, apparently paradoxical vascular effects of 
acetylcholine (ACh), in vitro and in vivo, remained unresolved for many years ; 
both vasodilator (Dale, 1914) and vasoconstrictor (Hunt, 1915) actions of the 
transmitter were observed. For example, blood vessels of the isolated perfused 
rabbit ear dilated to ACh, but this gave way to vasoconstriction over a period of 
hours (Bum & Robinson, 1951). Similarly, helical strips of rabbit descending 
thoracic aorta constricted to ACh concentrations greater than 0.1 pM, an effect 
mediated via muscarinic receptors (Furchgott & Bhadrakom, 1953), but relaxed 
to lower concentrations of the substance (Jelliffe, 1962). These apparent 
discrepancies were resolved when it became clear that ACh-induced vascular 
relaxation required the presence of endothelial cells (Furchgott & Zawadski, 
1980). ACh, it is now known, was acting on endothelial cell muscarinic 
receptors to release an endothelium-derived relaxing factor (EDRF). Results 
suggesting that ACh was a vasoconstrictor probably arose from unintentional 
rubbing of the intimal surface and removal of endothelial cells or from a 
gradual loss of endothelial cells.
The release of EDRF, now demonstrated in both arterial and venous 
preparations, underlay the relaxant effects of ACh, bradykinin, substance P, 
adenosine diphosphate (ADP), adenosine triphosphate (ATP) and the calcium 
ionophore A23187 (see Moncada et al, 1991b). In addition to relaxing vascular 
smooth muscle, EDRF inhibited platelet aggregation and adhesion to vascular 
endothelium (Azuma et al, 1986 ; Radomski et al, 1987a,b,c,d). In contrast, 
other vasorelaxants such as the nitrovasodilators, (3-adrenergic agonists and 
prostacyclin acted independently of the endothelium. EDRF was labile 
(Furchgott & Zawadski, 1980 ; Griffith et al, 1984), with a half-life of only 
seconds in physiological salt solutions (Griffith et al, 1984 ; Cocks et al, 1985), 
and was released at rest or following stimulation (Griffith et al, 1984 ; Martin
9et al, 1985 ; Rubanyi et al, 1985). The half-life of EDRF was species- 
dependent ; canine EDRF had a longer half-life than that of rabbit 
(Forstermann e/ al, 1984).
The chemical nature of the EDRF was not initially obvious. Early evidence 
suggested that it was a short-lived hydroperoxide, or free radical, formed 
following oxidation of arachidonic acid by a lipoxygenase pathway (Singer & 
Peach, 1983 ; Forstermann & Neufang, 1984 ; see Furchgott, 1984), that 
stimulated vascular smooth muscle soluble guanylate cyclase to elevate cGMP 
levels and produce relaxation (see Furchgott, 1984). In contrast, endothelium- 
dependent relaxation was reportedly resistant to lipoxygenase inhibition unless 
the lipoxygenase inhibitor was also an antioxidant (Griffith et al, 1984). It was 
thus proposed that EDRF, from aortic preparations, was not a lipoxygenase 
derivative or free radical, but an unstable compound with a carbonyl group at or 
near its active site (Griffith et al, 1984). Neither of these proposals proved to 
be correct.
Endothelium-dependent relaxation was associated with increased cGMP 
levels in vascular smooth muscle (Rapoport & Murad, 1983). Both 
endothelium-dependent vasodilators and nitrovasodilators induced relaxation 
through identical cGMP-dependent protein phosphorylation and 
dephosphorylation of myosin light chain (Rapoport et al, 1983). MeB and Hb 
each inhibited both endothelium-dependent and GTN-induced relaxation of 
rabbit aorta (Martin et al, 1985). These compounds bound directly to and thus 
inactivated the EDRF, although MeB may also have oxidized the active haem 
centre of soluble guanylate cyclase (Martin et al, 1985). The inhibitory actions 
of MeB and Hb on nitrovasodilator-induced effects were attributed to their NO 
binding and scavenging effects (Hermann, 1865 ; Gibson & Roughton, 1957 ; 
Martin et al, 1986 ; Marshall et al, 1988). In addition, superoxide anions 
destabilized the EDRF ; an effect that was inhibited by superoxide dismutase 
(SOD ; Gryglewski et al, 1986 ; Rubanyi & Vanhoutte, 1986). Dithiothreitol,
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hydroquinone and pyrogallol which formed superoxide anions (Moncada et al,
1986), inhibited the EDRF. In 1986, based on these pharmacological 
similarities between EDRF and NO, two groups suggested independently that 
the EDRF could be NO (see Furchgott, 1988 ; Ignarro et al, 1988). In 1987, 
proof was obtained that this was indeed the case.
1.2.1. NO in the Vasculature
Measurement of NO as the chemiluminescent product of its reaction with 
ozone (Palmer et al, 1987), provided the first direct evidence that the EDRF 
was NO. Bradykinin was used to show a concentration-dependent release of 
NO from cultured endothelial cells in amounts sufficient to account for the 
biological activity of EDRF (Palmer et al, 1987). Bioassay revealed that 
EDRF-induced relaxations and those induced by NO were indistinguishable ; 
both were inhibited by Hb and enhanced by SOD to similar degrees (Palmer et 
al, 1987 ; Hutchinson et al, 1987). The sensitivity of a number of vascular and 
non-vascular smooth muscles, including rabbit aorta, rat anococcygeus, guinea 
pig trachea and guinea pig taenia caeci, to EDRF and NO, were also the same 
(Gillespie & Sheng, 1988 ; Cocks & Angus, 1990), suggesting that EDRF was 
NO.
NO has now been identified as the EDRF in a large number of 
cardiovascular preparations which include porcine aorta (Palmer et al, 1987 ; 
Hutchinson et al, 1987 ; Radomski et al, 1987a), rabbit aorta (Gillespie & 
Sheng, 1988), guinea pig uterine artery (Tare et al, 1990) and rabbit hepatic 
arterial vascular bed (Mathie et al, 1991). In spite of this, there are some blood 
vessels where NO may not be the EDRF. For instance, in rat small mesenteric 
artery, ACh-induced relaxation was endothelium-dependent but was not 
mediated by NO (Garland & McPherson, 1992). Further, there could be more 
than one EDRF. Indeed, two EDRF's were allegedly released from porcine
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aortic endothelial cells (Boulanger el al, 1989); one under basal conditions and 
following stimulation with ADP, the other, which was most probably NO, 
following stimulation with bradykinin or the calcium ionophore A23187.
It has also been suggested that the EDRF may not be NO itself, but a NO- 
related compound, since NO is a highly labile gas with a half-life of only a few 
seconds (Griffith et al, 1984 ; Forstermann et al, 1984 ; Rubanyi et al, 1985 ; 
Cocks et al, 1985), making storage of the preformed molecule difficult. In fact, 
in cultured bovine aortic endothelial cells, the amount of NO released under 
basal conditions or in response to either bradykinin or the calcium ionophore 
A23187 was insufficient to account for the vasorelaxant properties of the 
EDRF (Myers et al, 1990). Similarly, in rat aortic rings, dinitrosyl iron 
complexes with cysteine, induced relaxations that were more similar to ACh- 
induced than to NO-induced relaxations (Vedernikov et al, 1992). Findings 
such as these led to speculation that the EDRF could be a hydroxylamine 
(Thomas & Ramwell, 1989), S-nitrosocysteine (Myers et al, 1990) or a 
dinitrosyl iron complex with cysteine (Miilsch et al, 1991 ; Vedernikov et al,
1992). The EDRF may well be stored and stabilized in one of these forms, but 
the majority of the evidence to date implies that the biological effects of EDRF, 
like those of the nitrovasodilators, are mediated ultimately by the release of 
NO.
1.2.2. NO Synthesis and Inhibition
Endothelium-derived NO was synthesized from the terminal guanidino 
nitrogen atoms of L-arginine (Palmer et al, 1988a), possibly via a 
hydroxylamine intermediate (DeMaster et al, 1989). This reaction was 
catalyzed by NO synthase and L-citrulline was formed as a by-product (Fig. 5 ; 
Palmer & Moncada, 1989). Two similar NO synthases were recognised ; one 
constitutive the other inducible. Both used L-arginine as their substrate to form
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NO and L-citrulline, required NADPH as an electron donor (Mayer et al,
1989 ; Miilsch et al, 1989 ; Lopez-Jaramillo et al, 1990 ; Busse & Miilsch, 
1990b) and contained one molecule each of flavin adenine dinucleotide (FAD) 
and flavin mononucleotide (FMN ; Bredt et al, 1991 ; Stuehr et al, 1991). The 
constitutive NO synthase required Ca++ and calmodulin (Busse & Miilsch, 
1990a ; Schini & Vanhoutte, 1992) and has been found in, amongst other cell 
types, the vascular endothelium (Mayer et al, 1989 ; Miilsch et al, 1989 ; 
Palmer & Moncada, 1989), the blood platelet (Radomski et al, 1990a), the 
peripheral nervous system (Gillespie et al, 1989 ; Li & Rand, 1989) and the 
CNS (Bredt & Snyder, 1990). In the endothelium, although originally believed 
to be cytosolic (Palmer & Moncada, 1989), the constitutive enzyme was 
membrane bound (Boje & Fung, 1990 ; Forstermann et al, 1991). In the CNS, 
this enzyme was cytosolic (Schmidt et al, 1989).
The inducible NO synthase was cytosolic (Marietta et al, 1988) and 
required tetrahydrobiopterin as a cofactor (Busse & Miilsch, 1990b). 
Cytokines such as interferon-y, tumour necrosis factor, interleukins 1 and 6 or 
bacterial endotoxin induced its expression (Drapier et al, 1988 ; Beasley et al, 
1991 ; Nussler et al, 1991 ; Schini et al, 1991) and it synthesized NO for long 
periods. Other substances such as transforming growth factor p, interleukin-8, 
platelet-derived growth factor or glucocorticoids (Ding et al, 1990 ; Knowles et 
al, 1990 ; Radomski et al, 1990b ; Rees et al, 1990 ; McCall et al, 1992 ; 
Schini et al, 1992) inhibited the expression of the inducible enzyme. This 
enzyme was found in macrophages (Hibbs et al, 1988 ; Stuehr et al, 1989), 
neutrophils (McCall et al, 1991), vascular endothelial cells (Radomski et al,
1990 ; Rees et al, 1990) and vascular smooth muscle cells (Busse & Miilsch, 
1990b ; Fleming et al, 1991 ; Mollace et al, 1991).
The activity of both enzymes was impaired in vitro by structural analogues 
of the NO precursor L-arginine (Palmer & Moncada, 1989 ; Busse & Miilsch, 
1990b ; Fleming et al, 1991). These compounds included NG-monomethyl-L-
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arginine (L-NMMA), NG-nitro-L-arginine (L-NNA) and NG-nitro-L-arginine 
methyl ester (L-NAME ; Fig. 6), but not their D-isomers.
The use of L-NMMA revealed that the basal release of NO, synthesized 
from L-arginine, was important in the regulation of blood flow and pressure. 
L-NMMA constricted rings of rabbit aorta when the endothelium was present 
(Palmer et al, 1988b), indicating that NO was continuously released in this 
tissue. Moreover, intravenous administration of L-NMMA, but not D-NMMA, 
increased blood pressure in anaesthetized rabbits (Rees et al, 1989), 
demonstrating that basally released NO helped maintain blood pressure at safe 
levels. This increase in pressure was reversed by L-, but not D-,arginine.
Venous tissues had a lower basal release of endothelium-derived NO 
(Seidel & LaRochelle, 1987), but an increased sensitivity to nitrovasodilators, 
when compared with arterial tissues. It was unclear whether this increased 
sensitivity was due to a greater concentration of soluble guanylate cyclase in 
venous smooth muscle compared with arterial smooth muscle, or whether the 
venous soluble guanylate cyclase was more sensitive to stimulation by NO 
(Moncada et al, 1991b).
1.2.3. NO-induced Hyperpolarization?
The vasorelaxant properties of NO have been known for some years, but 
there has recently been some debate on the ability, if  any, of NO to induce 
hyperpolarization (Komori et al, 1988 ; Tare et al, 1990 ; Rand & Garland, 
1992 ; Suzuki et al, 1992). ACh hyperpolarized and relaxed a number of 
vascular smooth muscles including rabbit saphenous artery (Komori & Suzuki,
1987), canine mesenteric artery (Komori et al, 1988), rat aorta (Taylor et al, 
1988 ; Chen et al, 1988), rat main pulmonary artery (Chen et al, 1988), canine 
coronary artery (Chen et al, 1989), guinea pig uterine artery (Tare et al, 1990), 
rabbit cerebral artery (Brayden, 1990) and rabbit basilar artery (Rand &
L-arginine
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Fig. 6
The structu res of the  precursor of NO synthesis, L-arginine, and  of so m e 
analo g u es  which inhibit NO synthesis.
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Garland, 1992). These hyperpolarizations required an intact endothelium and 
the current was probably earned by potassium (K+) ions. This membrane 
hyperpolarization may have contributed to the ACh-induced dilator response 
through the closure of voltage-dependent Ca++ channels (Taylor et al, 1988 ; 
Tare et al, 1990 ; Brayden, 1990), However, the hyperpolarization may not 
have been due to the actions of EDRF (Taylor et al, 1988 ; Huang et al, 1988 ; 
Komori et al, 1988 ; Chen et al, 1988 ; Chen et al, 1989 ; Brayden, 1990 ; 
Suzuki et al, 1992). There was evidence that endothelium dependent 
vasodilators caused the concomitant release of an endothelium-dependent 
hyperpolarizing factor (EDHF) that was distinct from the EDRF. For instance, 
endothelium-dependent relaxation, but not hyperpolarization, of vascular 
smooth muscle cells was inhibited by the inhibitors of NO, Hb and MeB 
(Huang et al, 1988 ; Chen et al, 1988). Exogenous NO did not hyperpolarize 
either canine mesenteric artery (Komori et al, 1988) or rabbit cerebral artery 
(Brayden, 1990). Moreover, SNP, believed to generate NO in vascular smooth 
muscle, relaxed rat aorta without increasing radiolabelled rubidium (86Rb ; a 
marker for K+) efflux (Taylor et al, 1988). Thus, in these arteries, NO would 
appear to be unable to hyperpolarize the smooth muscle.
But,the donors of NO, SNP or GTN, hyperpolarized the rabbit pulmonary 
artery (Ito et al, 1978), rat tail artery (Cheung & MacKay, 1985) and guinea pig 
uterine artery (Tare et al, 1990). ACh-induced hyperpolarization and 
relaxation of guinea pig uterine artery (Tare et al, 1990) and rabbit basilar 
artery (Rand & Garland, 1992) were reduced by the inhibitors of NO synthesis, 
L-NMMA and L-NAME, and authentic NO hyperpolarized and relaxed guinea 
pig uterine, mesenteric and coronary arteries, rabbit saphenous artery and rat 
tail artery among others (Tare et al, 1990). Thus, in some smooth muscles, NO 
clearly produced hyperpolarization. This increases the probability that in some 
arteries at least, endothelium dependent hyperpolarization was mediated via the 
release of NO. In others, it was probably mediated via a separate EDHF, the
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release of which required a rise in endothelial cell Ca++ levels, that produced an 
increase in K+ permeability (Suzuki et al, 1992). Why there should be this 
distinction is unclear ; there are no obvious differences between those arteries 
in which NO has been reported to cause hyperpolarization, and those in which 
it was ineffective. At present the identity of the putative EDHF is unknown.
1.3. NO in the Peripheral Autonomic Nervous System
The quest for NO in the peripheral autonomic nervous system stemmed 
from endeavours to identify the neurotransmitter from non-adrenergic, non- 
cholinergic (NANC) nerves. The identification of the EDRF as NO, coupled 
with the unsuitability of several candidates as transmitter substances, led to 
speculation that NO could be a NANC neurotransmitter.
Classically, sympathetic nerves were considered to release only 
noradrenaline and parasympathetic nerves were considered to release only 
ACh. Yet, from an early time, evidence existed that this was an 
oversimplification. For example, both motor and inhibitory responses were 
obtained from the stomach following electrical stimulation of the vagus nerve 
(Langley, 1898) and electrical stimulation of the sacral parasympathetic 
outflow via the pelvic nerves, led to penile erection that was unaffected by 
atropine (Langley & Anderson, 1895). Furthermore, atropine only partially 
blocked motor responses of mammalian urinary bladder following 
parasympathetic nerve stimulation (Langley & Anderson, 1895 ; Henderson & 
Roepke, 1934 ; Ambache, 1955). Only Henderson and Roepke, however, 
concluded that the nerves were releasing a transmitter other than ACh.
It was only after the introduction of selective adrenergic neurone blocking 
drugs that it became obvious that some smooth muscles were innervated by 
nerves that were neither adrenergic nor cholinergic. Non-adrenergic inhibitory 
nerves were first reported in the guinea pig taenia coli (Bumstock et al,
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1964). Then, following vagus nerve stimulation, relaxations of the cat stomach 
were shown to be resistant to both atropine and guanethidine (Martinson,
1965). Since this time, NANC responses have been described in a wide range 
of smooth muscles including both the small and large intestines, the retractor 
penis muscle, the anococcygeus muscle and the lower oesophageal sphincter 
muscle (see Rand, 1992 ; Sanders & Ward, 1992). NANC nerves are now 
known to be prevalent throughout the entire length of the gastrointestinal tract.
NANC nerves do not belong to a single population with only a single 
neurotransmitter. A number of putative transmitters, including ATP (Bumstock 
et al, 1970 ; Bumstock et a!, 1972 ; see Bumstock, 1981), 5-hydroxytryptamine 
(see Gershon, 1979) and several peptides, vasoactive intestinal peptide (VIP), 
substance P and neuropeptide Y among them (Cuello, 1982 ; Lundberg & 
Hokfelt, 1983 ; Bartfai et al, 1988) were implicated in NANC
neurotransmission or in cotransmission along with "classical" transmitters in 
the gut. Despite this, the NANC transmitter to smooth muscles such as the 
bovine retractor penis muscle (BRP) or rat anococcygeus remained a mystery. 
Then, a few years ago, using dilute hydrochloric acid, a novel inhibitory factor 
was isolated from the BRP (Ambache et al, 1975) and rat anococcygeus 
muscles (Gillespie & Martin, 1978). The study of this smooth muscle 
inhibitory factor recently provided the first evidence that NO was released from 
NANC nerves.
1.3.1. Smooth Muscle Inhibitory Factor
The inhibitory factor (IF) from BRP was neither adenosine nor a purine 
derivative (Bowman et aJy 1979), nor a peptide (Gillespie et al, 1981). It was 
labile and, following neutralization, mimicked the response to NANC nerve 
stimulation. It was only activated after a brief exposure to an acidic pH
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(Gillespie & Martin, 1978), was soluble in water or methanol, but insoluble in 
ether, acetone or ethanol, had a molecular weight of approximately 500 daltons 
and was retained on an anion exchange resin (Gillespie et al, 1981). It relaxed 
isolated blood vessels, yet when injected intravenously in the anaesthetized rat, 
did not lower blood pressure (Bowman et al, 1981). This lack of effect was 
due to the presence of Hb (Bowman et al, 1982). In BRP and rat 
anococcygeus, Hb blocked the relaxations and increases in tissue cGMP 
content produced by inhibitory nerve stimulation, SNP and the inhibitory factor 
(Bowman & Gillespie, 1982 ; Bowman & Drummond, 1984).
With hindsight, it was evident that the IF had a number of similarities to 
NO, but it was another three years, following the discovery that the EDRF was 
NO (Palmer et al, 1987), before the IF was suggested to be nitrite which 
released NO upon acidification (Furchgott, 1988b ; Martin et al, 1988). This 
idea fitted well with many of the reported observations. For instance, the 
relaxant activity of nitrite solutions was known to be greater following 
acidification (see Gillespie, 1990); both nitrite and the IF raised cGMP levels ; 
Hb inhibited the effects of both substances. But, the ability of the IF to bind to 
an anion exchange resin and its molecular weight of approximately 500 daltons 
(Gillespie el al, 1981) seemed incompatible with NO being the effector 
molecule.
Further evidence however, suggested that NO or a NO-releasing compound 
was the likely NANC inhibitory neurotransmitter in the BRP and rat 
anococcygeus muscles. Thus, using a cascade apparatus the BRP, rat 
anococcygeus, rabbit aorta and guinea pig trachea were shown to have an 
identical ranking order of sensitivity to EDRF, the inhibitory factor and NO 
(Gillespie & Sheng, 1988), suggesting that NO was the active principle of all 
three. However, although Hb prevented relaxations to each, a red blood 
corpuscle suspension containing an equivalent concentration of Hb abolished 
the responses only to EDRF and NO (Gillespie & Sheng, 1988). Thus, if NO
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was responsible for the relaxant properties of the acid-activated inhibitory 
factor, it probably existed in a form which rendered it unable to pass through 
the red blood cell membrane. L-NMMA raised tone and blocked NANC nerve 
responses in the rat anococcygeus - effects reversed by L-arginine - but was 
without effect in the BRP (Gillespie et al, 1989). D-NMMA had no effect on 
either tissue. The superoxide generator, pyrogallol, also inhibited NANC nerve 
responses in the rat anococcygeus but not in the BRP (Gillespie & Sheng,
1990). This antagonism was reversed by SOD. The more potent analogue of 
L-arginine, L-NNA, was not only more effective than L-NMMA in rat 
anococcygeus but also inhibited NANC nerve responses in the BRP, indicating 
that NO or a NO-releasing compound was released in each case. Moreover, 
NO synthase was found in tissue homogenates from rat anococcygeus and BRP 
(Mitchell et al, 1991 ; Sheng et al, 1992). Thus, the evidence indicated that in 
both BRP and rat anococcygeus the IF was NO or a related compound. But, 
since relaxations of the BRP were unaffected by L-NMMA or pyrogallol, it is 
possible that there were some differences in synthesis and inactivation of NO in 
the two tissues (see Gillespie, 1990).
It is perhaps unlikely that NO was transmitted as a gas. More probably it 
was transmitted bound to a carrier molecule to foim a more stable compound, 
in the fashion of the nitrovasodilators. This would then be broken down in the 
target cell to release NO. This idea fits better with the "classical" view of 
neurotransmission (Eccles, 1964), and would allow the storage of preformed 
transmitter in vesicles, a concept difficult to conceive of with NO itself because 
of its high membrane permeability (see Gillespie, 1990). Indeed, the NANC 
neurotransmitter in the BRP has recently been proposed to be a superoxide 
anion-resistant NO-releasing molecule (Liu, 1993).
NO synthase is concentrated in cell bodies and nerve fibres in the 
myenteric plexus of the intestine (Bredt et al, 1990). NO or a NO-related 
compound has now been implicated in NANC neurotransmission, or in
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cotransmission along with such substances as ATP or VIP, in a wide range of 
smooth muscles from the gastrointestinal tract. NANC nerves which release 
NO have been termed 'nitrergic' (Rand & Li, 1990). The evidence for 'nitrergic' 
transmission or cotransmission in a variety of gastrointestinal smooth muscles 
is discussed in the following pages.
1.3.2. The Lower Oesophageal Sphincter (LOS)
Inhibitoiy NANC nerves mediated the LOS relaxation that occurred during 
swallowing (Goyal & Rattan, 1976). In spite of earlier support for VIP as the 
transmitter (Goyal et al, 1980 ; Biancani et al, 1984), NO has emerged as the 
more likely candidate.
Field-stimulation of LOS muscle strips evoked frequency-dependent 
tetrodotoxin (TTX)-sensitive NANC relaxations (De Man et al, 1991). 
Authentic NO produced a concentration-dependent relaxation (De Man et al, 
1991 ; Knudsen et al, 1992). NO-induced responses were resistant to TTX. 
Hb inhibited the responses to electrical stimulation in both canine and opossum 
LOS (De Man et al, 1991 ; Knudsen et al, 1992). The inhibitor of NO 
biosynthesis, L-NNA, also inhibited LOS relaxation - an effect that was 
reversed by L-arginine (De Man et al, 1991 ; Tottrup et al, 1991), but not by 
D-arginine. Moreover, the inhibitors of guanylate cyclase, cystamine and MeB, 
blocked the hyperpolarization evoked by nerve stimulation or by SNP in 
opossum LOS (Conklin & Du, 1992). In opossum sphincter the effects o f NO, 
S-nitroso-L-cysteine or SNP did not exactly match the response to NANC 
nerve stimulation (Knudsen et al, 1992), but the action profile of SNP bore the 
closest resemblance. This suggests that, in this particular tissue, the NANC 
neurotransmitter may be a carrier molecule that, like SNP, generates NO 
intracellularly.
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1.3.3. The Gastric Fundus (Forestomach)
Increased intragastric pressure resulted in dilation of the gastric fundus in a 
process that was mediated via inhibitory NANC nerves (Abrahamsson & 
Jansson, 1969). This "adaptive relaxation" (Abrahamsson, 1973) accommodated 
the consumption of liquid or food. VIP and NO are the most likely mediators 
of this response (Li & Rand, 1990 ; D'Amato et al, 1992 ; Grider et al, 1992 ; 
Barbier & Lefebvre, 1993).
Electrical stimulation elicited frequency-dependent NANC relaxations of 
circular and longitudinal muscle strips of gastric fundus from rat (De Beurme & 
Lefebvre, 1988 ; Li & Rand, 1990 ; D'Amato et al, 1992 ; Shimamura et al,
1993), guinea pig (Grider et al, 1985 ; Grider et al, 1992) and cat (D'Amato et 
al, 1988 ; Barbier & Lefebvre, 1993). These were abolished by TTX (Li & 
Rand, 1990). VIP was known to be involved in these inhibitory responses 
(Grider et al, 1985 ; De Beurme & Lefebvre, 1988 ; D'Amato et al, 1988 ; Li & 
Rand, 1990 ; D'Amato et al, 1992 ; Barbier & Lefebvre, 1993) but, as they were 
only partially blocked by VIP-anti serum or by the peptidase, tiypsin (De 
Beurme & Lefebvre, 1988 ; D'Amato et al, 1988 ; Li & Rand, 1990 ; D'Amato 
et al, 1992 ; Barbier & Lefebre, 1993), another transmitter was likely to 
contribute.
L-NMMA, L-NNA and L-NAME, but not their D-isomers, inhibited nerve- 
mediated relaxations of gastric fundus (Li & Rand, 1990 ; D'Amato et al, 
1992 ; Shimamura et al, 1993 ; Barbier & Lefebvre, 1993) in a concentration 
dependent manner. These inhibitions were reversed by L-arginine, but not by 
D-arginine. Similarly, in isolated stomach of the guinea pig, "adaptive 
relaxation" was inhibited by L-NMMA and by MeB (Desai et al, 1991). Again 
the effect of L-NMMA was partially reversed by L-arginine.
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NANC nerve stimulation in the circular smooth muscle of rat gastric fundus 
also induced inhibitory junction potentials (i.j.p.'s) which were depressed by 
L-NNA (Shimamura et al, 1993 ; Kitamura et al, 1993). Moreover, 
hyperpolarizations occurred in response to S-nitrosocysteine, SNP or 
8-bromo cGMP (Kitamura et al, 1993). Hyperpolarizations following field 
stimulation or S-nitrosocysteine were partly due to activation of apamin- 
sensitive but tetraethylammonium-resistant K+ channels. However, only that 
part of the response which was resistant to apamin was mediated through an 
increase in cGMP. The apamin-sensitive part of the response was probably 
mediated via VIP.
However, a recent study in guinea pig gastric fundus (Grider et al, 1992) 
reported that VIP was the primary NANC transmitter and that this stimulated 
the production of NO from the target muscle cells. This NO, in turn, amplified 
the inhibitory response to VIP and presynaptically enhanced the release of VIP 
(Grider et al, 1992).
Thus, in guinea pig gastric fundus, NO and VIP were not simply released as 
cotransmitters. The mechanisms of release were more complex. This may yet 
prove to be the case in gastric fundi from other species
1.3.4. The Small Intestine
The release of NO has been demonstrated from NANC nerves innervating 
the duodenum, jejenum and ileum from a variety of species including dog, 
rabbit, rat, guinea pig and human (Toda et al, 1990 ; Boeckxstaens et al, 1990, 
1991a ; Maggi et al, 1991 ; Kanada et al, 1992 ; He & Goyal, 1993). For 
example :
Longitudinal ships of rabbit duodenum relaxed in response to field 
stimulation of NANC nerves. The relaxations were blocked by L-, but not
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D-NNA and this inhibition was reversed by L-arginine (Toda et al, 1990). 
NANC relaxations were mimicked by NO and GTN, and blocked by Hb.
In circular muscle of the canine jejenum, electrical stimulation evoked 
NANC i.j.p.'s which resembled the hyperpolarization induced by authentic NO 
(Stark et al, 1991). L-NMMA depressed the i.j.p. amplitude. This depression 
was reversed by L- but not by D-arginine. Haemoglobin (Hb) reduced the i.j.p. 
amplitude and abolished the effects of authentic NO.
NANC relaxations in circular muscle from human ileum were reduced by 
L-NMMA and L-NNA (Maggi et al, 1991). This effect was reversed by 
L-arginine, thereby implicating a role for NO.
NANC nerve stimulation relaxed circular muscle strips of the canine 
terminal ileum, as did authentic NO. L-NMMA, L-NNA and Hb inhibited the 
NANC relaxation to electrical stimulation in a concentration-dependent 
manner. Only Hb inhibited the response to exogenous NO. L-, but not 
D-arginine, overcame the inhibitory effects of L-NMMA and L-NNA 
(Boeckxstaens et al, 1990 ; 1991a).
Distension of rat ileum with a small balloon, induced dilation of the circular 
muscle on the anal side of the distended region. L-NNA or MeB inhibited, 
while SOD enhanced, the amplitude of this relaxation (Kanada et al, 1992). 
L-NNA inhibition was reversed by L-arginine. NO and 8- bromo cGMP relaxed 
the circular muscle.
Transmural stimulation of longitudinal muscle of the rat ileum produced a 
relaxation and rebound contraction. The relaxation was accompanied by an 
increased cGMP content (Kanada et al, 1992). Authentic NO also increased 
the cGMP content in circular and longitudinal muscle of rat ileum - an effect 
that was prevented by preincubation with MeB.
Electrical field stimulation of guinea pig ileum circular muscle produced a 
fast, ATP-mediated i.j.p.(He & Goyal, 1993). But, stimulation in the presence 
of apamin and substance P desensitization produced a slow i.j.p.. The
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amplitude of this slow response was reduced by L-NNA, and this inhibition 
was reversed by L-, but not by D-arginine (He & Goyal, 1993). The responses 
to exogenous ATP or NO were unaffected by substance P desensitization, but 
the hyperpolarization in response to VIP was enhanced. Moreover, the VIP- 
induced hyperpolarization was antagonized by L-NNA. These results indicated 
that NO and VIP together mediated the slow i.j.p.. The slow i.j.p. was 
normally masked by a depolarization due to the VIP-induced concomitant 
release of substance P (He & Goyal, 1993). Thus, NO clearly functions as a 
NANC neurotransmitter throughout the entire length of the small intestine.
1.3.5. The Ileocolonic Junction (ICJ)
By using specific inhibitors of the actions of NO, the ileocolonic junction 
was the first gastrointestinal tissue from which the release of NO was 
demonstrated.
Electrical stimulation produced NANC relaxation and hyperpolarization of 
the canine ICJ (Bult et al, 1990 ; Boeckxstaens et al, 1991a,b ; Ward et al, 
1992a). Both the relaxation and hyperpolarization were mimicked by authentic 
NO and antagonized by Hb. The inhibitors of NO synthase, L-NMMA and 
L-NNA, but not D-NMMA, inhibited the relaxations in response to nerve 
stimulation in a concentration-dependent manner (Bult et al, 1990 ;
Boeckxstaens et al, 1991a,b). This inhibition was antagonized by the precursor 
for NO synthesis, L-arginine, but not by D-arginine, thus implicating NO in the 
NANC nerve responses. In support of this, the relaxations were potentiated by 
SOD and mimicked by GTN (Bult et al, 1990 ; Boeckxstaens et al, 1991b). 
M&B 22948, a specific cGMP phosphodiesterase inhibitor, hyperpolarized 
canine ICJ (Ward et al, 1992a) suggesting that, in this tissue, NO was also 
tonically released. This tonic release may have helped regulate resting 
membrane potential or tone in the ICJ (Ward et al, 1992a).
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1.3.6. The Colon
In the canine proximal colon, i.j.p.'s induced by electrical stimulation of 
NANC nerves, may have been mediated by Ca++-activated K+ channels 
(Thombury et al, 1991). These i.j.p.'s were reduced by L-NAME (Dalziel et al,
1991) and restored by L-, but not by D-arginine. Hb blocked not only neuronal 
responses, but also the similar hyperpolarizations that occurred in response to 
authentic NO or S-nitrosocysteine (Thombury et al, 1991). Since 
S-nitrosocysteine was degraded at a sufficient rate to cause i.j.p.-like 
hyperpolarizations, these authors suggested that NO could be stored as a 
nitrosothiol in nerve terminals.
In the rat, colonic smooth muscle was tonically suppressed by NO or a 
related substance. L-NNA enhanced the spontaneous contractile activity of 
circular muscle of rat distal colon (Niklasson et al, 1992). Moreover, TTX 
increased the force of low frequency contractions before, but not after, 
incubation of the tissue with L-NMMA (Middleton et al, 1993). L-NMMA, 
but not D-NMMA, also increased the force of low frequency contractions. 
This increase was counteracted by L-arginine, implicating the tonic release of 
NO.
1.3.7. The Internal Anal Sphincter (IAS)
NANC nerve stimulation induced the IAS to relax (Lim & Muir, 1983). 
VIP has been suggested as a leading candidate for the role of NANC 
neurotransmitter in this tissue (Biancani et al, 1985 ; Nurko & Rattan, 1988) 
but, as in gastric fundus, NO is also likely to be involved.
For example, authentic NO relaxed IAS smooth muscle strips from 
opossums. In addition, L-NNA inhibited NANC relaxations in opossum and in 
human IAS, and these inhibitions were prevented by L-arginine (Rattan & 
Chakder, 1992 ; Burleigh, 1992). The superoxide generator hydroquinone,
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depressed the inhibitory nerve responses and was reversed by SOD (Chakder & 
Rattan, 1992). These observations implicated NO as a NANC transmitter in 
IAS. Interestingly, VIP-induced falls in IAS tension were also suppressed by 
both L-NNA and hydroquinone. This hydroquinone response was inhibited by 
SOD. Therefore, in opossum IAS, NO or a NO-like factor did not only play a 
role in NANC nerve-mediated relaxations but was also, at least partly, 
responsible for the inhibitory actions of VIP.
In guinea pig IAS, field stimulation gave rise to NANC i.j.p.'s (Rae & Muir,
1994). In the presence of apamin, to block the fast i.j.p. component, a slower 
i.j.p. component was revealed. This was abolished by L-NAME and reduced 
by Hb. Following L-NAME-induced abolition, the slow i.j.p. was partially 
restored by L-arginine (Rae & Muir, 1994). In subsequent experiments, 
neurones in the myenteric plexus stained positively for NADPH diaphorase, 
known to label NO synthase (Rae & Muir, 1994). Clearly, the NANC slow 
i.j.p. in guinea pig IAS was mediated by the release of NO. The fast i.j.p. was 
proposed to involve purines and/or peptides (Rae & Muir, 1994).
1.4. Pathology of NO
Although direct evidence of a role for NO in the pathology of disease is 
relatively scarce, its heterogeneity of action and tissue distribution (see 
Moncada el al, 1991b) create a number of opportunities for an abnormality in 
the synthesis o f , or in the tissue response to NO, to lead to disease. Among 
other conditions, essential hypertension, septic shock and a host of 
gastrointestinal disorders may be due, at least in part, to such abnormalities.
NO was released under basal conditions in the vasculature (Palmer et al, 
1988b ; Rees el al, 1989). In hypertensive rats, endothelium-dependent 
relaxation was inhibited (Winquist et al, 1984 ; Luscher et al, 1987). Further, 
in patients with essential hypertension, ACh-induced vasodilatation of the
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brachial artery was reduced, while the response to SNP was unaffected or even 
enhanced (Linder et al, 1990 ; Panza et al, 1990). Findings such as these led to 
the belief that the loss of NO-induced vasodilator tone could contribute to the 
development of essential hypertension (see Moncada et al, 1991b).
Bacterial endotoxin or a number of cytokines activated the inducible NO 
synthase in endothelial cells (Radomski et al, 1990b ; Gross et al, 1991) or in 
vascular smooth muscle (Busse & Miilsch, 1990b) in vitro. In vivo, bacterial 
endotoxin caused septic shock. This condition, mediated by the release of 
cytokines, was manifest by cardiovascular collapse. The inhibitor of NO 
synthase, L-NMMA, reversed the vascular response to bacterial endotoxin, an 
action that could be subsequently reversed by L-arginine (Kilboum et al, 1990), 
indicating that overproduction of NO aided the development of septic shock. 
Later studies suggested that the immediate hypotension and vascular 
hyporeactivity to noradrenaline in this condition, resulted from activation of the 
constitutive NO synthase (Szabo et al, 1993). The delayed hypotension, 
vascular hyporeactivity and eventual cardiovascular collapse, resulted from 
activation of the inducible NO synthase (Szabo et al, 1993). Inhibitory 
analogues of L-arginine are currently under study for the treatment o f septic 
shock.
NO was released from inhibitory NANC nerves throughout the 
gastrointestinal tract (see 1.3.). Consequently, any impairment of this process 
or in the ability of NO to induce the normal tissue response could lead to 
disease. One such example, is achalasia. This was described as a failure of the 
LOS to relax normally, probably due to the selective dysfunction of inhibitory 
NANC nerves (Feldman, 1991) which, in this tissue, probably released NO (De 
Man et al, 1991 ; Tottrup et al, 1991 ; Conklin & Du, 1992 ; Knudsen et al,
1992). In support of this, nitro vasodilators were among the most effective 
pharmacological therapies for this condition (Feldman, 1991).
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For some time, it has been known that acute or chronic inflammation or 
immune activation altered gut motility. The discovery of the inducible NO 
synthase in macrophages and neutrophils (Hibbs et al, 1988 ; Stuehr et al, 
1989 ; McCall et al, 1991) makes it increasingly likely that NO could be a 
mediator of this inflammation and/or play a role in the alteration of 
gastrointestinal motility. For instance, in patients with Crohn's disease, 
degeneration occurred in the myenteric and submucous plexuses (Dvorak et al, 
1980). Examination revealed that the plexuses were infiltrated by a number of 
immunologically active cell types, including macrophages. It seems plausible 
that cytokines released from these cells could stimulate the inducible NO 
synthase in surrounding tissues, thereby augmenting the inflammatory 
response. Indeed, in the mucosa of colonic tissue from patients with ulcerative 
colitis, inducible NO synthase activity was eightfold greater than controls 
(Boughton-Smith et al, 1993), though the cell type from which this increased 
activity derived was unclear. Infiltrating inflammatory cells, resident 
macrophages, or vascular endothelial, smooth muscle, epithelial, or other 
mucosal cells were all suggested as possible sources (Boughton-Smith et al,
1993). This elevation of NO synthase activity could have contributed to the 
mucosal vasodilatation and increased vascular permeability observed in 
ulcerative colitis. It remains to be seen whether inhibitors of NO synthesis or 
compounds such as L-arginine which increase its release, will have a 
therapeutic value in the treatment of conditions such as these.
1.5. Excitatory Effects of NO-donors
Given that the potent vasorelaxing properties of NO donors i.e. the 
nitrovasodilators, were employed in the treatment of disease for many years, it 
was not suiprising that the vast majority of research into their actions focused 
on their inhibitory effects. It was only recently, following the revelation that
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NO functioned as a biological mediator, with the consequent elevation of 
interest in NO and related substances, that any evidence of their excitatory 
properties came to light. Nonetheless, it is now clear that these substances do 
possess excitatoiy effects, particularly in spontaneously active smooth muscle.
For instance, in guinea pig ileum, SNP, GTN or 8-bromo cGMP each 
enhanced the peristaltic reflex (Sugisawa et al, 1991). The SNP-induced 
stimulation, but not that induced by 8-bromo cGMP, was prevented by MeB. 
SNP did not alter the baseline tension of the preparation, nor did it affect the 
circular muscle response to nerve stimulation (Sugisawa et al, 1991). These 
workers postulated that NO was formed from SNP in mechanosensitive neurons 
and that the resultant elevation in cGMP levels increased the sensitivity of 
intestinal stretch receptors.
Electrical field stimulation of myenteric plexus-longitudinal muscle 
preparations from rat ileum evoked TTX-sensitive, NANC-mediated 
contractions (Bartho et al, 1992). The NO synthase inhibitor, L-NNA, 
inhibited these contractions in a concentration-dependent manner, and this 
inhibition was antagonized by the precursor for NO synthesis, L-arginine 
(Bartho et al, 1992). SNP produced a short-lived contraction of this smooth 
muscle preparation. However, these findings did not exclude the possibility 
that NO, could in fact, have caused the secondaiy release of an excitatory 
substance.
Secondaiy excitation in response to NO was reported in oesophageal 
longitudinal muscle. In this preparation, SNP, authentic NO or 8-bromo cGMP 
each evoked a concentration-dependent relaxation followed by a rebound 
contraction (Saha et al, 1993). Neither MeB, nor another guanylate cyclase 
inhibitor, LY-83583, affected the SNP-induced relaxation, but both abolished 
the contractions induced by SNP or NO. Likewise, the cyclooxygenase 
inhibitor, indomethacin, while having no effect on oesophageal smooth muscle 
relaxation, blocked the contractions due to SNP, NO or 8-bromo cGMP (Saha
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et al, 1993). Thus, in oesophageal longitudinal muscle of the opossum, the 
cGMP-dependent excitatory action of NO donors also involved products of the 
cyclooxygenase pathway. In the circular muscle of canine proximal colon too, 
NANC nerve stimulation led to NO-induced inhibition followed by contraction 
(Ward et al, 1992b). Endogenous eicosanoids were involved in the 
NO-associated rebound depolarization.
Excitatory effects of NO, or related compounds, were not restricted to 
gastrointestinal smooth muscle. Excitation also occurred in spontaneously 
active vascular smooth muscle. In rat portal vein, although the amplitude of 
spontaneous contraction and extracellularly-recorded discharges was decreased, 
the frequency of spontaneous electrical and mechanical events was increased 
by GTN (Bray et al, 1987 ; Wylie, 1988). This was attributed to a rise in the 
intracellular cGMP concentration (Wylie, 1988).
Clearly, the mechanisms behind these actions were not the same in every 
tissue. In guinea pig ileum, the nitrovasodilator-induced increase in cGMP 
levels may have acted to increase the sensitivity of stretch receptors (Sugisawa 
et al, 1991). In canine proximal colon and opossum oesophagus, the excitation 
succeeded a preliminary relaxation and may have been partly or wholly 
mediated by eicosanoids (Ward et al, 1992b ; Saha et al, 1993). In other 
tissues, such as rat portal vein or ileum, (Bray et al, 1987 ; Wylie, 1988 ; 
Bartho et al, 1992), the mechanisms were less well understood. This thesis 
represents attempts made to examine the mechanisms behind the actions of the 
nitrovasodilators, in particular SNP, on pacemaker driven smooth muscle in 
vitro.
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1.6. Aims of the thesis
So far, the evidence has implicated NO as the EDRF from vascular tissues 
(see Moncada et al, 1991b) and as a neurotransmitter in many areas of the 
gastrointestinal tract (see Rand, 1992). To date, the most frequently described 
effects of NO have been inhibitoiy. However, many, if not most, established 
transmitters have demonstrated, either directly or indirectly, both inhibitory and 
excitatory properties. For instance, noradrenaline acting on a-adrenoceptors 
constricts vascular smooth muscle but relaxes gastrointestinal smooth muscle. 
Similarly, ACh's stimulation of muscarinic receptors in the gut causes 
contraction but, on endothelial cells, mediates the release of EDRF. There is , 
therefore, the possibility that inhibition is not the only type of physiological 
response to NO. Perhaps the ability to cause excitation is an inherent, but as 
yet undiscovered property of this molecule.
On the whole, it must be said that reports of NO-induced excitations are 
few. Yet, such actions could have important pharmacological, as well as 
clinical, implications. For instance, is it possible that the excitatoiy phenomena 
observed in some tissues could be mediated via a second messenger system that 
is distinct from guanylate cyclase/cGMP or are they, perhaps, the result of an 
action of NO on the smooth muscle pacemaker? Further, since the relaxant 
properties of nitrovasodilators are used in the treatment of a number of 
conditions including angina pectoris, congestive heart failure, hypertensive 
emergencies and achalasia, would any concomitant excitation compromise the 
therapeutic usefulness of these compounds? For example, GTN reduced the 
amplitude of spontaneous contraction in rat portal vein but the frequency of 
activity was increased (Bray et al, 1987 ; Wylie, 1988). Would this reduce the 
efficiency of these compounds for the treatment of hypertension or 
hypertensive emergencies? Moreover, nitro-vasodilators, whether directly or 
indirectly, stimulated contraction in a variety of gut smooth muscles from the
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oesophagus to the colon (Sugisawa et al, 1991 ; Bartho et al, 1992 ; Ward et al, 
1992 ; Saha et al, 1993). Would this make them any less useful for the 
treatment of gut disorders such as achalasia? Would the concomitant 
administration of a cyclooxygenase inhibitor, to inhibit secondary prostaglandin 
release, enhance their efficacy? Despite the potential importance of these 
findings, to date, an extensive study of the mechanisms behind the stimulatory 
actions of the nitro'vasodilators has not been undertaken.
In light of these facts, the effects and underlying mechanisms of the 
nitrovasodilators were examined on spontaneously active smooth muscle, in 
vitro, from the gastrointestinal and cardiovascular systems ; namely the rabbit 
distal colon (RDC) and the rat portal vein (rat PV). The excitatory properties, 
if  any, of the nitrovasodilators were of specific interest but their inhibitory 
properties were also examined. In order to examine these mechanisms, a 
variety of techniques were employed. These included the testing of agonist and 
antagonist drugs on the spontaneous extracellular electrical and mechanical 
activity of each tissue and measuring the effects of SNP on 86Rb efflux, 
radiolabelled transmitter (3H-noradrenaline) overflow and Ca++ mobilization or 
sequestration.
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Chapter 2 : Methods
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2.1. Choice of Tissues
Nitrovasodilators are used to treat a number of conditions in both the 
gastrointestinal and cardiovascular systems e.g. achalasia, angina pectoris, 
congestive heart failure. It was desirable to examine the effects of these drugs 
on smooth muscle preparations from each of these systems. When selecting the 
tissues to be examined, two main factors were considered. Firstly, since much 
of the evidence for nitrovasodilator-induced excitation has come from 
spontaneously active smooth muscles (Bray et al, 1987 ; Wylie, 1988 ; 
Sugisawa et al, 1991 ; Bartho et al, 1992), each tissue should have been 
spontaneously active. Secondly, for the sake of physiological relevance, NO 
should have been released from each tissue chosen, either as a neurotransmitter, 
or as a humoral factor.
The RDC was selected since it was spontaneously active and since the 
spontaneous electrical activity (Gillespie, 1962 ; see Sanders & Smith, 1989) 
and motility (see Christensen, 1989) of colonic smooth muscle had been well 
described. In addition, gut smooth muscle was known to receive a dense 
NANC innervation (Bumstock et al, 1963 ; Martinson, 1965 ; Holman & 
Hughes, 1965 ; Bianchi et al, 1968) which utilized NO (Li & Rand, 1990 ; 
Toda et al, 1990 ; Bult et al, 1990 ; Dalziel et al, 1991). It was necessary to 
demonstrate a neural role for NO in the RDC, before commencing the 
investigation.
The rabbit portal vein (RPV) was originally chosen as the second tissue 
since, in addition to releasing endothelium-derived NO, it was innervated by 
NANC nerves (Hughes & Vane, 1967) which released both ATP and NO 
(Brizzolara et al, 1993). Moreover, the portal vein was a spontaneously active 
blood vessel. However, preliminary experiments revealed the rat portal vein 
(rat PV) to be more suitable for the study of the actions of the nitrovasodilators 
on spontaneous electrical and mechanical activity. For these reasons, the RDC
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and the rat PV were mainly used during this investigation though, on a few 
occasions, the effects of SNP were also examined on non-spontaneously active 
smooth muscle. On these occasions, rat anococcygeus or rabbit abdominal 
aorta were used.
2.2. Dissection of Tissues
2.2.1. Rabbit Distal Colon (RDC)
The colon lies in the midline of the abdominal and pelvic cavities 
suspended by the mesocolon which is a continuation of the parietal peritoneum 
of the dorsal abdominal wall (Gillespie, 1955). The distal colon originates at 
the junction of the superior and inferior mesenteric arteries (see Christensen, 
1989) and extends to the anal canal. Embryologically, development is from the 
hindgut (Lewis, 1912).
The outermost layer of the colon is the serosa. Beneath this lies an outer 
longitudinal and an inner circular muscle layer between which is the myenteric 
plexus. Meissner's plexus is foimd in the submucosa and the lumen is lined 
with mucosal cells. The circular muscle layer contracts on the faecal pellets 
within the lumen, giving the colon a characteristic beaded appearance. 
Gillespie (1955) found no evidence in the terminal colon of a specialized region 
for storage or evacuation. Thus, in the rabbit, the entire length of intestine that 
in humans would include the rectum and anal canal, is here considered simply 
as the colon.
Adult New Zealand White (NZW) male or female rabbits (1.3-3.5 kg) were 
killed by C 0 2 (BOC) or sodium pentobarbitone (Euthatal ; 200mg m l'1) 
overdose (140mg kg-1), in a gas chamber or by intra-arterial injection 
respectively, then bled. When using C 0 2, anaesthesia was induced in under 2 
min whilst with sodium pentobarbitone, induction generally took less than 5 s.
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Immediately following death, a midline incision was made in the abdomen, the 
peritoneal cavity exposed and the gastrointestinal tract displaced. During 
dissection, tissues were kept moist with Krebs solution (see 2.9 for formula) 
bubbled with 95% 0 2 and 5% C 0 2 (pH-7.4). In male rabbits, the vasa 
deferentia and seminal vesicles and in females the uterus, were removed. In 
each case the pubic symphysis was split to reveal the distal colon ; the bladder 
and urethra were discarded. The colon was ligated 6-8 cm proximal to the anus 
and this terminal section removed to a Sylgard (Dow-Coming)-coated petri dish 
containing oxygenated (95% 0 2 ; 5% C 0 2) Krebs solution at room temperature. 
The tissue was trimmed free of fat and connective tissue before being opened 
longitudinally and faeces removed. The tissue was then transferred to a clean 
petri dish containing fresh oxygenated (95% 0 2 ; 5% C 0 2) Krebs solution and 
the mucosa removed by shaip dissection under a microscope (Carl Zeiss). The 
colon was cut into longitudinal (0.2 x 1.5 cm) or circular strips (0.3 x 2 cm), 
i.e. they were cut longitudinally or circularly, as required.
2.2.2 Rat or Rabbit Portal Vein (Rat PV or RPV)
Veins have three coats comprising an inner endothelial layer (tunica 
intima), a central layer of elastic and smooth muscle cells (tunica media) and an 
outer layer of connective tissue (tunica adventitia). The hepatic portal vein 
conveys blood from the gut to the liver. This blood vessel originates from the 
junction of the anterior mesenteric and lienogastric veins and courses ventrally 
for a short distance before entering the lobes of the liver (see Wells, 1961). 
The anterior mesenteric vein drains the ileum, caecum and upper part of the 
rectum, while the lienogastric vein drains the stomach and spleen. Below the 
junction with the lienogastric vein, the duodenal and posterior mesenteric veins 
also merge with the anterior mesenteric vein (see Wells, 1961). Like 
gastrointestinal smooth muscles, the portal vein possesses an outer longitudinal
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and an inner circular muscle layer (see Sutter, 1990). This was the first 
discovered spontaneously active blood vessel.
Adult male Wistar rats (200-400 g) were killed by stunning then bled whilst 
adult male or female NZW rabbits (1.3-3.5 kg) were killed as previously 
described (2.2.1.). In each case, following a midline abdominal incision, the 
peritoneal cavity was exposed and the gastrointestinal tract displaced. During 
dissection, tissues were kept moist with oxygenated (95% 0 2 ; 5% C 0 2) Krebs 
solution. Portal veins were exposed and cleared of surrounding tissue. The 
length of portal vein from the junction of the anterior mesenteric and 
lienogastric veins, to the bifurcation of the portal vein into left and right 
branches (2-3 cm ; Hughes & Vane, 1967), was removed to a Sylgard (Dow 
Coming)-coated petri dish containing Krebs solution bubbled with 95% 0 2 and 
5% C 0 2 at room temperature. Using a microscope (Carl Zeiss), veins were 
cleaned free of fat and connective tissue before being used.
2.2.3. R at Anococcygeus
The anococcygeus consists of parallel bundles of longitudinal smooth 
muscle fibres, that originate from a tendinous attachment to coccygeal 
vertebrae 1 and 2. Each muscle runs caudally behind the colon before passing 
ventrally around either side of the terminal colon where they fuse to form a 
Ventral bar' (Gillespie, 1972). Due to its close proximity to the terminal colon, 
the anococcygeus may be involved in the defaecation reflex (McGrath, 1973).
Following a midline abdominal incision, the vasa deferentia and seminal 
vesicles were removed from the freshly killed male rat (200-400g ; see 2.2.2.), 
the pubic symphysis split, and the bladder and urethra discarded. The colon, 
ligated and cut at the level of the pelvic brim, was pulled forward and the 
connective tissue behind it removed, until the two anococcygeus muscles were 
visible. Either muscle was ligated at its point of attachment to the coccygeal
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vertebrae and at the 'ventral bar'. Each anococcygeus (2-3 cm) was then 
transferred to a Sylgard (Dow Coming)-coated petri dish, containing 
oxygenated (95% 0 2 ; 5% C 0 2) Krebs solution at room temperature, and 
trimmed free of fat and connective tissue under a microscope (Carl Zeiss) 
before being used.
2.2.4. Rabbit Abdominal Aorta
Arteries, including the aorta, like veins, possess intimal, medial and 
adventitial layers. As blood leaves the heart it enters the aorta. This main 
artery runs caudally from the left ventricle through the thorax and abdomen to 
its bifurcation into the common iliac arteries (see Wells, 1961). That stretch of 
aorta which is enclosed in the thorax is generally known as the thoracic aorta, 
whilst that which is exposed in the abdomen is generally known as the 
abdominal aorta.
Adult male NZW rabbits (1.3-3.5 kg) were killed as previously described 
(see 2.2.1.). Following a midline abdominal incision, the vasa deferentia and 
seminal vesicles were removed from the freshly killed animal, the abdominal 
aorta exposed and cleared of surrounding tissue. The length of aorta, from the 
coeliac artery, to its bifurcation into left and right branches of the common iliac 
artery (5-6 cm), was transferred to a Sylgard (Dow Coming)-coated petri dish 
containing Krebs solution aerated with 95% 0 2 and 5% C 0 2, at room 
temperature. The aorta was cleaned free of fat and connective tissue under a 
microscope (Carl Zeiss) before being cut into sections (0.2 x 2 cm) and used.
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2.3. Analysis of NANC nerve responses in RDC 
Apparatus
Following lg calibration, circular strips (0.3 x 2 cm) of RDC were mounted 
in oxygenated (95% 0 2 ; 5% C 0 2) Krebs solution in a water jacketed (25 ml) 
organ bath at 37 ± 1°C for isometric tension recording of the response to 
NANC nerve stimulation and drugs. One end of each tissue was fixed, by 
thread, to an isometric force-displacement transducer (Grass FT03C) connected 
to a polygraph (Grass 7D), while the other was tied to a hook on the stimulating 
electrode (Fig. 7). Where possible, the optimal point of the length-tension 
relationship was determined by increasing the length of each strip 
incrementally. At each length, the tissues were stimulated electrically (8 pulses 
at 8 Hz, 40V supramaximal voltage, 0.2 ms) until the optimal length (i.e. that 
which gave the maximum contraction) was reached. The tissues were then 
allowed to equilibrate at this length for at least 30 min before experimentation. 
However, in a few tissues, only relaxations followed by rebound contractions 
(rather than initial contractions) were obtained in response to nerve stimulation, 
no matter the level of tension applied. In these cases, the muscle strips were 
allowed to equilibrate with a tension of approximately lg, for at least 30 min. 
Experiments were conducted in the presence of phentolamine and propranolol 
(each 3 x 10_6M) to respectively block a- and p-adrenoceptors, thus ensuring 
that the nerve responses were indeed non-adrenergic. Carbachol (3 x 10"5M) 
was used to raise tone. Electrical stimulation was achieved using Ag/AgCl ring 
electrodes (0.5 cm outside diameter) by passing square wave pulses (40V, 0.1- 
0.5 ms at 0.5-16 Hz) from an electrical stimulator (Grass SD9). Drugs were 
added directly to the Krebs solution.
Ag/AgCI 
ring electrodes
F To isolated stimulator
5mm
Epoxy resin
Stainless steel hook
Fig. 7 : Stimulating electrode for the measurement of the response to NANC nerve 
stimulation (16 pulses, 40V, 0.1-0.5ms, 0.5-16Hz). Circular strips o f  rabbit distal 
colon (0.3 x 2 cm) were pulled through the Ag/AgCI ring electrodes and one end 
was tied to a hook on the electrode assembly while the other was fixed, by thread, 
to an isometric force displacement transducer (Grass FT03C). Responses were 
recorded on a polygraph (Grass 7D). Tone was raised by carbachol (3 x 10‘5M). 
Phentolamine and propranolol (each 3 x 10'^M) were present throughout to ensure 
that responses were non-adrenergic.
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2.4. Analysis of activity in spontaneously active smooth muscles 
Apparatus
The Golenhofen apparatus (Golenhofen & von Loh, 1970 ; Fig. 8) was used 
since this allowed the simultaneous recording of extracellular electrical and 
mechanical events from many muscle cells. This equipment consists of four 
platinum wire ring electrodes (inside diameter approximately 2mm) contained 
within a narrow, water jacketed (37 ± 1°C) glass capillary (inside diameter 
approximately 2.5mm) perfused with oxygenated (95% 02 ; 5% C 0 2) Krebs 
solution. These electrodes could be used for either recording or stimulating as 
required. Mechanical signals were calibrated for lg  whilst electrical signals 
were calibrated by passing 0.1 mV from an A.C. preamplifier (Neurolog 
NL103).
Longitudinal strips of RDC (0.2 x 1.5cm) or intact segments of rat PV, 
RPV, rat anococcygeus or rabbit abdominal aorta (each 1-1.5cm in length) 
were pulled gently through the internal capillary of the Golenhofen apparatus 
and mounted between the electrodes. One end of each tissue was fixed by 
thread to an anchor hook (see Fig. 8) while the other was similarly attached to 
an isometric force displacement transducer (Grass FT03C), connected to a 
polygraph (Beckman R-611/R-511A or Grass 7D). Strips of RDC were left 
virtually unstretched (0.1-0.4g tension) while, to the other tissues, a resting 
tension of lg approximately was applied. Each tissue was allowed to 
equilibrate for approximately 45 min before the experiment began.
The recording electrodes were connected to an A.C. preamplifier (Neurolog 
NL103, low frequency cutoff 0.1Hz) and the signals filtered (Neurolog 
NL115). Both electrical and mechanical signals were amplified via a cathode 
ray oscilloscope (Tektronix, 5103N) before being recorded on, and further 
amplified by, an ultraviolet oscillograph (EMI, SE 6150 Mk II). Responses 
were permanently recorded on a 4-channel instrumentation tape recorder
Fig. 8 : The Golenhofen apparatus (Golenhofen & von Loh, 1970).
The tissue to be investigated was passed through a narrow, water-jacketed 
(37 ± 1°C) glass capillary perfused (3 ml m in'1) with oxygenated (95% 0 2 ; 5% 
C 0 2 ) Krebs solution, as indicated, and mounted between four platinum wire ring 
electrodes for extracellular electrical recording. One end o f each tissue was tied, 
by thread, to an anchor hook, while the other was similarly attached to an isometric 
force displacement transducer (Grass FT03C).
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(Racal, Store ,^-DS). Drugs were added to oxygenated (95% 0 2 ; 5% C 0 2) 
Krebs solution, which was pumped through polythene tubing (inside diameter 
3mm) using a Gilson pump (Minipuls 3) at a rate of 3 ml min-1. Before 
entering the Golenhofen apparatus, the Krebs solution flowed through a heat 
exchange coil, jacketed with water (37 ± 1°C) pumped by a Tecam (TWB) 
pump.
Spontaneous activity in RDC, RPV or rat PV, as measured from the 
Golenhofen apparatus, consisted largely of discrete bursts of action potentials 
which preceded, or were accompanied by, corresponding bursts of contraction 
(Figs. 9-11). The following parameters of activity (as indicated in Fig. 9) were 
measured:
a) frequency of bursts of spiking (bursts min-1)
b) maximum spike amplitude per burst of electrical activity (mV)
c) number of electrical spikes per burst (spikes burst-1)
d) duration of each electrical burst (s)
e) frequency of contractile bursts (bursts min-1)
f) maximum contraction per burst of mechanical activity (g)
g) number of mechanical peaks per burst (peaks burst-1)
h) duration of each mechanical burst (s)
For the purpose of this study, discrete electrical events were considered as 
bursts, even if they contained only a single spike. Similarly, discrete 
contractions were considered as bursts of mechanical activity, even if they 
contained only a single mechanical peak.
Each parameter was measured during the four minutes immediately prior to 
drug addition and compared with those four minutes after addition, when the 
drug was considered to be having its maximum effect. Washout of drug was 
always within 20 min. Each measurement was made, as far as possible,
3 bursts min
Fig. 9 : The spontaneous electrical (top) and mechanical activity
recorded from an unstretched, longitudinal strip o f  rabbit distal colon 
in the Golenhofen apparatus. Each burst o f electrical spiking was 
accompanied by contraction i.e. electrical and mechanical activity were 
synchronized. Each parameter o f activity measured is indicated.
w L M M ft
20s
Fig. 10 : The spontaneous electrical (top) and mechanical activity 
recorded from the rabbit portal vein, under a resting tension o f 
approximately lg, in the Golenhofen apparatus. Each burst o f 
electrical spiking was accompanied by contraction i.e. electrical and 
mechanical activity were synchronized.
20s
Fig. 11 : The spontaneous electrical (top), .and mechanical activity 
recorded from rat portal vein, under a resting tension o f  approximately 
lg , in the Golenhofen apparatus. Each burst o f electrical spiking was 
accompanied by contraction i.e. electrical and mechanical activity were 
synchronized.
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visually, by the naked eye. Generally, this presented no problem with any 
measurement other than that of the number of electrical spikes per burst. 
Sometimes, spiking was so frequent, particularly in portal vein, that it was 
extremely difficult to measure this parameter. Rarely in RDC, electrical 
spiking was continuous not burstlike, and was accompanied by very rapid, 
frequent contraction (Fig. 12). In these cases, in the RDC, the only parameter 
measured was the frequency of contraction.
2.5. Radiolabelled Rubidium (MRb)  Efflux
In these experiments, it was intended to measure the movement of K+ 
across the cell membrane in response to drugs. Radiolabelled rubidium (86Rb), 
a marker for K+ (Imaizumi & Watanabe, 1981 ; Martin & Gordon, 1983 ; 
Hamilton et al, 1986), was used to monitor this movement in strips of RDC and 
in intact sections of rat PV, simultaneously with measurements of spontaneous 
electrical and/or mechanical activity. 86Rb was chosen in place of 42K, as the 
longer half-life of this isotope (18.4 days as compared to 12 hr for 42K) made it 
more convenient and economical to use. This method has been routinely used 
to monitor K+ movement for some time (Imaizumi & Watanabe, 1981 ; Martin 
& Gordon, 1983 ; Hamilton et al, 1986).
Strips of RDC, or intact segments of rat PV, were dissected as previously 
described (see 2.2.1. and 2.2.2.) and incubated in oxygenated (95% 0 2 ; 5% 
C 0 2) Krebs solution (36 ± 1°C) containing 86RbCl (5-10 pCi m l'1) for 2-3 h. 
After incubation, tissues were rinsed for approximately 3 min in ice cold, 
nonradioactive Krebs solution, to remove excess isotope, before being drawn 
through and mounted between the platinum wire ring electrodes of the 
Golenhofen apparatus, as previously described (see 2.4.). The equipment for 
amplification, filtration and recording of electrical and mechanical signals was 
also the same as that previously described (see 2.4.). The tissue was perfused
500 (iv
20s
20s
CT.2g
0.3g
Fig. 12 : The spontaneous electrical (top) and mechanical activity 
recorded from an unstretched, longitudinal strip o f rabbit distal colon 
in the Golenhofen apparatus. In this case, activity was not burst-like, 
but was continuous.
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(3 ml m iir1) with warm (37 ± 1°C) Krebs bubbled with 95% 0 2 and 5% C 0 2, 
for the duration of the experiment. Drugs were added to the external Krebs 
reservoir. A fraction collector (Pharmacia Fine Chemicals, Frac-100) was used 
to automatically collect samples (6 ml) of superfusate eveiy 2 min throughout 
the experiment (Fig. 13). Scintillation fluid (10 ml ; Ecoscint A ; National 
Diagnostics) was added to each fraction collected and the level of 86Rb 
measured with a scintillation counter (Packard 2000 CA) as counts per minute 
(cpm). At the end of the experiment, the tissue was dissolved in soluene-100 
(1 ml ; Packard) and the amount of 86Rb remaining in the tissue measured. 
Data were expressed in terms of the efflux rate constant (E ; see 3.3.2.). The 
mean efflux rate constant during the 10 min prior to drug addition was 
calculated, and compared with the mean value for the 10 min immediately 
following drug addition.
2.6. Radiolabelled 3H-NoradrenaIine Overflow
The release of noradrenaline from nerve terminals cannot be measured 
directly (see Starke, 1977). Methods commonly used to measure, indirectly, 
the release of noradrenaline include evaluating the response of the postsynaptic 
cell or measuring, either chemically or radiochemically or by bioassay, the 
quantity of noradrenaline or of noradrenaline plus its metabolites that overflows 
into the incubation medium (see Starke, 1977). When adopting the 
radiochemical method, it should be remembered that a large part of the total 
radioactive release will be due to metabolites of noradrenaline. Though 
noradrenaline can be separated from its metabolites this is a lengthy process. 
Fortunately, it has been claimed that the overflow of total radioactivity 
approximates to release more closely than does the overflow of noradrenaline 
alone (see Starke, 1977). In this study, the release of noradrenaline and its 
metabolites from rat portal vein in response to drugs was measured,
Fig. 13 : Apparatus for measuring 86Rb efflux or 3H overflow. Each tissue 
loaded with either 86RbCl or [3H]-noradrenaline was passed through the 
platinum wire ring electrodes of the Golenhofen apparatus and perfused 
(3 ml min"l) with oxygenated (95% 0 2  ; 5% CO2  ) Krebs solution as 
before. One end of each tissue was tied, by thread, to an anchor hook while 
the other was similarly attached to an isometric force displacement 
transducer. The perfusate was collected eveiy 2 min using a fraction 
collector.
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radiochemically, by labelling the stores of transmitter in the nerves. The 
overflow was then analysed for radioactivity. In this case, the term 'overflow' 
is defined as the amount of neurotransmitter or its metabolites that escaped the 
uptake process and was collected from the tissue.
Rat PV's were dissected as previously described (see 2.2.2.) and incubated
>
in oxygenated (95% 0 2 ; 5% C 0 2) Krebs solution (36 ± 1°C) containing 
[3H]-noradrenaline (78 pCi ml-1, 2 x lO^M) for approximately 45 min, then 
rinsed (3 min) with ice cold Krebs solution to remove excess radioactivity, 
before being mounted in the Golenhofen apparatus. The apparatus was as 
previously described for the measurement of 86Rb efflux.
Portal veins, previously incubated with [^H]-noradrenaline, were 
superfused (3 ml min-1) in the Golenhofen apparatus throughout each 
experiment with oxygenated (95% 0 2 ; 5% C 0 2) Krebs solution containing 
ascorbic acid (1.1 x 10-4M) to inhibit catecholamine oxidation, imipramine 
(6 x 10-7M) and normetanephrine (10-5M) to repectively block uptake 1 and 
uptake 2, tranylcypromine (10-5M) to inhibit monoamine oxidase and 
yohimbine (10-7M) to block presynaptic a 2-adrenoceptors. Use of these 
conditions, was intended to optimize the presynaptic release of noradrenaline in 
response to drugs.
Samples (6 ml) of superfusate were collected automatically every 2 min 
using a fraction collector (see Fig. 13 ; Pharmacia Fine Chemicals, Frac-100) 
and added to scintillation fluid (10 ml ; Ecoscint A ; National Diagnostics). 
The amount of 3H per sample was measured with a scintillation counter 
(Packard 2000 CA). To overcome the problem of radioactive 'quenching', the 
amount of 3H in cpm was corrected for the efficiency of the counter and 
converted to disintegrations per minute (dpm). At the end of the experiment, 
the tissue was dissolved in soluene-100 (1 ml ; Packard) and the amount of 3H 
remaining in the tissue measured. Data were expressed in terms of the 
overflow rate constant (O ; see 3.5.3.). The mean overflow rate constant during
In retrospect:
The design of the experimental protocol for experiments that examined the 
overflow of [3H]-noradrenaline from rat portal vein could have been improved. 
These experiments showed that tyramine increased 3H overflow in the presence 
of the uptake-1 blocker, imipramine (6 x 10-7M). It would have been better to 
have omitted imipramine since this blocks the uptake mechanism utilized by 
tyramine to induce its effects. Alternatively, the more lipid soluble 
amphetamine, which is not entirely dependent upon the uptake-1 mechanism 
for its effects, could have been used - again without imipramine.
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the 10 min prior to drug addition was calculated, and compared with the mean 
value for the 10 min immediately following drug addition.
2.7. Measurement of [C a++]j
The measurement of cytoplasmic Ca++ concentration ([Ca++])j in 
mammalian cell populations was not| possible until the development of the 
fluorescent Ca++ indicator, quin-2 (Tsien et al, 1982a,b). This substance had 
both Ca++-binding and fluorescence properties and could detect changes in 
[Ca++]j in the physiological range (nm-pm). However, quin-2 was far from 
ideal. This compound did not undergo a very large shift in excitation or 
emission wavelength following Ca^-binding. Hence, as [Ca++]j measurement 
with quin-2 was reliant on absolute fluorescence changes, any changes in 
fluorescence which were not due to changes in [Ca++]j could lead to errors. 
Moreover, a high cytosolic concentration of quin-2 was necessary. Some of 
these problems were overcome by the development of another class of Ca4-1" 
indicators which included fura-2 (Grynkiewicz et al, 1985). The advantage of 
fura-2 over quin-2 was in its ability to increase fluorescence emission upon 
Ca++ binding. In this study, fura-2, rather than quin-2 was used to measure 
[Ca++],
Monolayeri of rat aortic vascular smooth muscle cells were incubated for 
45 min, at 37°C, with the membrane permeant, penta-acetoxymethyl ester form 
of fura-2 (2 pM ; fura-2/AM ; Sigma) in HEPES (20 mM)-buffered Dulbecco's 
modification of Eagle's medium (DMEM ; Gibco brl) containing 1% bovine 
serum albumin (Fraction V ; Sigma) and cremophor (2 pi ml-1 ; Sigma). At the 
end of this loading period, the cells were transferred to HEPES-buffered Krebs 
solution. The cells were left in this solution for 30 min at room temperature, to 
allow the extracellular fura-2/AM to be washed from the cells and the 
hydrolysis of fura-2/AM to the Ca++-sensitive acid form. Coverslips with
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fura-2 loaded cells were placed in a quartz cuvette, which contained HEPES
\
(10 mM)-buffered Krebs solution, in a spectrofluorimeter (Perkin Elmer 
LS3B), at an angle of 30° to the excitation beam (Fig. 14). This angle 
minimized the scattering of light towards the emission monochromator. The 
cuvette was maintained at 37°C and stirred continuously throughout the 
experiment. In order to check the viability of the cells, they were stimulated 
with angiotensin II (100 nM). The excitation monochromator was computer 
driven (IBM-PCAT ; Fig. 14) and alternated between 340 nM and 380 nM 
every 3.8s. Fluorescence emission was collected at 509 nM. At the end of 
each experiment (5 min after agonist stimulation), ionomycin (1 pM) and 
MnCl2 (20 mM) were added, to permeabilize the cells to divalent cations and to 
quench intracellular fura-2 fluorescence respectively. This allowed the 
calculation of auto-fluorescence (Hallam et al, 1988). Following subtraction of 
autofluorescence, the corrected fura-2 fluorescence values obtained at 340 nM 
were divided by those obtained at 380 nM, giving a corrected ratio (R). The 
equation of Grynkiewicz et al (1985) was used to calculate [Ca++] j :
[Ca++]| = Kd x [(R - Rmin) / (Rmax - R)] x Sa  / Sb2
where Kd is the dissociation constant for the Ca++-fura-2 complex ; Rinill is the 
minimal ratio (F34{) : F380) obtained in Ca++-free medium (with 40 mM 
EGTA) ; Rmax is the maximal ratio (F340 : F 380) obtained in medium 
containing saturating concentrations of Ca++ ; s f2 and Sb2 are the fluorescence 
emissions, measured at an excitation wavelength of 380 nM in the absence of 
Ca++, and in the presence of saturating levels of Ca++, respectively. At 37°C, a 
value of 225 nM was assumed for the Kd of the fura-2-Ca++ complex. Smooth 
muscle cells in suspension (in the presence of 40 mM EGTA the cells were 
detached from the glass cover slip) gave the following experimental calibration
Fig. 14 : Diagrammatic representation of the experimental apparatus for the 
measurement of [C a ++]j in rat aortic vascular smooth muscle cells (adapted 
from Buchan, 1991). To measure [C a ++]j, fura-2-loaded monolayers of 
vascular smooth muscle cells on glass cover slips were placed in a quartz 
cuvette containing HEPES (lOmM)-buffered Krebs solution (37°C) in a 
spectrofluorimeter (Perkin Elmer LS3B). The excitation monochromator 
was computer driven (IBM-PCAT) between 340nm and 380nm every 3.8s. 
Fluorescence emission data was collected at 509nm. At the end of each 
experiment [C a ^ J i was calculated.
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values that were used throughout to calculate [Ca++]j : Rmjn = 0.84, 
Sf2  / Sb2 = 5.25. Rmax was calculated at the end of each experiment.
2.8. Statistics
Where appropriate, results were expressed as the mean ± the standard error 
of mean (s.e. mean) ; n = the number of observations. Student's t-tests (paired 
or unpaired as appropriate) were used to test for significant differences 
(P < 0.05) between means.
2.9 Physiological Solutions
The Krebs physiological saline solution (Krebs & Henseleit, 1932) used 
during this study had the following ionic composition (mM) : NaCl 118.4, 
KC1 4.7, CaCl2 2.7, MgCl2 1.3, NaH2PC> 4 1.1, NaHC03 25.0 and (+)-glucose 
11.0. The pH was ~ 7.4.
2.10. Drugs
The following di*ugs were used : acetylcholine chloride (ACh ; Sigma), 
adenosine 5'-triphosphate (ATP ; Sigma), angiotensin II (Sigma), (-)-ascorbic 
acid (Sigma), atropine sulphate (Sigma), BAY K 8644 [methyl 1, 4-dihydro-2, 
6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)-pyridine-5-carboxylate ; kindly 
donated by Bayer A.G.], bovine haemoglobin (Sigma), BRL 38277 [(-)-6- 
cyano-3,4- dihydro-2,2- dimethyl- trans-A- (2-oxo-l-pyrrolidyl)-2H-l- benzo- 
pyran -3-ol ; lemakalim ; levcromakalim ; kindly donated by Smith Kline 
Beecham], 8-bromo cyclic guanosine monophosphate (8-bromo cGMP, sodium 
salt ; Sigma), carbamylcholine chloride (carbachol ; Sigma), diltiazem 
hydrochloride (Sigma), forskolin (Sigma), y-amino-n-butyric acid (GABA ;
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Sigma), glyceryl trinitrate (GTN ; kindly donated by Bard Pharmaceuticals), 
imipramine hydrochloride (Sigma), indomethacin (Sigma), isoprenaline 
sulphate (Macarthy's), isosorbide dinitrate (IDN ; Sigma), (L)-arginine (Sigma), 
2-methylthio adenosine triphosphate (2-methylthio ATP ; tetrasodium salt ; 
Research Biochemicals Incorporated), NG-nitro-D-arginine methyl ester 
(D-NAME ; Sigma), NG-nitro-L-arginine methyl ester (L-NAME ; Sigma), 
(-)-7,8-[3H]-noradrenaline (Amersham International, 37 MBq, lmCi), 
(-)-noradrenaline bitartrate (Sigma), (±)-normetanephrine hydrochloride 
(Sigma), phentolamine mesylate (Rogitine ; Ciba), phenylephrine hydrochloride 
(Sigma), potassium ferrocyanide (K4Fe(CN)6 ; Hopkin & Williams), 
propranolol hydrochloride (ICI), rubidium hydrochloride (86RbCl ; Amersham 
International, 37MBq, lmCi), sodium nitroprusside (SNP ; BDH), tetrodotoxin 
(TTX ; Sigma), tranylcypromine sulphate (Parnate ; Smith Kline & French), 
tyramine hydrochloride (Sigma), vasoactive intestinal peptide (VIP ; Sigma), 
yohimbine hydrochloride (Boots).
Drug stock solutions were prepared in distilled water with the exception of 
BAY K 8644 (70% methanol), BRL 38277 (70% methanol) and forskolin 
(dimethyl sulphoxide), which were prepared in the solvents indicated. Unless 
otherwise stated, these solvents, alone, were shown to have no apparent effect 
on the tissues under examination. Subsequent dilutions were prepared in Krebs 
solution. Solutions of BAY K 8644 in a volumetric flask were protected from 
light by covering with aluminium foil. To prevent oxidation, solutions of 
isoprenaline sulphate and noradrenaline bitartrate each contained (-)-ascorbic 
acid (50 pg ml-1). (-)-7,8-[3H]-noradrenaline, supplied in a 0.02 M acetic acid : 
ethanol (9 : 1, v : v) mixture, was resuspended in Krebs solution containing 
ascorbic acid (50 pg ml-1), (-)-ascorbic acid alone did not have any effect on 
the chosen tissues.
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2.10.1. Preparation of Solutions of NO
Stock solutions of NO (10 pM) were prepared immediately before use. 
One end of a length of rubber tubing (inside diameter 3 mm) was attached to a 
NO (99.9%, Air Products Ltd., UK) containing cylinder and the other end 
submerged under water. Air was ejected from the tubing by passing NO gas 
from the cylinder. Using a Hamilton air-tight syringe, the tubing wall was 
pierced close to the cylinder and 4.5 pi of NO gas removed. This was injected 
immediately through the rubber seal of a brown bottle completely filled with 
helium (British Oxygen Company)-deoxygenated distilled de-ionized water. 
The solution of NO was protected from light by storing in the fridge until used, 
usually within one hour of preparation.
2.10.2. Preparation of Oxyhaemoglobin (Hb)
Commercially available bovine haemoglobin (Sigma) contained a mixture 
of oxyhaemoglobin and the oxidized derivative, methaemoglobin. Stock 
solutions of pure haemoglobin (oxyhaemoglobin ; Hb) were prepared by the 
method of Martin et al (1985). Commercially available haemoglobin (1.34 g) 
was dissolved in 19.5 ml distilled water. A length (30-40 cm) of dialysis tubing 
which had been boiled for 30 min in distilled water, was knotted at one end and 
a filter funnel placed in the open end. Sodium hydrosulphite (Na2S20 4 ; 
69.6 mg) was dissolved in distilled water (0.5 ml) and added immediately to 
the haemoglobin solution. After stirring for a few seconds, the mixture was 
poured into the dialysis tubing. The open end was tied and the dialysis tubing 
placed in a measuring cylinder containing one litre of distilled water at 4°C. 
This was inverted gently every hour and left to dialyse for 3 hr. When ready, 
1 ml aliquots of Hb were placed in Eppendorf tubes (1.5 ml) and frozen at 
-25°C. They were stored for up to 1 week before use.
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Chapter 3 : Results
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3.1. Evidence that NO is a NANC Neurotransmitter in 
the Rabbit Distal Colon
In circular strips of rabbit distal colon (RDC), carbachol (3 x 10_5M) raised 
the tone to 7.73 ± 0.67g (n = 44). Following this, field stimulation (16 pulses, 
0.1-0.5 ms, supramaximal voltage) produced frequency-dependent (4Hz 
optimum), tetrodotoxin (TTX)-abolished relaxations and rebound contractions 
(n = 31; Fig. 15). At a frequency of 4Hz, these relaxations had a mean 
amplitude of 3.39 ± 0.45g (n = 31) while the rebound contraction had a mean 
amplitude of 4.23 ± 0.74g (n = 20).
Exogenous NO relaxed carbachol-induced tone in colonic smooth muscle 
(Fig. 16). NO (>10_5M) caused pronounced concentration-dependent 
relaxations that were succeeded by rebound contractions. A concentration of
2 x 10_5M gave the maximum response. At this dose, the NO-induced 
relaxations had a mean amplitude of 3.85 ± 1.08 g (n = 8) while the rebound 
responses had a mean amplitude of 1.53 ± 0.44g (n = 7). Haemoglobin (Hb ;
3 x 10-5M) abolished all responses to exogenous NO (2 x 10-5M ; n = 3 ; 
results not shown). The NO donor, SNP (5 x 10-6 M : n = 8) caused a 
relaxation of almost identical amplitude (3.88 ± 0.88g) to that of exogenous NO 
(Fig. 17). Unsurprisingly, the nitrovasodilator-induced inhibition was of longer 
duration, since SNP would continue to release NO until reduction of the 
nitrovasodilator was complete. The SNP-evoked response was not followed by 
a rebound contraction.
Hb (3 x 10_5M) significantly reduced (P < 0.01), but did not abolish, 
NANC nerve-mediated relaxations, suggesting that NO, though released, was 
not wholly responsible for these neuronally-mediated inhibitions ( n = 8 ; Fig. 
18). At a frequency of 4Hz, the relaxations were reduced from 2.97 ± 0.17g to 
2.4 ± 0.26g by Hb (3 x 10-5M ; n = 10) ; a reduction of approximately 20%. 
On a number of occasions, this concentration of Hb reduced, and sometimes
Fig. 15 : Relaxations and rebound contractions recorded from a
carbachol (3 x 10”5M)-contracted circular strip o f rabbit distal colon in 
response to NANC nerve stimulation ( « , 1 6  pulses, l-16Hz, 0.2ms, 
supramaximal voltage). A frequency o f 4Hz gave the optimum 
response. Phentolamine and propranolol (each 3 x 10'6M) were 
present throughout.
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Fig. 16 Top : Dose-dependent relaxations and rebound contractions 
recorded from a carbachol (3 x 10"5M)-contracted circular strip of 
rabbit distal colon in response to NO (# ,5x  10^-2 x 10"5M).
Bottom : The effect (± s.e. mean) of NO (lO^-S x 10_5M; n = 5, 
except 5 x 10"5M, n = 2) on carbachol (3 x 10“^ M)-contracted circular 
strips of rabbit distal colon, expressed as a percentage of the maximum 
relaxation (g) obtained. A concentration of 2 x 10“5M gave the 
maximum response.
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Fig. 17 : Comparison of relaxations in response to NANC nerve
stimulation (*,16 pulses, 4Hz, 0.2ms, supramaximal voltage), SNP 
( •, 5 x lO^M) and GABA ( «, lO^M) on a carbachol (3 x 10_5M)- 
contracted circular strip of rabbit distal colon. Neither SNP- nor 
GABA-induced relaxations were followed by a rebound contraction.
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Fig. 18 Top: Frequency-dependent relaxations and rebound
contractions recorded from a carbachol (3 x 10-5M)-contracted 
circular strip of rabbit distal colon in response to NANC nerve 
stimulation (• ,16 pulses, 2-16Hz, 0.2ms, supramaximal voltage) and
their inhibition by Hb (3 x 10"5M ;--------). Bottom : The effect
(± s.e. mean) of Hb (3 x 10"5M ; n > 7), expressed as a percentage of 
the maximum control relaxation, on the amplitude (g) of relaxation in 
response to NANC nerve stimulation (16 pulses, 0.5-8Hz, 0.2ms, 
supramaximal voltage) on carbachol (3 x 10-5M)-contracted circular 
strips of rabbit distal colon. Hb reduced significantly (*, P < 0.05 ; **, 
P < 0.01), the amplitude of relaxation.
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abolished, the rebound contractions in response to nerve-stimulation (Fig. 18 
top). In a few cases, the baseline tension was also slightly reduced (< 0.5g) by 
Hb (3 x 10_5M).
Similar effects were observed in the presence of the NO synthase inhibitor, 
L-NAME. NANC nerve responses were significantly reduced in amplitude 
(P < 0.001), but never abolished, by L-NAME (up to 10_3M). L-NAME 
(5 x 10_4M) caused a reduction from 3.1 ± 0.12g to 2.34 ± 0.21g ; a reduction 
of approximately 25% (n = 15 ; Fig. 19). Sometimes L-NAME, like Hb, also 
reduced (P < 0.01) the subsequent rebound effect (Fig. 19 top). Following 
electrical stimulation at a frequency of 4Hz, L-NAME (5 x 10_4M) reduced the 
rebound amplitude to 2.07 ± 0.39g from 3.05 ± 0.4lg (n = 15 ; Fig. 20). The 
stereoisomer of L-NAME, D-NAME, had no effect on either response (results 
not shown). After the addition of L-NAME to the carbachol-contracted tissue, 
a fall in tension, with a mean amplitude of 1.37 ± 0.3lg (n = 15), often 
occurred. This was unexpected, but was not considered to contribute to the 
inhibitory effects of L-NAME on NANC nerve stimulation since, in a number 
of experiments, D-NAME induced a comparable fall in tension, but did not 
reduce the nerve response during carbachol-induced tone (results not shown). 
The ability of the precursor to NO synthesis, L-arginine, to reverse the 
L-NAME-induced inhibitory response was examined in 8 experiments. On 2 
occasions, L-arginine (3 x 1(HM) reversed the inhibition produced by 
L-NAME (5 x 10"4M ; Fig. 21), but on the other 6 was ineffective.
It seems likely that inhibitory NANC nerve stimulation in the RDC released 
NO or a NO-related compound ; inhibition of the nerve response by Hb or 
L-NAME suggested that a NO component accounted for 20-25% of the 
response. Alternative putative transmitters were examined in an attempt to 
identify the other inhibitoiy transmitter(s) in the RDC. Neither ATP 
(< 5 x 10-4M ; n = 8) nor its analogue 2-methylthio ATP (< 5 x 10’5M ; n = 2) 
relaxed circular strips of RDC (results not shown). VIP (5 x 10_7M ; n = 3)
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Fig. 19 Top: Frequency-dependent relaxations and rebound
contractions recorded from a carbachol (3 x 10"5M)-contracted 
circular strip of rabbit distal colon in response to NANC nerve 
stimulation (*,16 pulses, 2-16Hz, 0.2ms, supramaximal voltage) and
their inhibition by L-NAME (5 x 10"4M ;------ ). Bottom : The effect
(± s.e. mean) of L-NAME (5 x lO^M ; n > 13), expressed as a 
percentage of the maximum control relaxation, on the amplitude (g) of 
relaxation in response to NANC nerve stimulation (16 pulses, 0.5- 
8Hz, 0.2-0.5ms, supramaximal voltage) on carbachol (3 x 10"5M)- 
contracted circular strips of rabbit distal colon. L-NAME reduced 
significantly (**, P < 0.01 ; ***, P < 0.001), the amplitude of 
relaxation.
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r e d u c e d  s igni f i cant ly  (♦*, P < 0 . 0 1 ) ,  the  ampl i tude  of  rebound c o n t r a c t io n .
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relaxed the tissue (by 1.1 ± 0.38g), but the onset of this relaxation was much 
slower, and the duration longer, than that in response to nerve stimulation 
(results not shown). GABA-induced relaxations (Fig. 17 ; n = 4) were more 
like those obtained in response to NANC nerve stimulation than were those to 
VIP. However, GABA induced relaxation only at high concentrations (1(HM) 
and, overall, the responses were considerably larger (9.05 ± 0.86g ; n = 4) than 
nerve-evoked relaxations. Thus, ATP, VIP or GABA were unlikely to be 
involved in NANC nerve responses in this tissue. On a number of occasions, 
rebound contractions following nerve stimulation (16 pulses, 0.1-0.5ms, 
supramaximal voltage) were reduced in amplitude by the cyclooxygenase 
inhibitor, indomethacin (10_5M ; n = 5 ; Fig. 22). This suggested that a product 
of the cyclooxygenase pathway i.e. a prostaglandin, may have mediated these 
events.
3.2. Patterns of Spontaneous Activity in the Rabbit Distal Colon
The Golenhofen apparatus was used to examine the spontaneous electrical 
and mechanical responses in longitudinal strips of the RDC. A number of 
parameters (see 2.4.) were measured.
Activity in the unstretched (0.1-0.5g tension) colonic ship was generally 
burst-like in nature (Fig. 9). Each spike-burst was accompanied by a 
corresponding burst of contraction and periods of relative quiescence existed 
between individual bursts. These electrical events occurred with a frequency of 
3.77 ± 0.18 min-1 (n = 80) and each contained 7.84 ± 0.62 spikes (n = 61). The 
duration of each spike-burst was 7.91 ± 0.77s (n = 57) and the amplitude of the 
largest spike in each was 248.46 ± 28.37 pV (n = 63). Since the muscle never 
contracted in the absence of electrical firing, and vice versa, the frequency of 
contractile bursts was also 3.77 ± 0.18 min-1 (n = 80). Each mechanical event
Control
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40s
V i ,7V
2Hz 4Hz 8Hz 16Hz
Fig. 22 : Frequency-dependent relaxations and rebound contractions 
recorded from a carbachol (3 x 10"5M)-contracted circular strip o f 
rabbit distal colon in response to NANC nerve stimulation ( ♦, 16 
pulses, 2-16 Hz, 0.2ms, supramaximal voltage) and rebound inhibition 
by indomethacin (10 '5M ; ----------).
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contained 2.78 ± 0.33 peaks (n = 79) and had a duration of of 12.23 ± 1.42s 
(n = 79). The maximum tension developed during each was 2.21 ± 0.13g 
(n = 79).
On rare occasions (< 10%) another pattern of activity was present (Fig. 12). 
In these cases, the electrical pacemakers did not fire in bursts but were 
continually active. Consequently, there were as many as 60 contractions in any 
4 min period. This made analysis extremely difficult. As a result, experiments 
were generally conducted on those tissues that exhibited the former, burst-like 
activity.
As the tissue was stretched from 0-5g, the amplitude of mechanical activity 
was enhanced (P <0.01 ; Fig. 23). Under an applied tension of 5g (n = 3) the 
amplitude of the mean phasic contraction was 5.16 ± 0.8lg. This was 
compared with control values of 2.56 ± 1.15g in the unstretched tissue, or 
4.1 ± 0.67g when the tissue was under 3g of stretch. Similarly, from Fig. 23, as 
the tissue was stretched from 0-3g the frequency of activity and the amplitude 
of electrical spikes were increased. However, probably because of the small 
number of samples examined, these actions did not prove to be significant. 
This enhancement of activity as tension was raised may have been due to a 
stretch-induced depolarization i.e. more cells would be at, or close to, their 
firing threshold. However, a further increase in tension to 5g caused the 
frequency of activity and the maximum spike amplitude to fall. The increased 
amount of stretch may have led to a form of depolarizing block that resulted in 
decreased frequency and spike amplitude. Alternatively, stretching could have 
damaged the tissue - perhaps certain nexuses or close junctions were 
destroyed - and thus reduced syncytial activity. In most of the following 
experiments, the unstretched muscle preparation was used.
The RDC was also sensitive to temperature changes (n = 3 ; Fig. 24). As 
the tissue was cooled from 37°C to 32°C the frequency of activity and the 
amplitude of electrical spiking was increased. Cooling to 29°C, raised the tone
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Fig. 23 : The effect o f stretch (0-5g) on the spontaneous electrical 
(left) and corresponding mechanical activity recorded from a single, 
longitudinal strip o f rabbit distal colon in the Golenhofen apparatus. 
Both the frequency (bursts min"1) and the electrical spike amplitude 
(mV) were initially enhanced (1 -3g) but declined as the tissue was 
stretched further (5g).
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of the tissue and caused both spontaneous electrical and mechanical activity to 
become so rapid that they were continuous, making accurate analysis 
impossible. All future experiments were conducted at a temperature of 
37 ± 1° C.
Electrical, as well as mechanical events in this tissue, were entirely 
dependent on the presence of extracellular Ca++ (Fig. 25). When MgCl2  
replaced CaCl2 in the Krebs solution, both spontaneous spiking and contraction 
were abolished (n = 3). Similarly, the Ca++-channel blocking drug, diltiazem, 
gradually reduced the frequency of responses until, at a concentration of 10_4M, 
all activity was abolished (n = 6 ; results not shown). None of the other 
parameters was significantly affected prior to this abolition of spontaneous 
activity. TTX failed to abolish responses in the RDC (n = 4 ; results not 
shown). Thus, pacemaker activity in this tissue relied on the presence of Ca++- 
rather than Na+ -spikes.
3.3. Actions of Nitrovasodilators on the Rabbit Distal Colon 
3.3.1. Spontaneous electrical and mechanical responses
The effects of certain nitrovasodilators, namely SNP, GTN and IDN, were 
examined on spontaneously active, unstretched longitudinal strips of the RDC 
mounted in the Golenhofen apparatus. The actions of these drugs were both 
complex and manifold. To further complicate matters, not every effect was 
produced by every compound. Despite this complexity, a sequence of events 
has emerged that generally characterizes the nitrovasodilator-induced response.
Each nitrovasodilator tested was able to regulate pacemaker activity to 
some degree, but SNP was most effective. The primary action of SNP 
(> 10_5M) was to induce a short-lived (< 10 min) period of quiescence 
(Fig. 26). Following the addition of SNP (10-4M), the mean duration of this
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period was 2.11 ± 0.61 min (n = 28). This property was shared by both GTN 
and IDN (each > 10'5M).
At the end of this quiescent period, spontaneous electrical and mechanical 
activity returned, suddenly, rather than gradually. The pacemaker now was 
reset to a different level of activity and responses generally had a more 
coordinated, regular appearance than in the control tissue (Fig. 27). However, 
the exact effects produced were dependent largely, on the inherent properties of 
the tissue. For instance, the actions of SNP on the frequency of firing varied 
according to the initial frequency of activity, before the addition of drug. For 
this reason, when studying the effects of SNP on this parameter, control tissues 
were allocated to one of two groups ; those with a low frequency of activity 
(< 6 bursts m in'1) and those with a high frequency of activity (> 6 bursts 
min-1). In those muscles with a low firing rate, the frequency was significantly 
enhanced by SNP (> 10-5M ; n > 31 ; P < 0.001 ; Fig. 28), without any 
alteration in the level of baseline tension. The response of a low frequency 
tissue to SNP (10_4M) can be seen in Fig. 27. In this case, the frequency of 
activity was increased to 466% of the control value. However, in those 
muscles where the firing rate was high, the frequency was reduced by SNP 
(10"5M ; n = 7 ; P < 0.001 ; Figs. 29 and 30). In either case, SNP coordinated 
the activity so that both electrical and mechanical responses occurred at more 
regular intervals. Tissues that fell into the high frequency category were rare, 
and both IDN and GTN were examined only on tissues with a low level of 
firing. Each of these compounds was capable of imitating the effects of SNP 
on frequency (Figs. 31 and 32) but, in the case of GTN, this happened only in 
isolated cases. Overall, GTN (10_6-10'4M), had no effect (n > 5 ; Fig. 28). 
IDN (> 10"5M) significantly increased (P < 0.01) the frequency of spontaneous 
events in the RDC (n = 7 ; Fig. 28).
Concomitant with this excitatory effect on frequency, the nitrovasodilators 
had an inhibitory effect on the amplitude of contraction (Figs. 27, 31, 32 and
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33). SNP (>10_5M ; n > 34), IDN (> 10'5M ; n = 6) and GTN (10-5M ; n = 7) 
each significantly lowered (P < 0.05) the amplitude of spontaneous contraction 
in longitudinal strips of RDC. However, rarely, at concentrations lower than 
those required to reduce this parameter, SNP (< 10_6M) enhanced the amplitude 
of spontaneous contraction (Fig. 34).
In a number of individual experiments, nitrovasodilators induced a sharp 
rise in the amplitude of electrical discharge. For example, in Fig. 27, this 
parameter was increased to 389% of the control value by SNP (10_4M). 
However, preparations in which SNP produced this effect were rare. Overall, 
the effect of SNP (10'6-10_4M ; n > 13 ; Fig. 35) was not a significant one. 
Similarly, IDN (10"6-10_4M ; n = 6 ; Fig. 35) did not significantly affect this 
parameter. GTN (10_6M ; n = 5 ; Fig. 35), however, significantly increased the 
spike amplitude (P < 0.05). In the majority of experiments in which spike 
amplitude was increased (by any nitrovasodilator), this change occurred 
simultaneously with the increased frequency and reduced contractile amplitude. 
But, in a few isolated cases the spike amplitude was increased only after these 
other changes had occurred (Fig. 36). This suggested that this effect was, in 
fact, secondary to the increase in frequency and reduction in the amplitude of 
contraction.
In addition to these effects, SNP (n = 25) and IDN (n = 6 ; each > 10_5M), 
significantly reduced the number of electrical spikes per burst (P < 0.05 ; 
Fig. 37). In the most susceptible tissues, electrical discharges now consisted 
only of single spikes (Fig. 27) though, for the purpose of this study, these 
events were still regarded as bursts of activity (see 2.4.). In less susceptible 
tissues, the frequency was increased but, although the number of spikes per 
burst was reduced, single spikes did not occur (Fig. 38). This reduction in the 
number of spikes per burst led to a concomitant reduction in the mean duration 
of electrical bursts by SNP (> 10_5M ; n > 2 4 ; P  <0.001) and IDN (10”4M ;
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Fig. 3 3  : The e f f e c t s  ( ±  s . e .  m e a n )  of  GTN (n =  7 ) ,  SNP (n ^ 1 8 )  and
IDN (n =  6 ; e a c h  10 *—10 4M), e x p r e s s e d  a s  a p e r c e n t a g e  of  the  
cont ro l  ( 1 0 0 K ) ,  on the  m ax im um  c o n t r a c t i l e  a m pl i t ud e  (g )  per bur st  of  
m e c h a n i c a l  activ i ty ,  in the  rabbit  distal  c o lo n .  GTN, SNP and IDN e a c h  
r e d u c e d  s ign i f ic a n t ly  (*,  P < 0 . 0 5  ; **, P < 0 .0 1  ; ***, P < 0 .  0 0 1 ) ,  the  
m a x im u m  c o n t r a c t i l e  ampl i tud e .
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Fig. 35:  The e f f e c t s  ( ±  s . e .  m e a n )  of  GTN (n ^ 5 ) ,  SNP (n ^ 13 )  and
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IDN (n =  6 ; eac h  10 —10 M), e x p r e s s e d  a s  a p e r c e n t a g e  of  the  control
(100%),  on the  max imum spike  ampl i tu de  (mV) per burst  of  e le c t r ica l  
activi ty,  in the  rabbit dista l  co lo n.  GTN i n c r e a s e d  s igni f ic an t l y  (*,  P < 0 . 0 5 ) ,  
t h e  maximu m spike  ampl i tude .
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Fig. 3 7  : The e f f e c t s  ( ±  s . e .  m ea n )  o f  GTN (n — 5 ) ,  SNP (n ^ 12)  and
/  - S  - 4  .
IDN (n =  6 ; e a c h  10 —10 M), e x p r e s s e d  a s  a p e r c e n t a g e  of  the  control
( 1 0 0 X ) ,  on the  nu mber  of  sp ik e s  per burst  of  e le c tr i ca l  act ivi ty ,  in the  
rabbi t dista l  co lo n.  SNP and IDN e a c h  redu ced s ig n i f i ca n t l y  (*,  P < 0 . 0 5  ; 
***, P < 0 . 0 0 1 ) ,  the  nu mber  of  s p ik e s  per burst .
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n > 5 ; P < 0.05 ; each Fig. 39). GTN (10-M0-4M ; n > 5 ; Figs. 37 and 39) 
had no effect on either of these parameters.
The reduction in the number of spikes per electrical burst corresponded, in 
the case of SNP (> 10_6M ; n > 32 ; Fig. 40), with a significant reduction in the 
number of peaks in each mechanical event (P < 0.001). Consequently, the 
mean duration of mechanical responses was significantly reduced by SNP 
(> lO^M ; n > 18 ; P < 0.001 ; Fig. 41). IDN did not have a significant effect 
on the number of peaks in each burst o f contraction (10_6-10“4M ; n = 7 ; 
Fig. 40), though there was a downward trend as the concentration of drug 
increased, but did significantly reduce the duration of mechanical responses 
(> 10-5M ; n = 6 ; P < 0.05 ; Fig. 41). GTN (lO 'M tH M  ; n > 5 ; Figs. 40 and 
41) had no effect on either of these parameters. All of these changes attributed 
to an action of the nitrovasodilators, lasted for the full length of the recording 
period of up to 20 min.
Clearly, in RDC, the nitrovasodilators produced excitation e.g. an increase 
in frequency or spike amplitude, in addition to their expected inhibition. In the 
gut, the main excitatoiy neurotransmitter is ACh. Experiments were conducted 
to investigate the possibility that the nitrovasodilators were stimulating the 
release of ACh, leading to excitation. Since SNP was most effective, in all 
subsequent experiments on RDC, the effects of this compound were used as a 
model for the effects of the nitrovasodilators in general. The pattern of activity 
in response to SNP differed from that in response to the excitatory 
neurotransmitter, ACh. ACh (5 x 10_8M ; n = 3) induced continuous spiking 
and enhanced the amplitude and frequency of phasic contraction. But, in 
contrast to the actions of SNP, in the presence of this agonist, the responses 
were less regular than controls. ACh (> 10_7M ; n = 4) induced a rise in tone 
(Fig. 42). Spiking remained continuous, tone was maintained, and the 
frequency and amplitude of mechanical activity was increased. Atropine 
(> 10_6M) prevented these actions of ACh, indicating that they were mediated
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Fig. 3 9  : The e f f e c t s  ( ±  s . e .  m e a n )  of  GTN (n =  5 ) .  SNP (n ^ 12)  and
IDN (n =  5 ; e a c h  10  *—10 *M), e x p r e s s e d  a s  a p e r c e n t a g e  of  the  control  
( 1 0 0 * ) ,  on the  durat ion ( s )  o f  e a c h  burst  o f  e le c tr ica l  activ i ty ,  in the  
rabbit  d is ta l  co lo n.  SNP and IDN e a c h  r e d u c e d  s ig ni f ic an t ly  (*,  P < 0 . 0 5  ; 
***, P < 0 . 0 0 1 ) ,  th e  durat ion of  e a c h  burst .
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Fig. 4 0  : The e f f e c t s  (±  s . e .  m e a n )  of  GTN (n ^ 5 ) ,  SNP (n 3s 1 8 )  and
/  - 1  - 4  .
IDN (n =  6 ; e a c h  10 —10 M), e x p r e s s e d  a s  a p e r c e n t a g e  of  th e  control
(100%),  on the  number  of  p e a k s  per burst  of  m e c h a n ic a l  activ i ty ,  in the  
rabbit  distal  co lon.  SNP reduced s ig ni f i ca nt ly  (**, P < 0 .0 1  ; ***, P < 0 . 0 0 1 ) ,  
the  nu mber  of pe ak s  per burst .
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Fig. 41 ; The e f f e c t s  ( ±  s . e .  m e a n )  of  GTN (n ^ 6 ) ,  SNP (n ^ 18 )  and
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IDN (n — 6 ; e a c h  10 —10 M), e x p r e s s e d  a s  a p e r c e n t a g e  of  the  control
(100%),  on the  duration ( s )  o f  e a c h  burst  of  m e c h a n i c a l  act ivi ty ,  in the
rabbit  distal  co lo n.  SNP and IDN e a c h  reduced s ig ni f ic ant ly  (*,  P < 0 . 0 5  ;
***, P < 0 . 0 0 1 ) ,  the  durat ion of  e a c h  burst .
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by muscarinic receptors (results not shown). SNP never raised tone in this 
preparation nor was its actions inhibited by atropine (n = 3).
An alternative possibility was, that the excitatory properties of the 
nitrovasodilators were due to antagonism of the inhibitory neurotransmitter, 
noradrenaline. The a - and P-adrenoceptor antagonists, phentolamine and 
propranolol, were examined together on the spontaneous activity of RDC. In 
the presence of these antagonists (each 10-5 M) the frequency of activity and the 
contractile amplitude were enhanced (Fig. 43). Spontaneous activity was 
desynchronized, became continuous and, on some occasions, baseline tension 
was slightly increased. This suggested that a basal release of noradrenaline 
could have moderated pacemaker activity and controlled the level of resting 
tension. However, although SNP (> 10"5M ; n > 31) increased frequency, 
activity was still burst-like and was more regular than in control tissue. 
Moreover, even at high concentrations, SNP never elevated baseline tension ; 
rather than antagonizing the release of inhibitory neurotransmitter it seems 
more likely that SNP was acting on the pacemaker itself.
The smooth muscle relaxant properties of nitrovasodilators are known to be 
mediated through NO release and subsequent cGMP stimulation (see Feelisch, 
1991 ; Moncada et al, 1991b). The possibility that the excitatory and/or 
inhibitory actions of these compounds on RDC were also mediated via this 
mechanism was investigated. The rise in frequency (P < 0.05) and the fall in 
contractile amplitude (P < 0.05) induced by SNP (10’4 M), were completely 
inhibited by the inhibitor of NO, Hb (1(HM ; n = 4 ; Figs. 44, 45 and 46). Hb 
(10_4 M) itself caused a rise in the frequency of spontaneous activity (Fig. 44) ; 
in its presence, SNP (10-4 M) then caused a fall in frequency, the opposite effect 
to that of SNP alone. Moreover, in the presence of Hb (10_4 M), SNP (KHM) 
produced a slight rise in contractile amplitude, yet SNP alone elicited a fall in 
amplitude. Thus, both the excitatoiy and inhibitory effects of SNP on RDC 
were opposed by Hb, suggesting that both were due to NO release. The
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Fig. 44 : The effect o f SNP (ICHM) on the spontaneous electrical 
(top) and mechanical activity (in each panel) recorded from an 
unstretched, longitudinal strip o f rabbit distal colon in the Golenhofen 
apparatus, and its inhibition by the prior addition (approximately 10
min before) o f Hb (10‘4M ---------). SNP alone (top right panel)
increased the frequency o f  activity and reduced the amplitude o f 
contraction. Following the washout o f SNP, Hb alone (bottom left 
panel) also increased the frequency o f activity. SNP in the continued 
presence o f Hb (bottom right panel) caused a fall in frequency and an 
increase in the amplitude o f contraction.
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Fig. 4 5  : The e f f e c t  ( ±  s . e .  m e a n ,  n =  4)  o f  SNP ( 1 0  4M), e x p r e s s e d
a s  a p e r c e n t a g e  of  the  control  (100%),  on the  f r e q u e n c y  (b u r s t s  min 1)
of  s p o n t a n e o u s  act ivi ty ,  in the  rabbi t distal  co lo n,  where the  f r e q u e n c y  
of  control  act iv ity  was low (<  6 bu rs ts  min 1),  in the  a b s e n c e  and in 
t h e  p r e s e n c e  of  Hb ( 1 0  M). Hb abol i sh ed  the  s ig n i f ic a n t  e xc i t at ory
r e s p o n s e  (*,  P < 0 . 0 5 )  of  the  t i s s u e  to SNP.
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Fig. 4 6  : The e f f e c t  ( ±  s . e .  mean ; n =  7 )  of  SNP ( 1 0  4M), e x p r e s s e d
a s  a p e r c e n t a g e  of  the  control  (100%),  on the  max imum  c o n t r a c t i l e
a m p l i tu d e  ( g )  per burst  of  m e c h a n i c a l  act ivi ty,  in the  rabbit  d is ta l
c o lo n ,  in th e  a b s e n c e  and in the  p r e s e n c e  of  Hb ( 1 0  4M). Hb a b o l i s h e d  
th e  s i g n i f i c a n t  inhibitory r e s p o n s e  (*,  P < 0 . 0 5 )  of the  t i s s u e  to  SNP.
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number of spikes or peaks per burst and the duration of both electrical and 
mechanical responses were reduced by Hb (10_4 M) alone (Fig. 44), making it 
difficult to assess any effects of SNP on these parameters.
Experiments in which the properties of 8 -bromo cGMP (1(HM) were 
studied, revealed that both the excitatory and inhibitory effects of SNP were 
likely to be mediated by stimulation of cGMP (Fig. 47). Following a short 
period of quiescence, this cyclic nucleotide derivative (8 -bromo cGMP) 
increased the frequency of both spike discharge and corresponding contraction. 
Electrical and mechanical responses now consisted almost wholly of single 
spikes and single peaks respectively (Fig. 47). By approximately 10 min, the 
increased frequency of contraction had persisted, but the amplitude of the 
mechanical response was reduced sharply. In the presence of 8 -bromo cGMP 
(10_4 M) the rate of spontaneous electrical and mechanical activity was 
increased significantly to 858 ± 8.3% (n = 3 ; P < 0.01 ; Fig. 48). SNP (lO^M ) 
caused an increase to 192.9 ± 16.7% (n = 31 ; P < 0 .0 0 1 ). On another 
occasion, when the activity was rapid (> 6  bursts min-1), 8 -bromo cGMP 
(10_4 M), like SNP, reduced the frequency of activity (results not shown). The 
contractile amplitude was decreased significantly (P < 0.05) to 12.9 ± 6.2 % of 
controls by 8 -bromo cGMP (10*4M ; n = 3) and to 50.15 ± 7.83% of controls 
by SNP (10_4M ; n = 31 ; P < 0.001 ; Fig. 49). This suggests that the effects of 
SNP, both excitatory and inhibitory, could have been mediated by elevation of 
cGMP levels.
In support of these suggestions, potassium ferrocyanide (K4 Fe(CN)6), in 
concentrations up to 10-4 M, which is structurally similar to SNP but which 
does not release NO (Fig. 50), did not alter any of the parameters significantly 
(n = 3; Fig. 51). This indicates that the effects of SNP on the RDC were not 
due to the ferrocyanide portion of the SNP molecule, but were likely to involve 
NO.
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Fig. 4 8  : The e f f e c t  ( ±  s . e .  m e a n )  of 8 — bromo cGMP ( 1 0  4M ; n =  3 )  and  
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Fig. 4 9  : The e f f e c t  ( ±  s . e .  m e a n )  of  8 — bromo cGMP ( 1 0  +M ; n = 3 )
and SNP ( 1 0  4M ; n =  3 1 ) ,  e x p r e s s e d  a s  a p e r c e n t a g e  of  th e  con trol  
( 1 0 0 X ) ,  on the  m axi m um  c o n t r a c t i l e  a m pl i t ud e  ( g )  per  burst  of  
m e c h a n i c a l  act ivi ty ,  in t h e  rabbi t dista l  c o l o n .  Each c o m p o u n d  r e d u c e d  
s i g n i f ic a n t ly  (+, P < 0 . 0 5  ; **+, P < 0 . 0 0 1 ) ,  the  am p l i tu d e  of  c o n t r a c t i o n .
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Fig. 50 : A comparison o f the staicture o f the nitroprusside anion with 
that o f the ferrocyanide molecule. In ferrocyanide, the NO-releasing 
group is replaced by cyanide.
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Clearly, the observed excitation in response to nitrovasodilators, in the 
RDC, is not an action that one would normally associate with NO. Indeed, this 
action would more likely be expected following inhibition of NO. This 
prompted a comparison of the effects of SNP with those of the inhibitor o f NO 
synthesis, L-NAME. L-NAME (10_4 M), when added to the unstretched RDC 
(Fig. 52), increased the level of baseline tension to 1.58 ± 1.14g (n = 4). and, 
sometimes, instigated continuous firing. Spontaneous activity now appeared 
less coordinated than the control. The increase in tension, if great enough, was 
accompanied by the conversion of spontaneous contraction to relaxation. Since 
the L-NAME-induced increase in frequency was secondaiy to an elevation of 
baseline tension, an effect never produced by SNP, and L-NAME caused 
activity to become less coordinated, the opposite effect to SNP, the actions of 
the two compounds were dissimilar.
The effects of cyclic adenosine monophosphate (cAMP) stimulation in 
RDC were compared with those of cGMP stimulation, by comparing the effects 
of isoprenaline with those of SNP. Isoprenaline acts on. (3-adrenoceptors to 
stimulate adenylate cyclase and raise cyclic adenosine monophosphate (cAMP) 
levels. This mediates smooth muscle relaxation. Like the nitrovasodilators, 
isoprenaline (> 10"7 M) significantly (P < 0.001) reduced the amplitude of 
spontaneous contraction and the number of spikes per burst o f electrical 
activity (n = 6  ; Fig. 53). However, unlike SNP, isoprenaline did not 
coordinate the pacemaker activity. In addition, isoprenaline (4 x 10’7 M) almost 
always abolished spontaneous electrical and mechanical activity in RDC. SNP 
never abolished activity even at concentrations as high as 10_3 M. The actions 
of isoprenaline (2 x 10_7M ; Fig. 53), but not SNP (results not shown), were 
prevented by propranolol (3 x 10_6M ; n = 3). Thus, a number of differences 
existed between the actions of isoprenaline and SNP. This made it unlikely 
that cAMP stimulation was in any way involved in the response to the 
nitrovasodilators.
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Fig. 53 : The effects o f isoprenaline alone (2 x 10‘7M) and in the 
presence o f propranolol (3 x 10-6M) on the spontaneous electrical 
(top) and mechanical activity, in each pair o f traces, recorded from an 
unstretched, longitudinal strip o f rabbit distal colon in the Golenhofen 
apparatus. Isoprenaline alone reduced the amplitude o f  electrical and 
mechanical responses. These effects were inhibited by propranolol.
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Activation of cGMP is believed to cause smooth muscle relaxation via a 
reduction in the level of intracellular Ca++. In spite of the fact that, in these 
experiments, there was no evidence of nitrovasodilator-induced relaxation 
(possibly because the tissue was unstretched throughout the experiments), the 
actions of SNP were examined to determine whether some, or all of them, were 
mediated by a fall in the intracellular Ca++ concentration. SNP (10_5 M) alone 
increased the frequency of electrical and mechanical events and reduced the 
amplitude of contraction (Fig. 54). In the continued presence of SNP, the 
amplitude of contraction was enhanced above control levels, by the 
Ca++-channel agonist, BAY K 8644 (10-7M ; n = 3), probably by increasing the 
concentration of Ca++ available for contraction. In this particular case 
(Fig. 54), SNP (10_5 M) also increased the amplitude of electrical spiking - an 
effect that was reversed by BAY K 8644 (10_7 M). If the drugs were added in 
reverse order, BAY K 8644 (10_7M ) alone, often raised the tone of the tissue 
and increased the firing rate until activity was continuous (Fig. 55). Following 
the addition of SNP (> 10_5 M), tension returned to normal and both 
spontaneous electrical and mechanical activity were regulated so that activity 
was again burstlike. From this evidence, it is likely that the SNP-induced 
reduction in contractile amplitude and, possibly, the increase in spike amplitude 
were due to a reduction in the level of intracellular Ca++. Further, the 
coordination of activity produced by SNP, following the prior addition of BAY 
K 8644, may have been the result of a fall in the cytosolic Ca++ concentration.
The actions of another well known smooth muscle relaxant, the opener of 
ATP-dependent K+-channels, BRL 38227 (levcromakalim or lemakalim), were 
also compared with those of the nitrovasodilators. This compound produced a 
graded, dose-dependent inhibition of spontaneous activity in the RDC (Fig. 56). 
The frequency and contractile amplitude were significantly reduced from 
3.5 ± 1.08 bursts min-1 and 2.16 ± 0.28g to 1.56 ± 0.52 bursts min-1  and 
1.2 ± 0.26g respectively, by BRL 38227 (10_5M ; n > 4 ; P < 0.05). At other
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times, this concentration of drug abolished all activity (n = 3). At higher 
concentrations, (10_4 M), BRL 38227 always abolished activity in this 
preparation (n = 5). Subthreshold concentrations of SNP and BRL 38277 were 
synergistic with one another (Fig. 57). Neither SNP (10"6 M) nor BRL 38277 
(10-7 M) induced quiescence when administered alone. However, when added 
together, both electrical and mechanical activity were abolished for a short 
period (1-10 min). Possibly, both SNP and BRL 38227 induced a K+ efflux.
3.3.2. Radiolabelled rubidium efflux
In order to measure the movement of K+ across the cell membrane, 
longitudinal strips of RDC were incubated in Krebs solution containing 
radiolabelled rubidium (86Rb ; a marker for K+ ; Martin & Gordon, 1983 ; 
Hamilton et al, 1986), before being mounted in the Golenhofen apparatus. 
Following the commencement of superfusion, the efflux of 86Rb from the RDC 
declined rapidly (Fig. 58). The rapid loss of isotope observed during the first 
5-6 min represented washout from the extracellular space. The loss of 86Rb 
was then constant indicating the loss of tracer from the cytoplasm of the 
smooth muscle cells. Data were expressed in terms of the efflux rate constant:
Efflux Rate Constant (E) = AA / AjA^
At is the time over which the fraction was collected, AA is the number of 
counts released in that time and At is the average number of counts remaining 
in the tissue at that time. The value of E clearly differs from tissue to tissue. 
Values of 4.22 ± 0.14 x 10-3  min-1  (Martin & Gordon, 1983) or 4.8 ±  0.4 x 10- 3  
min-1  (Bolton & Clapp, 1984) have been reported for E in the rabbit aorta while 
a value of 11.38 ± 0.4 x 10-3  min-1  has been reported in guinea-pig taenia caeci
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Fig. 57 : The effects of SNP (lO^M) and BRL 38227 (10“7 M), alone 
and together, on the spontaneous electrical (top) and mechanical 
activity, in each panel, recorded from an unstretched, longitudinal strip 
of rabbit distal colon in the Golenhofen apparatus. Due to the high 
frequency of control activity, SNP,alone, caused a reduction in 
frequency. Drugs were washed out between each panel. These drugs 
had a greater effect when added together rather than individually.
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Fig. 5 8  : The exp o n e n t ia l  dec l i ne  with t im e  of  the  re s t i ng  Rb ef f lux ,
/  3 .e x p r e s s e d  a s  the  f i r s t - o r d e r  rate  c o n s t a n t  (E ; x 10 ) ,  from th e  rabbit
86  86  
dista l  co lo n in cub ated  with RbCI. By 6 —8min,  a p pr ox im ate ly ,  Rb
eff lux  had reac h ed  a relat ively s t e a d y  value .
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(Bolton & Clark, 1981). In the RDC, the mean value of E was 6.59 ± 0.26 x 
1 0 " 3 min-1  (n = 2 0 ).
Since carbachol was known to significantly increase the rate of 42K or 86Rb 
efflux from gastrointestinal smooth muscle (Bolton & Clark, 1981), this drug 
was used to test that the system was functional. Carbachol (10"5 M) significantly 
enhanced the 86Rb efflux rate constant (P < 0.05) from 7.4 ±0.81 x 10"3 min"1 
to 22.7 ± 1.7 x 10"3 min ' 1 - an increase of approximately 200% (Fig. 59). This 
stimulation of 86Rb efflux may have been secondaiy to carbachol-induced 
depolarization and subsequent opening of voltage-operated K+ channels. 
Similar effects have been reported for contractile agonists in the rabbit aorta 
(Martin & Gordon, 1983).
Earlier experiments in RDC had indicated that SNP caused initial 
quiescence and abolished spontaneous activity (see 3.3.1.). Further, the effects 
of SNP were synergistic with those of the K+ channel opener, BRL 38227. 
Both these effects could be explained if SNP induced the opening of membrane 
K+ channels. Accordingly, the effects of SNP on the efflux of 86Rb were 
measured. However, the effects of SNP were disappointing. SNP (10"7 -10-4M ; 
n = 5 ; Fig. 59 & 60) did not significantly affect the rate of 86Rb efflux at any 
concentration.
The relaxant, BRL 38227 (10"7 -10"4M ; n > 4), which has been reported to 
open K+ channels in both vascular (Hamilton et al, 1986 ; Weir & Weston, 
1986b) and gastrointestinal (Weir & Weston, 1986a) smooth muscles was also 
examined. It was expected that this compound would significantly increase the 
efflux of 86Rb from the RDC. As with SNP, the results were disappointing. 
BRL 38227 (10"7 -10_4M ; n > 4) had no effect on the rate of 86Rb efflux. The 
effect of BRL 38227 (10_5 M) is shown in Fig. 59.
The (3-adrenoceptor agonist, isoprenaline, like BRL 38227, abolished all 
spontaneous activity in the RDC. In this case, it is likely that abolition was 
mediated by cAMP elevation. Isoprenaline was used to compare the effects of
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Fig. 5 9  : The e f f e c t s  (±  s . e .  m ea n )  of  car b a c h o l  (Carb ; n =  3 ) ,  
SNP (n =  5 ) ,  BRL 3 8 2 2 7  (BRL ; n =  8 )  and i s o p r e n a l in e  (Iso ;
- J  80
n =  3 ; e a c h  10 M), on the  res t ing  Rb ef f lux  (C),  e x p r e s s e d3
a s  the  e f f lux  rate c o n s t a n t  (E ; x 10 ) ,  from the  rabbit  d is ta l
80  00  
co lo n  inc ub at ed with RbCI. The res t ing  Rb ef f lux  was  s imi la r
in all e x p e r i m e n t s .  Only car bac hol  in c r e a s e d  s ig ni f ic ant ly  (*,
P < 0 . 0 5 ) ,  the  va lue  of  E.
- 7  - 6  . - 5  - 4
Log [ S N P ]
Fig. 6 0  : The e f f e c t  ( ±  s . e .  m e a n ,  n =  5 )  of  SNP ( 1 0  10  4M),
e x p r e s s e d  a s  a p e r c e n t a g e  of the  control  ( 1 0 0 X ) ,  on the  re s t ing
B8Rb ef f lux rate (E) from the  rabbit  dis ta l  co lon i n c u b a t e d  with
8 8  . . .
RbCI. SNP did not  s igni f ic ant ly  a f f e c t  the  value  o f  E at  any
c o n c e n t r a t i o n .
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cAMP elevation with those of SNP (cGMP elevation) and BRL 38227, on 86Rb 
efflux. Unfortunately, isoprenaline (10_5M ; n = 5 ; Fig. 59) was no more 
effective than these other compounds. Indeed, the rate constant for 86Rb efflux 
was not enhanced at any concentration of isoprenaline (lO-MCHM).
Excitatory effects such as those observed in RDC could have potentially far 
reaching implications for the use of the nitrovasodilators. Clearly, excitation is 
an undesirable property in drugs that are generally used for their smooth muscle 
relaxant ability - would this compromise their therapeutic usefulness? Since, 
these drugs are most often used in the cardiovascular system to treat conditions 
such as angona pectoris, congestive heart failure, pulmonary hypertension or 
hypertensive emergencies, it was important to examine their actions on 
spontaneously active vascular smooth muscle. The portal vein was chosen. As 
in the RDC, spontaneous electrical and mechanical activity in portal veins from 
rabbits and from rats was burst-like in nature (Figs. 10 and 11).
3.4. Patterns of Spontaneous Activity in the Portal Vein
In rabbit portal vein (RPV), under an applied tension of lg, bursts of 
electrical spiking and contraction (Fig. 10) had a frequency of 2.95 ± 0.41 
min-1  (n = 5). Each spike-burst had a duration of 7.40 ± 1.94s (n = 4) and 
contained 16.76 + 3.14 spikes (n = 4). The amplitude of the largest spike in 
each was 24.67 ± 2.60 pV (n = 3). Contractile bursts contained 1.50 ± 0.22 
peaks (n = 5) and had a mean duration of 12.17 ± 1.57s (n = 5). The tension 
developed during each, including the lg  applied, was 1.59 ± 0.2g (n = 5).
In rat portal vein (rat PV), under an applied tension of lg, the frequency of 
spontaneous activity (Fig. 11) was 2.61 ± 0.14 bursts min-1  (n = 49). Spike 
bursts had a mean duration of 6.81 ± 0.56s (n = 24) and consisted of 
15.08 ± 1 . 1 1  spikes (n = 20). The maximum spike amplitude per burst was
65
39.04 ± 3.69 pV (n = 24). Each mechanical event had a duration of 
8.31 ± 0.36s (n = 49) and possessed 1.63 ± 0.08 peaks (n = 49). The maximum 
tension developed during each, including the lg applied, was 1.48 ± 0.39g 
(n = 49).
Thus, of the three spontaneously active muscles employed, the RDC was 
generally the most active. For example, in the RDC, the frequency of activity 
was 3.77 ± 0.18 bursts min' 1 (n = 80) as compared to 2.95 ± 0.41 bursts m in - 1  
(n = 5) in the RPV and 2.61 ± 0.14 bursts min- 1  (n = 49) in the rat PV. The 
difference in the frequency of activity between RDC and rat PV was a 
significant one (P < 0.001). Similarly, the electrical spike amplitude in RDC 
was approximately 10 times as large as that in RPV and 6  times as large as that 
in rat PV. Further, the maximum tension developed during each burst of 
mechanical activity in RDC, was more than 0.5g greater than the responses in 
either RPV or rat PV, despite the fact that each portal vein had lg applied 
tension, while the RDC was left unstretched.
As in the RDC, both electrical and mechanical responses in the rat PV 
required the presence of extracellular Ca++ (Fig. 61). When CaCl2  in the Krebs 
was replaced by MgCl2, there was an initial increase in frequency and the 
amplitude of contraction and of spiking fell. After approximately 5 min all 
activity was abolished.
3.5. Actions of Nitrovasodilators on the Portal Vein 
3.5.1. Spontaneous electrical and mechanical activity
The effects of SNP, GTN and IDN were studied on the intact, 
spontaneously active portal vein of either species, mounted under a tension of 
lg, in the Golenhofen apparatus.
activity 
recorded 
from 
the 
rat 
portal vein, 
under 
a 
resting 
tension 
of 
approxim
ately 
lg, in 
the 
G
olenhofen 
apparatus, 
afler 
appioxim
ately 
2 
min 
(centre) 
and 
5 
min 
(right). 
The 
frequency 
of 
both 
electrical and 
m
echanical activity 
was 
increased, but 
the 
am
plitude 
of 
each 
reduced, 
before 
abolition.
NJ
OS
ZCOs
crc/s cs 
c/sO • • 
§. H
g W
ao= cr o
■8 Q
2  *+ -  +
= Sc/s
o 5
CD 2 O 3
PJ c* = *< CL_ 2S CP CD + 
O +
3 =■
o — 
, SL CD
»U
3U
I33
U|(
l3J
 +
+«Q
 
|0.
l)l
l<
O
66
Unlike in the colon, in which SNP increased the frequency of activity, there 
was no evidence of an SNP-induced frequency increase in the RPV. The filing 
rate gradually decreased until SNP (10_5 M) abolished both electrical and 
mechanical responses (n = 3 ; Figs. 62 & 63). The maximum contractile 
amplitude, the number of spikes or peaks per burst and the duration of 
responses were reduced before abolition. In the RDC, activity was never 
abolished by SNP even at concentrations as high as 10_3 M. Because of these 
qualitative differences in effect, the RPV was not pursued as a test model on 
which to study the actions of the nitrovasodilators, but was substituted by the 
rat PV.
The effects of the nitrovasodilators on the rat PV were similar to those in 
the RDC, but still differed in two main respects. Firstly, in the rat PV no 
quiescent period was ever induced by the nitrovasodilators. Secondly, since the 
frequency of activity was lower than in RDC, no evidence of a reduction in the 
frequency of activity was ever found (compare this with the effects of SNP on 
high frequency tissues in the RDC, Figs. 29 and 30). Apart from this, the 
effects were qualitatively, though not quantitatively, similar.
As in the RDC, SNP was the most effective nitrovasodilator tested. In the 
rat PV, SNP was more potent than in RDC and, at concentrations as low as 
10’7 M, significantly enhanced the frequency of spontaneous activity (Fig. 64 ; 
P < 0.001). However, the maximum effects observed in the rat PV were 
generally less than the corresponding effects in RDC. The effects of SNP 
(10_6 M) are shown in Fig. 65. In this example, the frequency of responses was 
increased to 233% of the control. In the rat PV, the effects of the other 
nitrovasodilators were disappointing. Neither GTN (10_7 -10"5M ; n > 4) nor 
IDN (10_7 -10'5M ; n = 4), had a significant effect on the frequency of 
pacemaker activity (Fig. 64). Baseline tension was unaffected by any of these 
drugs.
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Fig. 6 3  : The e f f e c t  ( ±  s . e .  m ean,  n ^ 3 )  o f  SNP ( 1 0  7- 1 0  5 M),
e x p r e s s e d  a s  a p e r c e n t a g e  of  the  control  ( 1 0 0 %), on the  fr e q u e n c y
( b u r s t s  min 1) of  s p o n t a n e o u s  act iv ity ,  in th e  rabbit  portal  vein.
SNP ( 1 0  *M) ab o l i s h ed  all activi ty ; th e r e  was  no e v i d e n c e  of  
e x c i t a t io n .
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Fig. 6 4  : The e f f e c t s  (±  s . e .  m e a n )  of-GTN (n ^ 5 ) ,  SNP (n ^ 2 9 )
—7 —3
and ION (n =  4  ; e a c h  10 —10 M), e x p r e s s e d  a s  a p e r c e n t a g e  of
the  contro l  ( 1 0 0 %), on the  f req u en cy  ( b u r st s  min ) o f  s p o n t a n e o u s  
act ivi ty,  in the  rat portal vein.  Only SNP i n c r e a s e d  s i g n i f ic a n t ly  (**,  
P < 0 .0 1  ; ***, P < 0 . 0 0 1 ) ,  the  f r e q u e n c y  of activi ty.
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Concomitant with the increase in frequency, the amplitude of the 
spontaneous contractions was significantly decreased by SNP (> 10_7M ; 
n > 29 ; P < 0.001 ; Figs. 65 & 6 6 ). Although GTN did not increase the 
frequency of activity in rat PV, this drug, at a concentration of 10_6 M, also 
lowered the contractile amplitude (Fig. 6 6  ; P < 0.05). IDN (10_7 -10’5M ; 
n = 4 ; Fig. 6 6 ) was without effect.
As in the RDC, in certain individual experiments on the rat PV, the 
amplitude of spike discharge was augmented (Fig. 65). In this particular case 
(Fig. 65), the amplitude was increased to 230% of the control by SNP (10_6 M). 
Examples of this effect were, however, in the minority. In the majority of 
cases, SNP (10'7 -10_5M ; n > 17 ; Fig. 67) did not increase the spike amplitude. 
In fact, SNP (10_5 M) significantly reduced the maximum spike amplitude 
(P < 0.01 ; Fig. 67). This was in contrast to the actions of IDN (10-5M ; n = 4) 
which significantly enhanced this parameter (P < 0.05 ; Fig. 67). GTN 
(10'7 -10_5M ; n > 4 ; Fig. 67) had no effect. With SNP, any changes in the 
amplitude of spontaneous spiking occurred simultaneously with the increases in 
frequency or reductions in contractile amplitude previously described i.e. it was 
not a gradual effect.
Both SNP (> 10_6M ; n > 14 ; P < 0.01) and GTN (10’7M ; n = 6  ; 
P < 0.05 ) significantly reduced the number of spikes per electrical burst and 
the mean duration of each burst in rat PV (Figs. 6 8  and 69 respectively). 
However, these reductions were not as great as those achieved in response to 
SNP in RDC (Figs. 37 and 39) - in rat PV, following nitrovasodilator addition 
the electrical discharge never consisted of single spikes. The effects of IDN 
were, again, disappointing. This substance (10”7 -10"5M ; n > 3 ; Figs. 6 8  and 
69) had no effect on either parameter.
Similarly, the number of peaks per mechanical burst was significantly 
reduced by SNP (10_7M and 10_5M ; n > 29 ; P < 0.05 ; Fig. 70). Neither GTN 
(10-7 -10'5M ; n > 5 ; Fig. 70) nor IDN (10'7 -10_5M ; n = 4 ; Fig. 70) had any
Log [ N i t r o v a s o d i l a t o r ]
Fig. 6 6  : The e f f e c t s  ( ±  s . e .  m e a n )  of  GTN (n ^ 5 ) ,  SNP (n ^  2 9 )
/  - 7  - 5  x
and IDN (n =  4  ; e a c h  10  - 1 0  M), e x p r e s s e d  a s  a p e r c e n t a g e  of
t h e  con trol  ( 1 0 0 %), on the  m a x im u m  c o n t r a c t i l e  a m pl i t ud e  per  burst  
of  m e c h a n i c a l  activi ty,  in the  rat portal  ve in.  GTN and SNP e a c h
r e d u c e d  s ig ni f ic ant ly  (*,  P < 0 . 0 5  ; **, P <  0 .0 1  ; ***, P < 0 . 0 0 1 ) ,
t h e  m ax im u m  c o n t r a c t i l e  am pl i tud e .
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F ig .6 7  : The e f f e c t s  ( ±  s . e .  m e a n )  of  GTN (n 5 ) ,  SNP (n ^ 1 7 )  and
IDN (n =  4  ; e a c h  10 —10 M), e x p r e s s e d  a s  a p e r c e n t a g e  of  the  control
(100%),  on the  maximum spike  ampl i tu de  (mV) per burst  of  e le c tr ica l  act ivi ty,  
in th e  rat portal  vein.  SNP reduced but IDN i n c r e a s e d  s ig ni f ic ant ly  (*, P < 0 . 0 5  ; 
**, P < 0 . 0 1 ) ,  the  maximum  spike  ampl i tude .
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Fig. 6 8  : The e f f e c t s  ( ±  s . e .  m ea n )  of  GTN (n 36 5 ) ,  SNP (n 3s 1 4 ) and
—7  —5
IDN (n =  4  ; e a c h  10 —10 M), e x p r e s s e d  a s  a p e r c e n t a g e  of  the  control
( 1 0 0 %), on the  number  of s p i ke s  per burst  of  e l e c t r ic a l  act iv ity ,  in the  rat 
portal  vein.  GTN and SNP e a c h  red uc ed  s ig n i f ic a n t ly  (*,  P < 0 . 0 5  ; **,
P < 0 . 0 1 ) ,  the  number  of sp ik e s  per burst .
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Fig. 69  : The e f f e c t s  ( ±  s . e .  m ea n )  of  GTN (n *  5 ) ,  SNP (n i  17)  and
- 7  - 5
IDN (n =  4  ; eac h  10 —10 M), e x p r e s s e d  a s  a p e r c e n t a g e  of  the  control
( 1 0 0 %), on the  durat ion ( s )  of ea ch  burst  of  e lect r ica l  activ i ty ,  in the  rat 
portal  vein.  GTN and SNP e a c h  reduced s igni f ica nt ly  (*, P < 0 . 0 5  : **,
P < 0 . 0 1 ) ,  the  durat ion of  e a c h  burst.
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Fig. 7 0  : The e f f e c t s  ( ±  s . e .  m ea n )  of  GTN (n ^ 5 ) ,  SNP (n J* 2 9 )  and
-7  -5
IDN (n =  4  ; e a c h  10 —10 M), e x p r e s s e d  a s  a p e r c e n t a g e  of  the  contro l
( 1 0 0 %), on the  numb er  of pe ak s  per burst  of  m e c h a n i c a l  act ivi ty,  in t h e  rat  
portal  ve in.  SNP reduc ed s igni f icant ly  (*,  P < 0 . 0 5 ) ,  t h e  nu mb er  of  p e a k s  
per burst .
68
effect. Despite its lack of effect on this parameter, however, GTN (10-7M ; 
n = 6  ; P < 0.05 ; Fig. 71) significantly decreased the mean duration of 
mechanical bursts ; an effect also achieved by SNP (> 10_6M ; n > 33 ; 
P < 0.001 ; Fig. 71). IDN (10'7 -10-5M ; n > 3 ; Fig. 71) had no effect.
The concept that, as in RDC, these nitrovasodilator-induced effects would 
be mediated via NO release and cGMP stimulation was investigated. Hb 
(10_5 M) inhibited both the excitatory and inhibitory effects of SNP on 
spontaneous activity (Fig. 72). The rise in frequency (P < 0.05 ; Fig. 73) and 
the fall in contractile amplitude (P < 0.05 ; Fig. 74) induced by SNP (10-5 M), 
were antagonized by Hb (10_5M ; n = 4), added 10 min before SNP, indicating 
that the actions of this nitrovasodilator were mediated through the release of 
NO. Hb (10_5 M), alone, was without effect.
Using 8 -bromo cGMP it was established that the actions of SNP could be 
mediated through cGMP stimulation. This compound mimicked a number of 
the effects of SNP in the rat PV (Fig. 75). The number of spikes in and the 
duration of each electrical burst, the maximum contractile amplitude and the 
duration of each mechanical burst were significantly inhibited by 8 -bromo 
cGMP (> 10_5M ; n > 3 ; P < 0.05), suggesting that these actions of SNP could 
be mediated by a cGMP-dependent mechanism.
In support of the idea that the effects of SNP were, indeed, mediated 
through NO release and cGMP activation, K4 Fe(CN ) 6  was found to have no 
effect on the mechanical responses of rat PV. The frequency, amplitude, 
number of peaks per burst and duration of the response were unaffected by 
K4 Fe(CN ) 6  (10'6 -1(HM ; n > 3 ; results not shown). Thus, as in RDC, in the 
rat PV, the effects of SNP on pacemaker activity were not mediated by the 
ferrocyanide portion of the molecule.
Interestingly, in the rat PV, the actions of SNP were also mimicked by 
cAMP activation. The effects of cAMP stimulation were examined in two 
separate experiments using a) isoprenaline and b) forskolin. The P-
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Fig. 71 : The e f f e c t s  (±  s . e .  m e a n )  of GTN (n ^ 5 ) ,  SNP (n ^ 2 9 )  and
/  - 7  - 5  .
IDN (n =  4 ; e a c h  10 —10 M), e x p r e s s e d  a s  a p e r c e n t a g e  of  the  control
( 1 0 0 %), on the  duration ( s )  o f  e a c h  burst  of  m e c h a n i c a l  activ i ty ,  in t h e  rat  
portal  ve in.  GTN and SNP e a c h  red uc ed  s igni f ic ant ly  (*,  P < 0 . 0 5  ; **,
P < 0 . 0 1  ; ***, P < 0 . 0 0 1 ) ,  the  durat ion of  e a c h  burst .
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Fig. 72 : Inhibition o f the excitatory and inhibitory effects o f SNP 
(10"6M), by Hb (10_5M), on the spontaneous electrical (top) and 
mechanical activity recorded from the rat portal vein, under a resting 
tension o f approximately Ig, in the Golenhofen apparatus. SNP, alone, 
increased the frequency of both electrical and mechanical activity and 
reduced the amplitude of contraction. In the presence o f Hb, SNP had 
no effect.
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Fig. 7 3  : The e f f e c t  ( ±  s . e .  m ean,  n =* 4)  of  SNP ( 1 0  M), e x p r e s s e d
a s  a p e r c e n t a g e  of  the  control  ( 1 0 0 %), on the  f r e q u e n c y  ( b u r s t s  min ) 
of  s p o n t a n e o u s  activity,  in the  rat portal  vein,  in the  a b s e n c e  and in the  
p r e s e n c e  of  Hb (1 0  ^M). SNP s igni f icant ly  i n c r e a s e d  (*, P < 0 . 0 5 )  the  
f r e q u e n c y  of activi ty in the  a b s e n c e ,  but not  in the  p r e s e n c e ,  o f  Hb.
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Fig. 7 4  : The e f f e c t  ( ±  a .e .  m ea n ,  n =* 4 )  of  SNP ( 1 0  9 M), e x p r e s s e d  
a s  a p e r c e n t a g e  of  the  control  ( 1 0 0 %), on th e  maxi mum  con tr a c t i l e  
am pl i tu de  ( g )  per burst  of m e c h a n ic a l  act ivi ty ,  in the  rat portal  vein,  
in the  a b s e n c e  and in the  p r e s e n c e  of  Hb ( 1 0  SM). SNP s ig ni f icant ly  
r ed u ced  (*,  P < 0 . 0 5 )  the  ampl i tude  of  c o n tr a c t io n  in th e  a b s e n c e ,  
but  not  in the  p r e s e n c e ,  of  Hb.
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adrenoceptor agonist, isoprenaline, like SNP, increased the frequency of 
spontaneous activity and reduced both the spike and contractile amplitudes, the 
number of spikes or peaks per burst and the duration of electrical or mechanical 
responses significantly (P < 0.05 ; Fig. 76). Isoprenaline was, in fact, more 
potent than SNP, and enhanced the frequency and lowered the amplitude of 
contraction at concentrations as low as 10_8M (n = 9). The potent adenylate cyclase 
activator, forskolin, had a similar action to that of isoprenaline on both 
spontaneous electrical and mechanical activity except that, at higher doses 
(10_6 M), forskolin abolished all activity (Fig. 77). Isoprenaline never abolished 
activity even at 10-5 M. It is, however, unlikely that SNP, itself, was stimulating 
cAMP. There is no evidence of this in the literature and, besides, the cAMP 
activators examined were at least ten times as potent as SNP in producing the 
desired effects. The available evidence indicates that both the excitatory and 
the inhibitory effects of SNP are probably mediated via NO release and cGMP 
stimulation.
In theory, the release of a contractile agonist such as noradrenaline or other 
catecholamine, would be expected to increase the frequency of spontaneous 
activity in rat PV. In an attempt to shed light on the mechanisms underlying 
the excitation to SNP, more in hope than in expectation, the effects of SNP 
(10_5 M) were investigated in the presence of phentolamine and propranolol 
(each 3 x 10*6 M) in rat PV (Fig. 78). The results were unexpected. SNP 
(10“5 M), alone, increased the frequency of activity and reduced the contractile 
amplitude, number of peaks per burst and duration of mechanical bursts. These 
effects of SNP were antagonized by the a-adrenoceptor antagonist,
(wh"ic.k f t l s o  p o s s e s s e s  rt& n b < T a/i£ -s tab iV iz .i.-v j p < " » p a c h e s )
phentolamine, together with the P-adrenoceptor antagonist, propranolol^(each 
3 x 10_6M ; Fig. 78), suggesting that SNP was either stimulating the secondary 
release of noradrenaline or was acting directly on adrenoceptors. These results 
prompted a study of the ability of SNP to liberate radiolabelled noradrenaline 
(3 H-noradrenaline) from adrenergic nerves in the rat PV (see 3.5.3.).
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3.5.2. Radiolabelled rubidium efflux
The movement of K+ across the cell membrane was studied by incubating 
intact sections of rat PV in Krebs solution containing 86Rb (Martin & Gordon, 
1983 ; Hamilton et al, 1986), before mounting them in the Golenhofen 
apparatus. Following the commencement of superfusion, the 86Rb efflux rate 
declined rapidly (Fig. 79) due to the loss of isotope from the extracellular 
space. The rate was then constant. This constant phase represented the loss of 
86Rb from the smooth muscle cells themselves. The mean value of the efflux 
rate constant (E) was 11.2 ± 0.74 x 10- 3  min-1 (n = 24). This was considerably 
larger than the values obtained in RDC (6.59 ± 0.26 x 1 0 - 3  min-1) or rabbit 
aorta (4.22 ±0 .14  x 10- 3  min-1, Martin & Gordon, 1983 ; 4.8 ± 0.4 x 10- 3  
min-1, Bolton & Clapp, 1984), but was comparable with the value reported in 
guinea-pig taenia caeci (11.38 ± 0.4 x 10- 3  min-1, Bolton & Clark, 1981).
In this tissue, both noradrenaline and BRL 38227 were used as controls, to 
test that the system was functional. These drugs were selected since 
noradrenaline was known to have significantly increased 86Rb efflux from 
aortic vascular smooth muscle (Martin & Gordon, 1983), while BRL 38227 is 
the active (-)-enantiomer of the racemate, BRL 34915 (cromakalim), which had 
been reported to enhance the 86Rb efflux from rat portal vein (Hamilton et al, 
1986 ; Weir & Weston, 1986b).
In rat PV, noradrenaline induced a 86Rb efflux (Fig. 80). The value of E 
was significantly increased (P < 0 .0 1 ) from 13.3 ± 1.3 x 10- 3  min- 1  to 18.04 ± 2 
x 10- 3  min- 1  by noradrenaline (10-5M ; n = 5). This efflux of rubidium in 
response to noradrenaline, may have been secondary to a primary influx of 
Ca++ which affected the gating mechanism. This has been reported in rabbit 
aorta (Martin & Gordon, 1983).
BRL 38227 (10-5M ; n = 7) also enhanced the efflux of 86Rb in rat PV. E 
was significantly increased (P < 0.05) from 10 ± 1.7 x 10- 3  min-1 to 11.9 ± 2 x
/  \
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Fig. 79  : The exp one nt i a l  de c l in e  with t i m e  of  the  r e s t in g  Rb
eff lux ,  e x p r e s s e d  a s  the  f i r s t - o r d e r  rate c o n s t a n t  (E ; x 10 ) ,
BB
from the  rat portal  vein in c u b a te d  with RbCI. By 15 min,
BB
ap pr ox im at e l y ,  Rb eff lux had r e a c h e d  a relat ively s t e a d y  valu e .
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Fig. 8 0  : The e f f e c t s  (±  s . e .  m e a n )  of  noradre nal in e  (NA, n -  5 ) ,  
SNP (n =  1 2 ) ,  BRL 3 8 2 2 7  (BRL ; n =  7)  and i s o p r e n a l i n e  (Iso ;-3 . 60 . x
n =  4  ; e a c h  10 M), on the  res t ing  Rb ef f lux  (C),  e x p r e s s e d
/ 3\a s  the  e f f lux rate c o n s t a n t  (E ; x 10  ) ,  from the  rat portal  vein  
6 6 8 6  
in c u b a te d  with RbCI. The rest ing Rb ef f lux var ied b e tw e e n  10 and
1 5 . 8 .  Noradrenal ine  and BRL 3 8 2 2 7  e a c h  i n c r e a s e d  the  va l ue  of  E
s ig ni f i can t ly  (*, P < 0 . 0 5  ; ♦*, P < 0 . 0 0 1 ) .
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10- 3  min"1 by this concentration of drug (Fig. 80). This effect was almost 
certainly mediated through the primary opening of membrane K+ channels as 
has been previously reported (Hamilton et al, 1986 ; Weir & Weston, 1986).
The results with SNP were slightly disappointing. SNP (n > 4) had no 
effect on the 86Rb efflux rate constant at any concentration (10-7 -10-4 M) 
indicating that the effects of cGMP stimulation did not involve an efflux of K+. 
The effects of SNP (10'5 M) are compared with those of noradrenaline (10-5 M) 
and BRL 38227 (10-5M) in Fig. 80.
The effects of cAMP stimulation, which resembled the response to SNP on 
electrical and mechanical activity, was also examined on 86Rb efflux using 
isoprenaline. Like SNP this compound was ineffective. Isoprenaline did not 
significantly increase the 86Rb efflux rate at any concentration (10-7 -10-4M ; 
n = 3 ; Fig. 80). Thus, neither the response to cGMP stimulation nor the 
response to cAMP stimulation involved the efflux of K+.
3.5.3. Radiolabelled (3H) noradrenaline overflow
Experiments in which the actions of SNP on mechanical activity were 
inhibited by phentolamine and propranolol, together, suggested that SNP 
possibly stimulated the release of noradrenaline (see 3.5.1.). To examine this 
possibility, intact sections of rat PV were incubated with radiolabelled (3 H) 
transmitter and the effect of drug on the overflow measured. Following the 
commencement of supeifusion, the overflow of 3H from the rat PV declined 
exponentially (Fig. 81), until after about 1.5-2 hr it reached a steady level. 
Drugs were added after three hours, at which time the overflow of 3H was 
assumed to be constant. The value of the overflow rate constant (calculated 
using the same equation as was used for the efflux rate constant, with the 
exception that d.p.m. rather than c.p.m. were inserted) was 1.89 ± 0.12 x 10-3  
min-1.
0 3 0  6 0  9 0  1 2 0  1 5 0  1 8 0
T i me  ( m i n )
3
Fig. 61 : The exp one nt ia l  dec l ine  with t ime  of the  re s t in g  H overflow,  
e x p r e s s e d  a s  the  overflow rate c o n s t a n t  ( 9  ; x 1 0 3) ,  from the  rat portal  
vein in c u b a te d  with [ 3 H ] - n o r a d r e n a l i n e .  By 1 . 5 —2 hr, ap p ro x im a te ly ,  [ 3 H] 
overf low had re ac he d a relatively s t e a d y  value .
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The indirect sympathomimetic, tyramine, was used as a control to check 
that the system was functional. This drug should have released noradrenaline 
from the nerve terminals, thereby increasing the overflow. This was the case. 
Tyramine (10_5M ; n = 10) significantly increased (P < 0.001) the overflow rate 
of 3H from 1.29 ± 0.09 x 10- 3  m n r 1 to 1.62 ± 0.11 x 10- 3  m n r 1 (Fig. 82).
SNP was ineffective. This compound did not significantly increase the rate 
of 3H overflow at any concentration (10_7 -10_5M ; n > 7 ; Figs. 82 and 83).
3.6. Effects of SNP on non-spontaneously active smooth muscle
The effects of SNP were examined on non-spontaneously active smooth 
muscle to determine whether SNP-induced excitation was unique to pacemaker 
driven tissues. The evidence from the muscles examined, suggested that this 
was probably the case. When the non-spontaneously active rat anococcygeus 
or rabbit abdominal aorta were mounted, under a resting tension of lg, in the 
Golenhofen apparatus, then SNP did not induce spontaneous activity at any 
concentration (10'7 -10_4 M), nor did it have any effect on the resting tension (in 
each tissue, n = 3 ; results not shown). In each tissue, noradrenaline (10-5 M) 
raised the tone, indicating that the tissues were active and functioning as 
normal.
3.7. Effects of SNP on [Ca++]j
Experiments in which the C a ++ channel agonist BAY K 8644 reversed the 
actions of SNP, and vice versa, on the spontaneous activity of RDC (see 
3.3.1.), provided indirect evidence that the SNP-induced actions (in particular 
the reduced amplitude of spontaneous contraction) were, at least partly, 
mediated by a reduction in the level of intracellular C a ++ ( [ C a ++]j). The ability 
of SNP to reduce [C a ++]j was examined directly in rat aortic vascular smooth
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Fig.  8 2  : The  e f f e c t s  ( ±  s . e .  m e a n ,  n ^  7 )  o f  SNP c o m p a r e d  with t h o s e
—5  3
o f  t y r a m i n e  ( e a c h  10  M), on t h e  r e s t i n g  H o v e r f l o w ,  e x p r e s s e d  a s  t h e  
o v e r f l o w  r a t e  c o n s t a n t  ( 0  ; x 1 0  ) ,  f r o m  t h e  rat  p o r t a l  ve in  i n c u b a t e d  with 
[ 3 H ] —n o r a d r e n a l i n e .  Only t y r a m i n e  i n c r e a s e d  t h e  r e s t i n g  3H o v e r f l o w  (+**,
P <  0 . 0 0 1 ) .  The  f o l l o w i n g  d r u g s  w e r e  p r e s e n t  t h r o u g h o u t  : a s c o r b i c  a c id  
( 1 . 1  x 1 0  +M) t o  p r e v e n t  c a t e c h o l a m i n e  o x i d a t i o n ,  i m i p r a m i n e  ( 6  x 1 0  ?M) 
a n d  n o r m e t a n e p h r i n e  ( 1 0  5 M) to r e s p e c t i v e l y  inh ib i t  u p t a k e — 1 a n d  u p t a k e  — 2
-3 , .
p r o c e s s e s ,  t r a n y l c y p r o m i n e  ( 1 0  M) to  inhibi t  m o n o a m i n e  o x i d a s e  a nd  y o h i m b i n e  
( 1 0  ? M) t o  b l o c k  p r e s y n a p t i c  a — a d r e n o c e p t o r s .
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Fig.  8 3  : The e f f e c t  ( ±  s . e .  m e a n ,  n ^  3 )  o f  SNP ( 1 0  7 —10  *M)
e x p r e s s e d  a s  a p e r c e n t a g e  o f  t h e  c o n t r o l  ( 1 0 0 %), on t h e  r e s t i n g
3 [H]  o v e r f l o w  r a t e  f r o m  t h e  rat  p or ta l  ve in  i n c u b a t e d  with 3 [ H ] -
n o r a d r e n a l i n e .  SNP did n o t  s i g n i f i c a n t l y  a f f e c t  t h e  r a t e  o f  o v e r f l o w  
a t  a n y  c o n c e n t r a t i o n .
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muscle cells, grown on glass cover slips. In these cells the basal concentration 
of intracellular free Ca++ was 119 ± 11.5 nM (n = 6). In order to check the 
viability of the cells, they were stimulated with angiotensin II (10_7M). This 
significantly increased (P < 0.01) the basal free [Ca++]j to 250.5 ± 100 nM (Fig. 
84), indicating that the cells were viable. The results with SNP were 
disappointing. Despite SNP (10_5M) significantly reducing the amplitude of 
spontaneous contraction in RDC (P < 0.001), this concentration of drug had no 
effect on [Ca'hf]i (Fig. 84).
C S N P  An g  II
Fig.  8 4  : The  e f f e c t  o f  SNP ( 1 0  5M) or a n g i o t e n s i n  II (Ang II ; 10  ?M), 
e x p r e s s e d  a s  a p e r c e n t a g e  o f  t h e  c o n t r o l  ( 1 0 0 & ) ,  on  t h e  i n t r a c e l l u l a r  f r e e  
c a l c i u m  c o n c e n t r a t i o n  ( [ C a ++]j ; nM ; n =  6 ) ,  o f  rat  a o r t i c  v a s c u l a r  s m o o t h  
m u s c l e  c e l l s .  Only a n g i o t e n s i n  II i n c r e a s e d  s i g n i f i c a n t l y  (P <  0 . 0 1 ) ,  t h e  
i n t r a c e l l u l a r  f r e e  c a l c i u m  c o n c e n t r a t i o n .
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Chapter 4 : Discussion
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Examination of the actions of the nitrovasodilators on spontaneously active 
smooth muscle revealed a number of distinct effects. There were certain 
differences in the responses of different tissues to these drugs but, in the main, 
nitrovasodilator-induced responses in RDC and rat PV followed the same broad 
pattern. This pattern differed from that in the RPV. Since SNP was the most 
effective compound tested, this was used as a model for the actions o f this 
group of drugs.
In the RDC, but not in the rat PV, the immediate effect o f the 
nitrovasodilators was to induce a short period of quiescence. This generally 
lasted between 1 and 5 min although, rarely, up to 10 min. Spontaneous 
electrical and mechanical activity, the pattern of which differed from the 
control, then returned abruptly. In response to SNP, IDN or, occasionally, 
GTN, the frequency of both electrical and mechanical responses was 
significantly increased, suggesting that these drugs exerted an effect on the 
pacemaker. Additionally, in the few RDC strips where the initial frequency 
was high (> 6 bursts min-1), SNP slowed the pacemaker activity. It appeared 
that SNP could either increase or decrease the pacemaker frequency depending 
on the level of control activity. Simultaneously, each nitrovasodilator 
significantly reduced the mean contractile amplitude per burst of mechanical 
activity. This pattern of spontaneous events was mimicked in the rat PV, in the 
absence of the prior period of quiescence. In this tissue, SNP significantly 
increased the frequency of activity while SNP and GTN each significantly 
decreased the amplitude of spontaneous contractions. In most cases, in either 
tissue, these effects were accompanied by a reduction in the number of 
spikes/peaks per burst and the duration of electrical/mechanical bursts and, 
occasionally, by an increase in the amplitude of electrical spikes. Rarely, the 
increase in spike amplitude came after the other changes, suggesting that it was 
secondary to them. In RPV, there was no evidence of any excitation in 
response to SNP ; the frequency of electrical and mechanical activity, the
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c o n t r a c t i l e  a m p l i t u d e ,  t h e  n u m b e r  o f  s p i k e s / p e a k s  p e r  b u r s t  a n d  t h e  d u r a t i o n  
e l e c t r i c a l / m e c h a n i c a l  b u r s t s  w e r e  e a c h  r e d u c e d  t h e n  a b o l i s h e d  b y  t h i s  d r u g .
T h e  q u i e s c e n c e  o b s e r v e d  i n  R D C  i n  r e s p o n s e  t o  t h e  n i t r o v a s o d i l a t o r s ,  i t  
w a s  p r e s u m e d ,  a r o s e  f r o m  a  m e m b r a n e  h y p e r p o l a r i z a t i o n  w h i c h  c o u l d  n o t  b e  
d e t e c t e d  b y  t h e  e x t r a c e l l u l a r  r e c o r d i n g  t e c h n i q u e  e m p l o y e d .  I n d e e d ,  
n i t r o v a s o d i l a t o r s  h y p e r p o l a r i z e  a  n u m b e r  o f  s m o o t h  m u s c l e s  i n c l u d i n g  r a b b i t  
p u l m o n a r y  a r t e r y  ( I t o  et al, 1 9 7 8 ) ,  r a t  t a i l  a r t e r y  ( C h e u n g  &  M a c K a y ,  1 9 8 5 ) ,  
g u i n e a  p i g  u t e r i n e  a r t e r y  ( T a r e  et al ,  1 9 9 0 )  a n d  g u i n e a  p i g  i n t e r n a l  a n a l  
s p h i n c t e r  ( R a e  &  M u i r ,  1 9 9 3 ) .  S i n c e  m o s t  s m o o t h  m u s c l e  h y p e r p o l a r i z a t i o n s  
a r e  t h e  r e s u l t  o f  a  K +  e f f l u x ,  t h i s  m e c h a n i s m  w a s  p r e s u m e d  t o  o p e r a t e  h e r e .  
E v i d e n c e  t o  s u p p o r t  t h i s  v i e w  w a s  o b t a i n e d  w h e n  S N P  a n d  t h e  K +  c h a n n e l  
o p e n e r ,  B R L  3 8 2 2 7 ,  w e r e  f o u n d  t o  b e  s y n e r g i s t i c  i n  t h e  a b o l i t i o n  o f  
s p o n t a n e o u s  a c t i v i t y .
I n  l i g h t  o f  t h e s e  r e s u l t s  f r o m  t h e  R D C ,  K +  e f f l u x  w a s  s t u d i e d  d i r e c t l y  b y  
l o a d i n g  b o t h  R D C  a n d  r a t  P V  w i t h  t h e  m a r k e r  f o r  K + ,  8 6 R b ,  m o u n t i n g  t h e  
t i s s u e s  i n  t h e  G o l e n h o f e n  a p p a r a t u s ,  a n d  a n a l y s i n g  t h e  s u p e r f u s a t e  f o r  
r a d i o a c t i v i t y .  I n  R D C ,  t h e  e f f l u x  r a t e  c o n s t a n t  f o r  8 6 R b  ( E )  w a s  6 . 5 9  ±  0 . 2 6  x  
1 0 - 3  m i n - 1 .  T h i s  w a s  c o n s i d e r a b l y  l e s s  t h a n  t h e  r e p o r t e d  v a l u e  i n  g u i n e a - p i g  
t a e n i a  c a e c i  o f  1 1 . 3 8  ±  0 . 4  x  1 0 ’ 3  m i n - 1  ( B o l t o n  &  C l a r k ,  1 9 8 1 ) ,  i n d i c a t i n g  t h a t  
t h e  m e m b r a n e  p e r m e a b i l i t y  o f  t h i s  t i s s u e  f o r  K +  i o n s  w a s  g r e a t e r  t h a n  t h a t  o f  
R D C .  I f  S N P  i n d u c e d  t h e  o p e n i n g  o f  m e m b r a n e  K +  c h a n n e l s ,  t h e n  t h e  v a l u e  o f  
E ,  i n  r e s p o n s e  t o  S N P ,  s h o u l d  h a v e  b e e n  i n c r e a s e d .  U n d e r  t h e  e x p e r i m e n t a l  
c o n d i t i o n s ,  S N P  d i d  n o t  i n c r e a s e  t h e  v a l u e  o f  E  i n  R D C .  H o w e v e r ,  B R L  3 8 2 2 7  
w a s  a l s o  i n e f f e c t i v e .  E v e n  a t  c o n c e n t r a t i o n s  t h a t  a b o l i s h e d  b o t h  e l e c t r i c a l  a n d  
m e c h a n i c a l  e v e n t s ,  B R L  3 8 2 2 7  d i d  n o t  e n h a n c e  8 6 R b  e f f l u x  i n  R D C .  T h i s  w a s  
u n e x p e c t e d  s i n c e  B R L  3 8 2 2 7  i s  t h e  a c t i v e  ( - ) - e n a n t i o m e r  o f  t h e  r a c e m a t e  
c r o m a k a l i m  ( B R L  3 4 9 1 5  ;  C l a p h a m  et al ,  1 9 9 1 )  w h i c h  o p e n s  K +  c h a n n e l s  i n  a  
v a r i e t y  o f  s m o o t h  m u s c l e s  ( W e i r  &  W e s t o n ,  1 9 8 6 a , b  ;  Q u a s t ,  1 9 8 7  ;  S h e t t y  &  
W e i s s ,  1 9 8 7  ;  M c P h e r s o n  &  A n g u s ,  1 9 9 0 ) .  T h e  8 6 R b  e f f l u x  r a t e  w a s ,  h o w e v e r ,
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increased by the muscarinic agonist, carbachol. The mechanism for this efflux 
may have involved a Ca++ influx, subsequent depolarization and the secondary 
opening of voltage-operated K+ channels, as has been reported for the actions 
of noradrenaline on 86Rb efflux in rat aorta (Martin & Gordon, 1983).
In rat PV, E was 11.2 ± 0.74 x 10"3 min-1 ; a value comparable to that 
(11.38 ± 0.4 x 10-3 min”1) found in guinea-pig taenia caeci (Bolton & Clark, 
1981). This indicates that the membrane permeabilities of these two tissues to 
K+ were roughly equivalent, but almost double that of RDC (6.59 + 0.26 x 10-3 
min-1), and some three times that of rabbit aorta (4.22 + 0.14 x 10”3 min”1, 
Martin & Gordon, 1983 ; 4.8 ± 0.4 x 10”3 min-1, Bolton & Clapp, 1984). As in 
RDC, SNP did not induce a 86Rb efflux. Noradrenaline (10”5M) did, however, 
augment 86Rb efflux (from 13.3 ± 1.3 x 10”3 min”1 to 18.04 ± 2 x  10”3 min”1) ; 
probably via the opening of voltage-operated K+ channels, secondary to Ca++ 
influx and contraction. BRL 38227 (lO^M) abolished both electrical and 
mechanical activity in rat PV, but did not augment efflux. In higher 
concentrations (10”5M), BRL 38227 abolished all activity and enhanced 86Rb 
efflux (from 10 ± 1.7 x 10-3 min-1 to 11.9 ± 2 x 10”3 min”1). This was in 
keeping with earlier observations that the relaxant actions of the racemate, BRL 
34915, in the portal vein could be dissociated from its ability to open K+ 
channels (Weir & Weston, 1986b ; Shetty et al, 1987). In rat PV, BRL 34915 
(cromakalim ; 5 x 10”7M) abolished spontaneous activity, but it was only when 
the concentration was increased tenfold (5 x 10_6M) that any evidence of a K+ 
efflux was found (Shetty et al, 1987). Perhaps, as has been suggested for BRL 
34915 (Weir & Weston, 1986b), at the lower doses of BRL 38227, the 
anticipated small increase in 86Rb efflux from the rat PV was negated by a 
concomitant reduction in efflux due to the abolition of spontaneous spiking 
throughout the tissue. Alternatively, the ineffectiveness of BRL 38227 in RDC 
and, at lower doses, in rat PV, to enhance 86Rb efflux could have been the 
result of a preferential action of this drug to enhance 86Rb efflux from
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pacemaker cells. Similar effects, in guinea pig portal vein, were explained by 
this proposal (Quast, 1987).
For this reason, in spite of the fact that, in RDC, neither SNP nor BRL 
38227 increased the 86Rb efflux rate constant, the possibility that the synergism 
between these compounds, in producing quiescence in this tissue, was the result 
of an enhanced K+ efflux, cannot be eliminated entirely. However, in light of 
the high concentrations (10_4M) tested, it is, perhaps, unlikely that the 
ineffectiveness of these drugs on the rate of 86Rb efflux was due to their effect 
being masked by the cessation of spontaneous electrical activity. At this 
concentration of BRL 38227, the expected large increase in efflux should have 
been measurable despite the abolition of spontaneous spiking. In fact, BRL 
34915 (6.4 x lO^M) significantly increased the value of E in guinea-pig taenia 
caeci (Weir & Weston, 1986a). A more likely explanation is that the synergism 
observed between SNP and BRL 38227 in RDC, was mediated by a 
preferential effect of each on the pacemaker cells to hyperpolarize them and 
abolish both spontaneous electrical and mechanical activity. The overall 
increase in K+ permeability required would have been so small as to go 
undetected.
On the other hand, the nitrovasodilator-induced quiescence of spontaneous 
activity in RDC, may not have arisen from a membrane hyperpolarization ; 
hence no 86Rb efflux would be expected. NO failed to hyperpolarize a number 
of smooth muscles (Taylor et al, 1988 ; Huang et al, 1988 ; Komori et al, 
1988 ; Chen et al, 1988 ; Chen et al, 1989 ; Bray den, 1990 ; Suzuki et al, 
1992). In the vasculature, an endothelium derived hyperpolarizing factor 
(EDHF) has been postulated to account for endothelium-dependent 
hyperpolarization (Chen et al, 1988 ; Suzuki et al, 1992). However, in a 
variety of smooth muscles, NO did cause hyperpolarization (Ito et al, 1978 ; 
Cheung & MacKay, 1985 ; Tare et al, 1990 ; Rae & Muir, 1993). Clearly the 
ability of NO to hyperpolarize is a tissue dependent effect. While it is
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impossible to discount the possibility that another mechanism may have been 
responsible for the nitrovasodilator-induced quiescence in RDC, the synergism 
observed between SNP and BRL 38227 suggests that hyperpolarization was 
probably involved.
Theoretically, excitation may be induced through the release of an 
excitatory neurotransmitter or through the antagonism of an inhibitory 
neurotransmitter. In RDC, it was considered that the increase in frequency 
following nitrovasodilator-induced quiescence could have been mediated 
through the release of ACh or through the inhibition of noradrenaline release. 
However, this was unlikely. Neither ACh, nor the adrenoceptor antagonists 
phentolamine and propranolol, together, mimicked the actions of the 
nitrovasodilators. In the presence of these compounds, although the frequency 
of electrical and mechanical activity was increased, activity was irregular and 
baseline tension often increased. Nitrovasodilators usually regulated activity 
and never raised the tone. Moreover, the effects of ACh, but not SNP, were 
inhibited by atropine. Rather than interfering with neurotransmitter release in 
RDC, nitrovasodilators were more likely to have acted on the pacemaker itself.
Similarly, in rat PV, the possibility that SNP acted through the release of 
noradrenaline to increase the frequency of activity was considered. In support, 
the SNP-induced increase in the frequency of the mechanical response was 
inhibited by phentolamine and propranolol, together, suggesting the 
involvement of adrenoceptors. To test this, noradrenaline overflow from the rat 
PV was studied by loading the nerves with [3H]-noradrenaline, mounting the 
tissue in the Golenhofen apparatus and analysing the overflow for radioactivity. 
The results obtained in response to SNP were in contrast to those expected in 
light of experiments in the presence of phentolamine and propranolol. SNP did 
not increase the overflow of [3H]-noradrenaline at any concentration 
(10_7-10'4M). In contrast, the indirect sympathomimetic, tyramine (10_5M),
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increased [3H]-noradrenaline overflow from rat PV. Thus, the effects of SNP 
in rat PV were unlikely to be mediated through the release of noradrenaline.
In RDC, the nitrovasodilator-induced reduction in contractile amplitude, 
that occurred concurrently with the increase in frequency, was apparently due 
to a reduction in the intracellular Ca++ concentration. The Ca++-channel 
agonist, BAY K 8644, reversed the SNP-induced reduction in amplitude until 
contractions exceeded controls. On those occasions when SNP evoked a rise in 
spike amplitude, this was overcome by the Ca++ channel agonist, BAY K 8644. 
Following SNP addition, the muscle cells apparently sensed the depletion of 
intracellular Ca++ levels and attempted to compensate by transporting more 
extracellular Ca++ across the membrane leading to an increased spike 
amplitude. BAY K 8644 would presumably increase Ca++ influx further and, 
as cytoplasmic Ca++ stores were replenished, enhance the amplitude of 
contraction and restore spike amplitude. When added in reverse order, i.e. 
BAY K 8644 before SNP, then SNP reversed the actions of the Ca++ channel 
agonist. BAY K 8644 alone raised the basal tension of RDC and caused both 
electrical and mechanical activity to become constant. SNP then relaxed the 
tissue, activity became burst-like and contractile amplitude was slightly smaller 
than in control. BAY K 8644 presumably evoked a Ca++ influx to elevate 
tension and cause continuous firing. SNP then lowered cytosolic Ca++ levels, 
possibly through an action of NO to raise cGMP levels, tension fell, and 
activity again became burst-like.
To test directly for an action of SNP on cytosolic C a ++ levels, the 
membrane permeant form of fura-2 was used to measure [C a ++]i in rat aortic 
vascular smooth muscle cells. There were disadvantages with the choice of 
cells. The aorta was not spontaneously active and SNP failed to have any 
effect on a stretch of aorta mounted under a tension of lg in the Golenhofen 
apparatus. On the other hand, since access was available to an established rat 
aortic vascular smooth muscle cell line and since SNP relaxed rat aorta when
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tone was raised (Lincoln, 1983 ; Taylor et al, 1988), it was decided to use these 
cells. It was anticipated that if  SNP reduced free cytosolic Ca++ levels in RDC, 
then it may also have done so in aortic cells. Unfortunately, this was not the 
case. In contrast to angiotensin II which raised [Ca++]j, SNP had no effect. At 
present, there is no way of telling if the ineffectiveness of SNP was specific to 
the aortic smooth muscle cells or if it was a more general phenomenon. 
However, since BAY K 8644 reversed SNP and vice versa, in RDC, it is likely 
that SNP lowered [Ca++]j, at least in this tissue. Perhaps then, this effect was 
restricted to spontaneously active smooth muscle or perhaps, as seems more 
likely, in rat aorta, SNP would only be seen to reduce this parameter following 
the application of a stimulus to first increase it. In support of this, 8-bromo 
cGMP lowered [Ca++]j in cultured aortic cells following prior depolarization 
with K+ (Cornwell & Lincoln, 1989) and SNP relaxed noradrenaline contracted 
rat aorta by a mechanism that probably involved Ca++ sequestration or binding 
(Lincoln, 1983).
Results from experiments in the presence of Hb, 8-bromo cGMP or 
K4Fe(CN)6, indicated that both the excitatory and inhibitory properties of the 
nitrovasodilators on spontaneous electrical and mechanical activity, whether in 
RDC or rat PV, involved the release of NO. On each tissue examined, both the 
excitatory and the inhibitory effects of SNP were inhibited by the NO binding
w / i i c k  Ca/\ a l 5 o  a s  a  S i r f k  fo r  iV» L a  c e l l u l a r  N o  C G r y g l e w i k i  e - t a l ,  W 2 ) .
substance, HbO This action was complicated somewhat in RDC, as Hb, itself, 
sometimes increased the frequency of spontaneous events, reduced the number 
of spikes/peaks per burst and the duration of electrical/mechanical responses ; 
effects normally associated with SNP. In the presence of Hb, SNP failed to 
either further increase frequency or reduce the amplitude of contraction. In rat 
P V, the effects of Hb on the SNP response were easier to observe as Hb, itself, 
did not alter the pattern of spontaneous activity. SNP was inactive in the 
presence of Hb, providing strong evidence that the actions of SNP, on 
spontaneously active smooth muscle, involved the release of NO from the SNP
82
molecule. This proposal was lent credence by the fact that K4Fe(CN)6, which 
is structurally similar to SNP but which does not release NO, had no effect on 
the spontaneous activity of either RDC or rat PV.
The NO so released from nitrovasodilators is believed to stimulate the haem 
centre of soluble guanylate cyclase to raise cGMP levels, lower the cytosolic 
Ca++ concentration and produce relaxation (Collins et al, 1986 ; Schini et al, 
1987 ; Gerzer et al, 1988 ; Bukoski et al, 1989). Thus, if  the SNP-induced 
excitation was mediated through NO release, analogues of cGMP would be 
expected to mimic these excitatory effects. This was the case in RDC, where 
the effects of SNP were similar to those of 8-bromo cGMP, indicating that the 
actions of SNP were probably mediated via a cGMP-dependent mechanism. In 
fact, in RDC, 8-bromo cGMP (10-4M) was actually more effective at increasing 
frequency and reducing contractile amplitude than an identical concentration of 
SNP ; in rat PV, 8-bromo cGMP was less effective. The contractile amplitude, 
number of spikes per burst of electrical activity and the duration of both 
electrical and mechanical events were each reduced significantly by 8-bromo 
cGMP in rat PV but, unlike SNP, this cyclic nucleotide derivative did not 
significantly increase the frequency of activity. This apparent ineffectiveness 
could signify that differences exist in the relative membrane permeabilities of 
the two tissues to 8-bromo cGMP or SNP. As SNP is believed to be activated 
intracellularly (Gryglewski et al, 1992), it should be ineffective unless it can 
freely permeate the membrane. Similarly, a rise in the intracellular 
concentration of cGMP mediates the response to NO. If 8-bromo cGMP was 
unable to freely permeate the membrane, then it too should be ineffective. As 
both SNP and 8-bromo cGMP were highly active in RDC, it is probable that 
both passed easily through the smooth muscle or pacemaker cell membrane. 
Due to its activity in rat PV, the same is most likely true for SNP in this tissue. 
However, 8-bromo cGMP did not enhance frequency in rat PV. Although the 
intracellular concentration of cyclic nucleotide attained was sufficient to reduce
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contractile amplitude, spikes per burst and electrical/mechanical duration, 
perhaps, due to a lower membrane permeability, it was insufficient to increase 
the frequency of activity.
Surprisingly, in rat PV, the nitrovasodilator-induced response also 
resembled that following adenylate cyclase activation. The frequency of 
activity was increased and the other parameters reduced by the activators of this 
enzyme, forskolin or isoprenaline (each > 10_8M). But, at higher doses 
(> 10_6M) the cAMP activator, forskolin, abolished all spontaneous responses. 
Similarly, in RDC, the (3-adrenoceptor agonist, isoprenaline, reduced the 
amplitude of contraction and the number of spikes per burst of electrical 
activity at low concentrations (< 10“7M) and abolished all activity at higher 
concentrations (4 x 10"7M). However, in RDC, the frequency of activity was 
not increased by isoprenaline. SNP abolished activity in neither RDC nor rat 
PV. Moreover, in the gastrointestinal smooth muscle, isoprenaline, unlike 
SNP, did not regulate pacemaker activity. Thus, although the effects of SNP 
and cAMP activation were similar, there were differences. It is therefore 
unlikely, on balance, that SNP was inducing cAMP activation sufficiently to 
explain its effects.
Despite increasing the frequency of activity in RDC and rat PV, SNP and, 
by implication NO, failed to raise tone. But, there is evidence from 
experiments in the carbachol-contracted RDC that NO, probably indirectly, 
caused rebound contraction. Thus, NO can apparently evoke both direct 
(increased frequency, spike amplitude of spontaneous activity) and indirect 
(rebound contraction) excitation. For instance, in this study, electrical 
stimulation of carbachol-contracted colonic smooth muscle evoked NANC 
nerve-mediated relaxations that were followed by rebound contractions. The 
relaxations were partially inhibited by the inhibitors of NO, Hb or L-NAME, 
while the rebounds were partially blocked by L-NAME and, occasionally, by 
Hb. Each response was mimicked by authentic NO ; the actions of which were
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blocked by Hb. This provided strong evidence that NO was at least partially 
responsible (20-30%) for both the inhibitory NANC nerve response and the 
rebound excitation, in RDC. However, the rebounds following NANC nerve 
stimulation were also partially blocked by the inhibitor of prostaglandin 
synthesis, indomethacin. Thus, in RDC, this excitatory phenomenon could 
have been due to an indirect action of NO on the smooth muscle, via the 
secondary release of prostaglandins. Similar mechanisms have been reported 
for NO-induced rebound contraction in taenia coli and proximal colon (Ward et 
al, 1992b). Moreover, in the oesophagus, SNP or NO induced a rebound 
contraction, via a cGMP-dependent pathway, that was inhibited by 
indomethacin (Saha et al, 1993). This rebound contraction of oesophagus in 
response to SNP was in contrast to the effect of SNP in RDC. This drug did 
not stimulate a rebound effect in the colon, possibly because the long-lasting 
relaxation to SNP would have masked the effects of any transient prostaglandin 
release. The identity of the other inhibitory transmitter(s) are at present 
unknown but, as neither ATP, VIP nor GABA produced relaxations which 
mimicked those in response to nerve stimulation none of these substances was 
likely to be involved.
From an examination of the actions of the nitrovasodilators on pacemaker 
activity, it was clear that these compounds differed in their ability both to 
enhance and to inhibit activity in the chosen tissues. The excitatory and 
inhibitory actions of SNP, on either tissue, were greater than those of the other 
compounds. Despite being highly active in RDC, IDN was without effect in rat 
PV. Conversely, GTN significantly affected more parameters in rat PV than in 
RDC, but did not appear to have an obviously dose-dependent effect. My 
results differed from those of Bray et al (1987) and Wylie (1988) in that, in my 
experiments, GTN did not increase the frequency of activity in the rat PV.
The fact that the effects of SNP were unmatched by GTN or IDN is in 
keeping with the finding that the biotransformation of SNP differs from that of
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the organic nitrates (Gryglewski et al, 1992). In vitro, at physiological pH, 
only small amounts of NO were released from SNP (Feelisch & Noack, 
1987b ; Gryglewski et al, 1989), yet this substance possessed potent 
vasorelaxant activity. Further, in the case of SNP, there was no correlation 
between formation of NO and soluble guanylate cyclase activation in vitro, as 
there was with the organic nitrates (Feelisch, 1991). These discrepancies were 
explained by the proposal of an intracellular site for the biotransformation of 
SNP (Gryglewski et al, 1992). The organic nitrates i.e. GTN, IDN were not 
activated at this site, but were effectively decomposed to release NO only when 
they came into contact with cysteine or N-acetylcysteine (Feelisch, 1991). 
Consequently, there should be less chance of the NO so released coming into 
contact with guanylate cyclase, perhaps making them less effective than SNP. 
However, since IDN, but not GTN, was active in the RDC, differences may 
exist between these two compounds themselves. Based upon stoichiometric 
principle, if  each nitrate grouping was acting independently of the other 
features of the molecule then IDN should release two molecules of NO and 
GTN should produce three molecules of NO, thus making GTN the more 
potent. Indeed, GTN has a greater vasodilator activity than IDN in the 
Lagendorff heart preparation (Noack, 1984). Similarly, an empirical parameter, 
F(5.8 A) - "the frequency with which the molecule can exist in a conformation 
wherein oxygen atoms in the nitrate group and any other oxygen atoms are 
separated by a distance of 5.8 A" - has recently been described (Tzeng & Fung, 
1992). This parameter reflects the probability that an organic nitrate will 
interact with its metabolizing enzyme, since this enzyme is believed to possess 
at least two attachment sites, separated by a distance of 5.8 A, which bind to 
the oxygen atoms in the organic nitrate (Tzeng & Fung, 1992). GTN, with an 
F(5.8 A) of 12, should be more potent than IDN, with a value of 7. Yet, in 
RDC, this was not the case. The reason for this discrepancy is unknown, but 
there are a number of possibilities. Firstly, if each nitrate grouping in the
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organic nitrate was not acting independently of the rest of the molecule, then 
the stoichiometric principle would not hold. Secondly, when a molecular 
model which was more accurate in measuring distances within cyclic 
compounds was used to calculate F(5.8 A), then IDN gave a value of 11 (Tzeng 
& Fung, 1992). The F(5.8 A) for GTN, which is not cyclic, was not calculated 
using this model but clearly the values obtained are dependent on the model 
used. Thirdly, assuming that the F(5.8 A) for GTN is, indeed, greater than that 
for IDN, it is possible that the metabolizing enzyme in RDC does not have 
active sites that are 5.8 A apart. The possibility that, in RDC, the discrepancy 
in the activities of GTN and IDN was due to migration of GTN into the plastic 
tubing of the apparatus (Cossum et al, 1978) resulting in concentration loss, 
was unlikely, since GTN had a greater effect than IDN in rat PV.
Differences also existed between the effects of IDN in the RDC and rat PV 
- IDN was without effect in rat PV - indicating that differences between 
gastrointestinal and vascular smooth muscles themselves may govern the effects 
of drugs. It is unclear whether the insensitivity of rat PV to IDN represents a 
difference, between the two tissues, in the sensitivity to NO or in the 
biotransformation of IDN to release NO. At first glance, it appears unlikely 
that the insensitivity of rat PV to IDN is due to an insensitivity to NO since 
SNP was actually more potent in rat PV than RDC. However, the efficacy i.e. 
the ability of SNP to produce the desired effect, was greater in RDC than in rat 
PV. It is possible, therefore, that the vascular smooth muscle is indeed less 
sensitive to these particular actions of NO.
Clearly, the smooth muscle response to the nitrovasodilators was species 
dependent. For example, SNP increased the frequency of pacemaker activity in 
the rat PV but, after a gradual decline in the frequency and amplitude of 
contraction, SNP (10_5M) abolished activity in the RPV. The precise reasons 
for this are unclear. Perhaps the pacemakers in RPV were less sensitive to the 
excitatory actions of SNP or perhaps SNP had a more potent cGMP stimulating
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action in RPV, leading to a greater reduction in cytosolic Ca++ levels and hence 
gradual abolition of activity.
The effects of SNP were also examined on non-spontaneously active 
smooth muscles to determine whether a pacemaker was necessary for excitation 
to occur. In this study, there was no evidence of nitrovasodilator-induced 
excitation in the non-spontaneously active rat anococcygeus or rabbit 
abdominal aorta. However, the use of intracellular recording techniques 
revealed that SNP, following an initial hyperpolarization, increased the 
frequency of spiking in guinea pig vas deferens (Rae, unpublished observation). 
Pacemaker activity such as that seen in RDC or rat PV does not appear, 
therefore, to be prerequisite for NO-induced excitation to occur, although the 
ability of the nitrovasodilators to produce this effect is likely to vary among 
tissues.
The actions of the nitrovasodilators on spontaneously active smooth muscle 
were both complex and at odds with those normally expected of smooth muscle 
relaxants. How were these effects mediated ? To complicate matters, 
examination of the results revealed a number of paradoxes. For example :
1) The Ca++-channel agonist, BAY K 8644, reversed the effects of SNP, and 
vice versa, in RDC, but use of the fluorescent Ca++-indicator, fura-2, yielded 
no evidence that SNP reduced [Ca++]j in rat aortic vascular smooth muscle 
cells.
2) Again in RDC, SNP was synergistic with the opener of ATP-dependent K+ 
channels, BRL 38227, but neither drug increased the efflux of the K+ marker, 
86Rb, from this tissue.
3) The a - and p-adrenergic antagonists, phentolamine and propranolol 
respectively, together, inhibited the mechanical effects of SNP on rat PV, but
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SNP did not enhance the overflow of [3H]-noradrenaline from the nerve 
terminals.
Despite these paradoxes, by making some simple assumptions, it was 
possible to predict a model to explain the effects of SNP on RDC. Although 
there were some differences between RDC and rat PV the responses were 
basically similar. There are, therefore, likely to be a number of similarities in 
the mechanisms underlying the actions of SNP in either tissue.
Immediately after drug addition, both electrical and mechanical activity 
were abolished. Although SNP failed to produce a measurable increase in 86Rb 
efflux as evidenced from measurements in the whole tissue, it is possible that 
the effect of the drug was directed to the pacemaker cells alone, leading to 
inhibition and quiescence. This pacemaker quiescence may have involved 
membrane hyperpolarization mediated by an enhanced efflux of K+ (86Rb) but, 
in the whole tissue, would have been of insufficient size to be detected by the 
techniques employed in this investigation. This possibility is supported by two 
observations : a) BRL 38227 and SNP were synergistic in RDC b) a 
mechanism such as this has been proposed to account for the dissociation 
between the relaxant and K+ channel opening potencies of BRL 134915 in 
guinea pig portal vein (Quast, 1987)
After the period of quiescence, a more coordinated form of rhythmic 
activity than in untreated tissues returned, usually in under 5 min This 
coordinated behaviour was indicative of a direct effect of this drug on the 
pacemakers. Each pacemaker now seemed to be firing in time with the others 
and each burst of electrical spiking and mechanical contraction was of uniform 
amplitude. SNP increased the frequency of electrical and mechanical activity 
and the amplitude of spontaneous contractions was reduced. The rise in 
frequency was not an effect of SNP on transmitter (i.e. ACh, noradrenaline) 
release, but was most likely due to a synchronizing action of NO on the
pacemaker. The decline in contractile amplitude was, however, unlikely to have 
been mediated through an action of SNP on the pacemaker. Early experiments 
suggested that this effect could have arisen simply from the inability of the 
muscle cell to provide enough Ca++ to cope with the increased pacemaker rate 
following SNP addition. But, further examination revealed that the amplitude 
o f contraction declined even when the increase in frequency was only slight. In 
this case, the muscle cell should not have been troubled to satisfy Ca++ 
demand. A more likely explanation for the effect of SNP on mechanical 
amplitude was that this drug acted on the smooth muscle cell to reduce 
cytosolic Ca++ levels (and hence contractile tension) via the NO mediated 
stimulation of soluble guanylate cyclase and elevation of cGMP levels (Collins 
et al, 1986 ; Schini et al, 1987 ; Bukoski et al, 1989). This explanation was 
supported by BAY K 8644 reversal of the effect of SNP.
Simultaneous with the aforementioned changes, the number of spikes/ 
peaks burst"1 and the duration of electrical/mechanical responses were each 
reduced. Like the increase in frequency, these effects were probably 
consequent to an action of SNP on the pacemaker. If SNP induced each 
pacemaker to fire simultaneously rather than fragmentedly, then the number of 
electrical spikes per burst would be reduced, since the number of membrane 
Ca++ channels opening in response to a single pacemaker depolarization would 
be increased. This in turn would lead to a reduction in the number of 
mechanical peaks per burst and in the duration of electrical/mechanical bursts. 
In the most susceptible tissues, the rise in frequency could even have 
contributed to the inhibition and uniformity of electrical and mechanical 
responses. If the pacemaker cells fired and repolarized at a sufficient rate, this 
would ensure that the contractile amplitude, number of spikes/peaks burst"1 and 
duration of electrical/mechanical bursts were all reduced. If every pacemaker 
depolarized simultaneously at regular, frequent intervals then the responses 
would be uniform (see Fig. 27).
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Rarely, a coordinated, increased amplitude of spiking and/or contraction 
occurred in response to SNP ; the latter only at low concentrations (10_6M). 
The increase in contractile amplitude at these low doses, like a number of the 
other effects of SNP, could be explained if  the primary action of SNP was on 
the pacemaker cells, to reset them to the same coordinated rhythm, so that they 
fired synchronously. At higher concentrations, contractile amplitude was 
always reduced indicating that SNP was now probably acting on guanylate 
cyclase to lower Ca++ levels. In most cases, the increase in spike amplitude 
occurred at the same time as the other nitrovasodilator-induced effects (i.e. 
increased frequency, reduced contractile amplitude) suggesting that this was 
also a result of pacemaker synchronization. Interestingly though, rarely, the 
increased spike amplitude was observed only after the other SNP-induced 
effects had occurred, suggesting that this excitation may, in fact, have been a 
consequence of the inhibitory response to SNP. For example, in receptive 
tissues, as cytosolic Ca++ levels fell, and a reduction in contractile amplitude 
occurred, a compensatory mechanism could have been activated, whereby the 
muscle itself tried to replenish Ca++ stores by transporting more extracellular 
Ca** across the membrane. Since electrical activity in RDC consisted of Ca++ 
spikes, this would lead to the enhanced spike amplitude observed. However, if  
[Ca++]i had been reduced sufficiently by SNP, then this mechanism would be 
unable to provide enough Ca++ to restore the contractile ability of the tissue to 
normal. This could explain why the spike amplitude was dramatically 
enhanced in some tissues (see Fig. 27) while the amplitude of spontaneous 
contraction was decreased.
Although the pattern of events in the rat PV was similar, there were 
exceptions. SNP never abolished activity, even for a short while, in rat PV. If 
SNP initiated pacemaker hyperpolarization in this tissue, it was of insufficient 
amplitude to prevent action potential conductance and induce quiescence. 
Also, phentolamine and propranolol, together, inhibited the actions of SNP on
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the mechanical activity of rat PV. The underlying mechanisms are unclear. 
SNP failed to enhance [3H]-noradrenaline overflow. Thus, it is unlikely that a 
presynaptic effect of the compound on transmitter release was operative in rat 
PV. In any case, a presynaptic modification of the noradrenaline release 
process is unlikely since, in RDC, the response to SNP was excitatory and that 
to noradrenaline is known to be inhibitory in the gut (Bumstock, 1979). 
Moreover, when longitudinal strips of RDC were incubated with phentolamine 
and propranolol, together, the resultant activity did not resemble that induced 
by SNP. The emphatic response following the addition of 8-bromo cGMP to 
RDC, in fact, indicated that the effects of nitrovasodilators were due to a direct 
action of NO on guanylate cyclase. In rat PV, it is more likely that the 
inhibition of SNP in the presence of phentolamine and propranolol was 
mediated at a postsynaptic locus, where these antagonists in some way 
modified the characteristic response to NO.
Care should be applied when selecting NO donors with which to examine 
the effects of NO. Evidently, these compounds possess a wide spectrum of 
activity and some drugs are considerably more effective than others. For 
instance, in RDC or rat PV, SNP was more effective than either of the organic 
nitrates tested. This may reflect the fact that SNP is likely to be activated 
differently from either GTN or IDN. In each of these tissues, SNP produced 
significant dose-dependent changes in every parameter of activity measured, 
with the exception of the maximum spike amplitude per burst of electrical 
activity, in RDC. Even then, this parameter was profoundly increased in a 
number of individual experiments. IDN was highly active in the RDC, but was 
inactive in the rat PV, while GTN, although mimicking the effects of SNP on a 
few occasions, was relatively inactive in either tissue. Since, SNP significantly 
increased the frequency of spontaneous electrical and mechanical activity in 
both tissues, this compound may not be the most suitable for investigation of
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the relaxant properties of nitrovasodilators, particularly in spontaneously active 
tissues.
Nitrovasodilators have, for some time, been used for their relaxant effects 
in the cardiovascular system in the treatment of angina pectoris, congestive 
heart failure and essential hypertension, or in the gastrointestinal system, in the 
treatment of achalasia. Excitation such as that observed in RDC or rat PV 
would clearly be an unwanted side effect. In this study, the organic nitrates 
produced less excitation than SNP in both cardiovascular and gastrointestinal 
tissues. Consequently, these drugs would appear to be more suited than SNP 
for the treatment of conditions where there main benefit arises from smooth 
muscle relaxation. However, in the RDC, although SNP produced a dramatic 
excitation of frequency this significant change generally occurred only at non- 
physiological concentrations (> 10_5M) and would be unlikely ever to be 
encountered in practice. But, at lower concentrations (10-6M), in certain 
experiments, SNP increased both the amplitude of spiking and contraction. 
Thus, in particularly sensitive tissues, the relaxant effects of SNP could quite 
possibly be compromised by any concomitant excitatory effects. Further work 
is required to fully elucidate the mechanisms underlying the effects of 
nitrovasodilators on spontaneously active smooth muscle and to determine 
whether the usefulness of compounds such as SNP in disease therapy, is indeed 
compromised by the effects of unwanted excitation.
Conclusions
This project was undertaken to examine the influence of nitrovasodilators 
.on spontaneously active smooth muscles ; namely the rabbit distal colon 
(RDC) and the rat portal vein (rat PV). The results indicated that the actions of 
these drugs were complex. Despite NO being involved in inhibitory NANC
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neurotransmission in a number of preparations (see Moncada et al, 1991b ; 
Rand, 1992 ; Sanders & Ward, 1992), including the RDC, nitrovasodilators 
both excited and inhibited spontaneously active smooth muscle. SNP was the 
most effective nitrovasodilator tested in either tissue confirming that this drug 
may be activated differently from the organic nitrates i.e. GTN, IDN.
Inhibition, in the RDC, appeared either as an abolition of rhythmic 
electrical and mechanical responses (quiescence) and/or as a reduction in the 
maximum contractile amplitude, number of spikes/peaks per burst and/or 
duration of electrical/mechanical responses. Quiescence was probably 
mediated by K+ efflux while the reduction in the amplitude of contraction was 
probably mediated through the lowering of [Ca++]j. The effects on the number 
of spikes/peaks per burst and/or duration of electrical/mechanical responses 
were possibly the result of a direct action of the nitrovasodilator on the 
pacemaker. Events in the rat PV were similar with the exception that no 
quiescence was ever induced.
Excitation, in either tissue, appeared as an increased frequency of spiking 
and contraction or, more rarely, as an increased amplitude of spiking and/or 
contraction. The increase in frequency was probably mediated by a direct 
action on the pacemaker cells whereby they were synchronized to fire 
simultaneously and more frequently. This would account for the enhanced 
amplitude of contraction in those cases where it occurred. The increase in 
spike amplitude may have been a reflex reaction as the tissue attempted to 
compensate for the reduction in intracellular Ca++ (which led to a decreased 
contractile amplitude), by transporting more Ca++ across the membrane. Both 
the inhibition and the excitation in response to nitrovasodilators were due to the 
release of NO.
These results confirmed earlier findings of nitrovasodilator-induced 
excitation in rat PV (Bray et al, 1987 ; Wylie, 1988), guinea pig ileum 
(Sugisawa et al, 1991) and rat ileum (Bartho et al, 1992). Similar effects have
a l s o  r e c e n t l y  b e e n  i d e n t i f i e d  i n  o u r  l a b  i n  t h e  n o n - s p o n t a n e o u s l y  a c t i v e  g u i n e a  
p i g  v a s  d e f e r e n s  ( R a e ,  u n p u b l i s h e d  o b s e r v a t i o n s ) .  I n t r a c e l l u l a r  e l e c t r i c a l  
r e c o r d i n g s  r e v e a l e d  t h a t  S N P  c a u s e d  a  s h o r t - l i v e d  h y p e r p o l a r i z a t i o n  f o l l o w e d  
b y  a  b u r s t  o f  i n c r e a s e d  s p i k i n g  -  a s  i n  R D C  ( i . e .  q u i e s c e n c e  f o l l o w e d  b y  
e n h a n c e d  a c t i v i t y ) .  P e r h a p s  t h e n ,  t h e s e  e x c i t a t o r y  r e s p o n s e s  a r e  m o r e  
u b i q u i t o u s  t h a n  w a s  f i r s t  i m a g i n e d .  T h e s e  r e s u l t s  s u g g e s t  t h a t  e n d o g e n o u s  N O ,  
l i k e  o t h e r  n e u r o t r a n s m i t t e r s  ( i . e .  A C h ,  n o r a d r e n a l i n e ) ,  m a y  p o s s e s s  b o t h  
i n h i b i t o r y  a n d  e x c i t a t o r y  p r o p e r t i e s .
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